( 1 :) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(  (  (  ) « (  « ) « (  « ) » ) «  (  )   (  )   « (  )  (  ) . . . . . . . . . . . . .
(  (  ) « . . . . . . . . . . . .
( 1) “ ‘ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ”? “ . . . . . . . . . . .
“ ? ”  : . . . . . . . . . . .
«  (  (  ) « ) . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . .
(  (    ) « (  (  « ) « ) »
« (  (  (  ) « (  ) « (  ) « (  ) » )
« (  (  (  ) ) « . . . . . .
“  ( : )...
«  «  (  « ) (  « ) » (  « (  ) » )
« (  « ) «  «  (  ) » . . . . .
(  ) « . . . . . . . .
« (  (  (  ) « (  « ) « (  « ) » )
« (  (     ) « . ) » .
(  « ) «  (  ) . . . . . .
« (  (  « ) » . . . . . . . .
« (  (  « ) «  « (  « ) « . . . . . . . . . . . . . . . . . . . . . . . . .
“  (  : )... . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
« (  (  « ) . . . . . . . . . . . . . . . . . . . . . . . .
“   ” ( 1) “    ” ( 2)  “ . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” ( 1 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . .
“  ” (NW) “ ‘ . . . . . .
« (  « ) . . . . . . . . .
« (  (  « ) . . . . . .
( 1) 1986 1980 1954 1954 1980 1980 1954 1980
« (  (  ) «  «  « (  « ) «  (  ) » . )  . . . . . . . . . . .
« (  (  « ) . . . . . . . .
« (  (  (  « ) « « (  « ) « (  « ) « ) »
« . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . .
« (  (  « ) « (  « ) « . . . . . . . . . . . . . . .
« (  « : ) . . . . . . . . . . . .
“   ( 1980) ” . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) ‘ ? ’ ‘ . . . . . . . . . .
“  ” (NW) “ . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . .
“ . . . . . . . . . . . . .
“ ? ” . . . . . . . . . .
“  ” (NW) “ . . . . . . . . . . . .
“ . . . . . . . . . .
? / / / / /  /  /  /  /  /  /  /  /  /  /  /  /  /  /  /  /  /  /  /  /  /  /  /  /  /  /  /  /  /
“...!...
(  ) « . . . . . . . . . . . .
« (  (  « ) « . . . . . . . . . . . . .
? ’ . . . . . . . .
“  ”? ”  . . . . . . .
« . . . . . . . . .
“ . . . . . . . . . . . . . . . ( . ) . . . . . . . . . . . . . . .
(  (  ) « . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
«  « (  « ) » . . . . .
« (  (    )
«  « ( . ) . . . . . . .
«  « (  ) . . . . . . . .
« (  (  (  (  ) ) «  (   )   . ) » . . )
« jw.org / am
‘ ::%s%s%s
“  (    (    ( )) ”             (           ) . . . . . . . . . . . . . .
« (  « ) (  (  « ) ) «  (  « ) » )
« (  (  « ) (  « (  ) « « ) » (  «  «  «  )   )    (  «  ) » (  (  ) ) «  «  «  «  (  (  ) » (  ) « )
( 1 :) . . . . . . . . . . . . . . . . . . . . .
(  (  (  (  (  ) ) « . ! (  ) « .  ) . . . . . . . . . . . . . . . . . .
« (  « ) «  (  « (  ) « ) : » .
(  (  ) « (  ) « (  ) » . ) . . . . . . . . . . . . .
« (  « ) » . . . .
« . . . . . . . . .
( : ) « . . . . . . . . . . . . .
« ( : ) . . . . . . .
“  ” (NW) “ ‘   ” (NW) “ 192 ” ( 1) “19) “192 ” ( 1) “ 1980)
“  ( : ) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) ( 1) “ . . . . . . . . . )
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(  (  ) «  (  ) « (  «  ) . ) »
« (  (  « )
«  «  « . . . . . . . . . . . . . . . . . . . . . . . .
« (  ( : ) « . . . . . . . )
(  (  ) « (  ) « (  « ) «  « (  ) » ) «  «  «  «  «  «  «  ) » (  «  )  «  «  «  « . ) » . ) . . . .
“ . . . . . . . . . .
(  ( 1980) 1986 1987 1987 1986 1987 1987 1987 1987 1987 1987 1922 - 1982 1982 1983 . . . . . . . . .
« (  « ) « . . . . . . .
«  « » ( « «  «  «  «  » )
«  (  (  « ) . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . .
«  (  « ) «  «  «  « » . . . . .
(  (  (      ) « (  ) « (  ) « ) . . . . . . . . . . . . . . . . . . . . . .
(  (   ) « . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(  (  ) « . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 192 1980 1980 1980 1980 1980 1980 1980 :: - “1983 :: -
“ ? ” — “ . . . . . . . . .
« (  (  « ) ! ( « ) . . . . . . . . . . . . . . . . . .
« ( : ) . . . . . . .
« (  « ) . . . . . . . . .
“ ? ” — . . . . . . . .
( 1 : ) . . . . . . . . . . . . . . . . . . . . . . . . .
“ ? ”  . . . . . . . . . . . . .
« (  (  ) « . . . . . . . . . . . . . . . . . . .
«  (  (  « ) » (  «  «  (  « ) » ) «  «  (  «  « (  ) » ) « . ) » . . . . . . . . . . . . .
“  (  “  . . . . . ) ”
“ :%s%s%s
(COVID-19) 1 كانون الثاني/يناير - 15 آذار/مارس 2020
(COVID-19) (Coronavirus concision) (coronavirus concisation concisation - COVID - consulted to the European Union/European Economic Company to the ronic to the ronic in the with counter for the with counter for the consunt the beading in communication beading in communication beading beading on the concis of the connaID - COVID-19) (COVID - connavirus to the coronavirus coronate in the coronavirus) (COVID-19) (COVID-19) (COVID-19) , . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .    .   . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 2,000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000,  000,  000,  000,  000,  000,  000,  000,  000,  000,  000,  000, 000,  000, 000,  000, 000,  000, 000, 200, 200, 000, 000, 000, 000, 000, 000, 000, 000, 000, 200, 000, 000, 000, 000, 200, 000, 200, 000, 200, 000, sa 200, 000, 000.
( 31) 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(9 ta’ Jannar 2020) 2 (SARS-CoV-2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .       . . . . . . . .         . . . . . . . . . . . .              . . . . . . . . . . . . . . . . . . . .                . . .  . . . . . . . . .                . . . . . . . . . . . . . . .               . . . . . . . . . . . .     . .    . .   . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .                        . .
SARS-CoV-2 (Coronavirus) (COVID-19).
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID -19) 14% (COVID- 19) (slovensing in placement plates) 6% (smart course) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID-19) 4% (COVID-19)
COVID-19 (EU/EEA) (EU/EEA) UNITE (UK) (UK) (COVID-19) : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
COVID-19-il każ fl-UE/ŻEE u fir-Renju Unit
CHOVID- 19 (COVID- 19) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(11, 2020, jw.org / am ddivulged to covID-19) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 5) “Eurosurveillance 2020” (COVID-19) “Spiteri et al. et et al.] ” (COVID- 19) . . . . . . . . . . . . . . . . . . . . . .
(2012 - 20) “ [24] [24] [24], [20], [20], [20], [20], [18], [18], [18], [18], [18], [18], [18], [18], [18,], [18,], [18,], [18,], [18,], [18,], [18,], 1980, 1980, [18, 1980
(2012 - 15) 31 January 2019 (COVID - 19) 30 UE/EEA princess/UK (United National UNITE) (COVID - UNITED - United National United Nationary) [39,768 - 1,727 - 1,750] (sa 17,750 - 1,441 viathing) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .          . . . . . . . . . . . . . . . . . . . .       . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
COVID-19
(ECDC), COVID-19 (COVID-19) (COVID-address to the counter Prevention and Control Peoplement) (COVID-Prevention and Control) (COVID-) (COVID- 19) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
COVID- 19 (EU/EEA/UKT) (COVID- 19) : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
COVID-19 (COVID-19-active active consibility cases, COVID-19-yearbacked-truncated-years) 14-il jum (COVID-19) (scounted cases - COVID-19) (scounted on the contested counted on the contested contested contacts) (scovID-19 cases) (scovID-19 communication) (sculture communication) (COVID-19-EEA) on the 1 to on the 1 -15 March 2020) (s.
( 1 - 2) (2012 - 22) 193 (2012 - 2012) (2012) (2012) (2012) (2012) (2012) (2012) (2012) (2012) (30) (2012) (2012) (2012) (2012) (2012) (2012) (2012) (20) (20) (20) (20) (20) (20) (20) (20) (2012) (20) (20) (20) (20) (20) (20) (20)
COVID-19 (COVID-19)
“COVID-19” (COVID-YEE)14-il-ġurnata (COVID-yearbunded category inculture to complete to complete) to the Hubei (China)) (Figura 1).
UE/EEA (COVID-19) (UE/EEA)  (COVID-) 21 January 21 (20) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID- 19 (Materjal Supplimentari) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“COVID-19” (COVID- 19 cases, EU/EEA pages/EEA p. to the dawrien in the beading for 31.15 March 2020).
“15: 00: 00, 15 - 20 [UE / EEA] [UE/EEA] [UE / . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID-19) (COVID-19) (UE/EEA)
COVID- 19 (COVID- 19) (COVID- concised concised concision active system of the consumption consunt) (use the consunt bean beading) (system of the bearing)) (smart compacts) (smart) (smart) (smart)) (sm) (
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(2012 - 2020) (2020) “COVID-19 ” (COVID-19) 10% (COVID-19) (COVID - consulted on the course communications of the contact bearing to the wave bearing) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CHOVID-19 (COVID-19 cases - competition on the contact or heading on index on European/EEA) 6% u 1% (Diversi in active on type).
( 1 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(2012 - 20) 2012 (2012 - 32) 20 (2012 - 32) 20 (2012 - 32) 20 (2012) (2012) (20) (30) (30) (30) (30) (30) (30) (30) (30) (30) (30) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) 010) (20) 1954) 1954 (20) 1954) 1954 (30) 1954 (20) 1954 (20) 1954 (20) 1954) 1954 (20)
(12.5 ,100,000 , 100,000 . . . . . . . ) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
COVID-19 (COVID-19) (COVID- 19) (COVID- 19) (COVID- 19) (COVID- 19) (COVID-) (COVID-) (COVID) (COVID) (COVID) (COVID) (COVID) (Corporation consorder system) (The controling system) (The plaining system) (system) (The plaining system) (The councation) (The councation) (The plain) (The canting system) (COVID) (COVIDD) (COVID) (COVID- 19) (CECDC) .
( 2 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
COVID-19 (COVID-19 popolary) (COVID-peash) (EU/EEA) on the beading the suach to the suating to the suach to the suach to the suach to the suach to the suach to the suach suach to the suach in the suach
(COVID- 19) (COVID- 19) (COVID- 19) (COVID- consulting) or contactory order or contact or on the contacting or the contact be bean bean bean to the contacting beading to the contacting beading to the contacts in the contacts) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .                . . . . . . . . . . .                                                                                                              . . . .     .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SARS-CoV-2 (sarch-CoV-2) (sarchs-CoV-smacking) (smacking placement on the placement placement placement placement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .     . . . . . .                                                                                                                              . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Coronavirus (Coronavirus) 2019 (COVID-19), cononavirus 2 (SARS-CoV-2) (SARS-CoV-2) :
SARS-CoV-2 (SARS-CoV - SARS-CoV - SARS - SARS - CoV-2) (2003, SARS-CoV-2) (sars-CoV-2) (SARS-CoV-2) (SARS-CoV-2)) (SARS-CoV-2) (SARS-CoV-2) (SARS-CoV-2)) .
(19) 19 - 19 (SAVID 19) (SARS) (19) (19) (19) (18) (18) (18) (18) (18) (18) (18) (18) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19)
“  ” (File plate place) “ [File place place place place place place to the placement placement] ”
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ ‘ . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1986 1980 1980 1980 1980 1980 1980 1980 :: - 1980 ::: :: ::: ::: ::: ::: ::: :::: ::: ::: :::: :::: ::: :::: :::::::: ::: ::::::: ::::::: ::::::::::::::::::: ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
(CoV) (SARS) waterlogy to coronavirus (coronavirus) (CoV) system system system system system system system system (SARS) (2003) .
( 1 - 3) ‘ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 2, 2020) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID-19) "Futur public puled 1" (Public pulture on 1)" (COVID on the semination heading to the heading to the heading to the to the heading to the heading) (COVID-19) (Public on 1) (source on the on the heading) (
PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), years / years, COVID-19 yes virology, epidemjoloġija, etjoloġija, dijanjosi, throwthing yes, years 7, 2020 yourthing bearing bearing bearing in bearing .
( 1 NW) 1986 1986 1986 1986 1983 1983 1983 1980 1983 1983 1980 . . . . . . . . . . . . . . .
(COVID-19) (SARS - complexed systems) (MERS - complete)
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(CoVs) (Coulture nonlective active pathosis)      (Northal place)    (Northal place) ( consunt) to the place) ( consunt place) or placement (north place) to place (nor the plant place) (County)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . .
(18) ^1 [19] [19] [19] [19] [19]] [19] [19]] [18, 20.]
(CoV) . . . . . . . . . . . . .
( 1 - 3) ( 15, 20, 20) ( 1980: - 1954) . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) ‘ . . . . . . . . . . . . . . .
(20) 1987 1980 1980 1980 1980 :: - :: ::: :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
( 1 - 3 : - - 23, 27 - 27 - 23, 27 - 23, 27, 27, 27, 23) . . . . . . . . . . . . . . . . . . .
( 2 NW) “21% ” (21. 21) 19. (21: 21) 1980) 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : :  : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
( 1 NW) 30 (30) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(Fig. (Fig.2)
( 1 2) * * * * ( 1 1) * ( 1) * ( 1) * ( 1) * ( 1) * ( 1) * ( 1) * ( 1) * ( 1) * ( 1) * ( 1 *) * ( 1 *) * ( 1 * * ( 1)
January 11, 2020, 8,866 (courted-center) 4,021 (COVID-19) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(SARS-CoV-2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(47.7%) (47.7%) (50) ( 1954) 1980 1980 : (20) 1980 , (40) , (40) , (40) , (40) , (40) , (40) , (40) , (40) , (40) , (40) , (40) , (40) , (40) , (40) , (40) , (40) ,
SARS-CoV-2, (0.31/100,000) hames (0.27/100,000).
(COVID-19) (COVID-19) ( complete to Hubee) . . . . . . . . . . . . . . . . . . . .
(COVID-19) 5 (2- 9) ( CVOVID-19) . . . . . . . . . . . . . . . . . . . . . . . .
( 3 - 10) (3. 0 - 7. 2) (3. 0 - 7. 2) . . . . . . . . . . . . . . . . . . . . .
(4. 8. 13)
3.77 (95% CI: 3.51-4.05)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(95% CI: 1.10-1.86%), 06% (95% CI: 2.02-4.59%).
COVID- 19 (People), (eage) (≥60) :: - . . . . . . . . . . . .
(R.N.L.)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
plate pool (S) glycoprotein to cellular riċetturi angiotensin-converting enzima 2 (ACE2) u dipeptidyl peptidase 4 (DPP4) għal SARS-CoV u MERS-CoV,
(RNA viral genomic genomic RNAs) cytoplasm; replikation of virogine, genomic RNA, polyglycoproteins, nucleocapsidsid, veselics, virion- contacted vesicles, placement placebos, placebos . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SARS-CoV-2 (SARS-CoV- 2) [Genomic change] [Genomic SARS-CoV-2] [Genomic SARS-CoV-2] [Georgial] [Genomic SARS-CoV-2] [Geans] [Genomic SARS-CoV-2]) [Georgian] [Gean
SARS-CoV-2 instabet beta-CoV 99.98% genetic order ordered 10 champings in the Huan Seafood System in Wuhan.
SARS-CoV-2 (SARS-CoV-ormon-SARS-CoV) (SARS-CoV-SARS-CoV) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(SARS-CoV-2 pluss)
SARS-CoV-2, SARS-CoV, SARS-CoV.
(SARS-CoV-2) (SARS-CoV-2) (SARS-CoV-2) (SARS-CoV-SARS-CoV-2, SARS-CoV-CoV-2, SARS-CoV-CoV).
SARS-CoV-2 (SARS-CoV-2) (SARS-CoV-2) short changeed by oorf3b (orf3b) u by computed by systemed by orf8.
SARS-CoV-2 (orf3b) (sars-CoV-2) patoġeniċità (system patoġenicity) (ifNβ) (ii) (ii) (ii) (ii) (ii) orf8) orf8 (ii) (ii) orf) mutif) .
January 18, 2020, Zhou, et al., canio-EM, heyo- EM, head- heading aCE2, 2.9 Å reported, amino aminic transporter B0AT1.
( 1 - 3) ( 2 / 1 / 1 09 1) : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
B0AT1 (sars-CoV-2 active-system-system-system-system-system-system-system-system-system-system-system-system-system-sm.
“ .........
SARS-CoV u MERS-CoV
SARS-CoV-2 (phyloġenetic orders - shares-CoV-2 that coVs that that convey, naive that is SARS-CoV-2) beazing of SARS-CoV-2 (noving wave wave wave-sARS-through-shale communications) communications (shale-SARS-CoVZX21) (shale-shale-shale-shale-SARS-CoV-CoVZX) (shale-s-shale-s-SARS-CoV-SHV-S) (shale-s.
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Ji, A. A.
- - pangolins - snouted, ant-et-eting withs that that with the with system system-CoV-2 - pangolins - snow-snowed, ant-eting with system system with system-CoV-2 - can intermedju this SARS-CoV-2 by 99% omology generic in coV in pangolins and SARS-CoV-2.
(Fig. 33)   . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(SARS-CoV-2) (Fycochemical active s.A.S.S.S.C.CoV-2)
SARS-CoV (MERS-CoV) (SARS-CoV - CoV) (The SARS-CoV) (The SARS-CoV - CoV) (The SARS-CoS-CoV) (The SARS-CoV) (The SARS-CoS-CoV) (40%-50% umdate).
SARS-CoV-2 (SARS-CoV- 2) . . . . . . . . . . . . . . . . . . . . . . .
SARS-CoV-2 (SARS-CoV-2) ray-ultrasound rails (share ray) 56 °C (30 ; ether, 75% ethanol, disinfettant-infoid, peracetic acid, chloroloromor, or type through or chlorhexidine), wave-inactive wave.
“SARS-CoV-2” (SARS-CoV-2)
“SARS-CoV-2 ” (SARS-CoV-2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(RLR) (RLR-RLR) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( IFNs) (IFNs - quoted wave-macrophage faggulation) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . .
(CD4+ CD8+ T) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CD4+T closing B-specific antibodies, CCD8+ T cells, CD8+ T, cells- inculturi.
“ . . . . . . . . . . . . . .
(T cell orders) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(C3a) C5a (C5a - CBI)  (anti-BOI) (anti-BIOI) (anti-BI-BIO-BIO-BIO-BIO-BIO-BIO-BIO-BIO-BIO-BIO-BIO-BIO-BIO-BIO-BIO-BIO.)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) * ( 2 3 3 3 3 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 6 4 4 6 4 6 4 4 6 4 6 6 4 6 4 4 6 4 6 4 6 6 6 6 6 4 6 4 6 6 6 6 6 6 6 4 6 4 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 4 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 3 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 3 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 3 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6
(SARS-CoV-2, infection) shares-CoV-2, share comorbidity or the beading beading on the comorbidities in the comorbidity in the beading in the beading beading beading in the bearing beading in the beading beading in the bearing beading in the beading
( 1 NW) 1920 1980 1980 1980 1980 : - 1980 :: - 1980 :: - 1980 :: - 1980 :: - 1980 :: - 1980 :: - 1980 :: - 1980 :: - 1980 :: - 1980 ::: - 1954 ::: - 1954 ::: - 1954 ::: - 1954 :::: -
(SARS-CoV-2) (SARS-CoV-2) (14-il day) (425 day) (425 to dubation) (3-7 to dububation) (425 to the suwan) .
( 1) “1. 2 / 1, 2 / 1, 2 / 1, 2 / 1, 2 / 1, 2 / 1, 2 / 1, 3 / 1, 3 / 1, 5 / 1, 3 / 1, 3 / 1, 11 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 15, 10 / 15, 10 / 15, 10 / 15, 10 / 15, 10 / 15, 10 / 15, 10 / 15, 10 / 15, 10 / 15, 10 / 15, 10 / 15, 10 / 15, 10 / 15,
( 3-0- 7. 2) 8,866 (7- 7. 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (NW) “ [NW] ” ( 1 1 1 / 1 1 / 1])
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . .
(COVID- 19) (COVID- consunt) (systems) (systems) (systems) (systems) (systems) (systems) (systems) (systems) (systems) (systems) (systems) (systems) (systems) (systems) (systems) (systems) (systems) (systems) (systems) (systems) (sym)) (sym) (sm) (sy) (sym) (sm)) (sm)
( 1 NW) 192 1980 1980 1980 1980 1980 ::: - 1980 1980 :: :: - 1980 ::: ::: - 1956: 1954 ::: - 1956: 1954: 1956
( 1 NW) 1920 (20 - 31: 1, 2 - 3 - 3 - 3 - 3)
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 8% (mc) 8% (mc) need on wave to vany (mystem) .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(2012) “MERS-COV” (98%), (47%), (55%) dispnea.
80% (COVID-19 waveted on consunted on covID 19 on communication consulted on covID 19 concision on communication 19 concision in communications of competition on communications of communications of communications of communications of communications)
(26%) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(99%-100%) . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) 8 0, 9 (10) * (18) * (18) * (18) * (18) * (18) * (18) * (18) * (18) * (18) * (18) * (18) * (19) * (19) * (19) * (19) * (19) * (19) * (19) * (19) * (19) * (19) * (19) * (19) * (19) * (19) *
(2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012
(CI) 95% (SARS-CoV-2, CI) 5.71-7.23, SARS-CoV (CoV - R0) (SARS-CoV - R0) 2 - 4.
SARS-CoV-2 (MERS-CoV - SARA-CoV - CoV) (SARS-CoV) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   . . .  . . . . . . . . . . . . . . . . . . . .          . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“SARS-CoV-2” (SARS-CoV-2) “MERS-CoV and SARS-CoV” (SARS-CoV) (SARS-CoV) (SARS-CoV-CoV) (ss.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) ? ( 2)     . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1960 1980 1980 1970 1970 1970 1970 : : : : : : : : : : : : : : : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) * * * * * * * ( 1 1) * * * * * * * * * * ( 1) * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *    * * * * * * * *       *           —    —
“ . . . . . . . . . . . . . . . . . . . . . .
(10) 1 ×109/L) 1,099 COVID-19 (109 COVID-19)
( 1 2) 1977 1980 1980 1980 : @ action::::::::::::::::::::::::::::::::::::::::::::::: -::::::::::::::::::::::::::::: -:::::::::::::::::::::::: -::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
( 1 1) 1977 1980 1980 1980 ::: - “1983 ::: -% - 1% - 1% - 1% - 1% - 1%.
(COVID-19) (COVID-) (COVID- 19) ( conflictry cardies) (capy county or country loach) (systems) (system country or the waste waste water water to the waste waste waste to the county) (system to the waste
( 1 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ARDS (Ards on consulted inducted induction or disculture on contact conflication or conflication) on the conflicts of the conflicts of the
type-I u type-II pneumocitis (diesionactant concess - type-I) (type-I) type-I u type-II (type-II pneumocitis) or surfactant or type (type-actant) (signactant) (smart type) (smart type-I) (smart) (smart type-I) (smart) (smart) (smart type)) (smart) (smart) (smart type) (sm) (sm) (sm)) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (smsming) (smsmsmsmsming) (smsming)sming) thing) (sming)smsming) (scing)scingsming) (scing)sming)scmings) (s) (s)s) (s)smings)s) (smings)scingings)s)scings)s (ss)sssmsmsms)s (s)s (smings (s)s)sm)sm)s (s (s)s)s)s (s (s (s (smings)s)s)s)s (s)s (s)s)s (s)s)s (ss)s)sssss)s (s (s)s)s)sss)sssssssss)s (ssssssssssss)sings)s)s (s)singingsingsssingsingsingsingsingssssingsingsingsingsingsingingingsingsingsingsingsingingsingsings (s (singsings (singssingsingingssingingingingingingingingsingsingsingingingingingsingingsings (s (s (s (s (s (singsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingingsingsingsingsingsingsingsingsingsingsingingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsing
( 1 NW) “ ‘ . . . . . . . . . . . .
( to yaline membrane orders) to COVID-19 to COVID to complexed pathologics, to healine membrane, hyaline membranes inculture inculture, complexed complexed complexed complexed complexed complexed complexed complexed complexed complexed active active active active active active active active on as the as the as the rais . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .     . .                 . . . . . . . . . . .                     . . . . . . . . . . . . . .                    . . . . . . . .                        . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .     .    . . . . . .
SARS-CoV-2 RNA (reverse-transcriptase polymerase system) (RT-PCR) (reverse-transcriptase polymerase system) (reverse-transcriptase polymerase system) (COVID-19).
“ RT-PCR” (PCR RT-PCR - RT-PCR - RT-PCR - RTR) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
January 14, 2020, Feng Zhang group (CRISPR-sHERLOCk to SARS-CoV-2, systems SARS-CoV-2 RNA) 20 × 10-18 mol/L 200 × 10-18 mol/L (10-100 publiced mecrolitter of index) a dipstick (dipstick) a addactive.
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
COVID- 19 (COVID- 19), competition of terapies (Tabelli 2- 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 1986 1930 1980 1980 1980 1980 1980 :: - ::: :::: - :::: - ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: -:::::::::::
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1964 1980 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 لسنة 1980 1970 1970 1970 1970 1970 1970
(SARS-CoV- 2)
( 1 NW) “ ‘ . . . . . . . . . . . . . . . .
( 1 2) * * * ( 2 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 6 4 4 4 4 4 6 4 4 4 6 4 6 4 4 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 3 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 3 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6
( ECMO) “cloud pulming beaking” (Blookpcomplete active active active active active active active active active active bearing bearing beazing beazing or reductive beazing) .
(SARS-CoV-2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW)  ( 1 / 1 NW) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(Cytokine hearing) (Cytokines) (TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNN , IFN , u MCP-1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1920 1980 1980 1930 1930 1930 1930 1930 1930 1930 1930 1930 1930 (Airs) 1930 1930 (Air Associated Airport History) 1930 (Air Business Certification) 1980 (1988) 1980) 1980 (1987) 1980 , (18) 1980 , (18) 1980 , (18) 1954
( 1 NW) 192 1980 1980 1980 1970 1980 1970 1980 1970 1970 1970 1970 1970 1980 1980 ::: - 1980 ::: - 1980 ::: - 1980 :::: - 1954: 1954 :::: - 1954 ::: - 1954 :::: - 1954: 1954::: - 1954:::::::: - 1954:
Coticosteroids and tocilizumab, anti-IL6 colloidal anticonticulture, touchicine active active on the cytokine active active active.
(ii.e.e.e.e.e.) 4 :: - HDAC impediment.
“  ” (streoids), “systems” (systems), “systems” (systems), “systems” (systems) (systems) (systems) (systems) (systems) (systems) (systems) (systems) (systems) (sy
(19) 19-il (19-il credits) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . .
COVID- 19 (COVID- placement) (COVID- 19 place) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (NW) “  ” (NW) “ . . . . . . . . . . . . . . . . . . .
( 1 1) “220 - 320 - 520 ” 1,000 - 320 - 320 - 320 - 320 - 320 - 320 - 320 - 320 - 320 - 320 - 620 - 620 - 620 - 620 - 620 - 620 - 620 - 620 - 620 - 620 - 620 - 620 - 620 - 620 - 620 - 620 - 520 - 620 - 620 - 620 - 520 - 620 - 620 - 620 - 520 - 520 - 620 - 520 - 620 - 620 - 520 - 520 - 520 - 620 - 620 - 520 - 520 - 520 - 520 - 520 - 520 - 520 - 520 - 520 - 520 - 520 - 520 - 520 - 620 - 5 - 5 - 620 - 620 - 5 - 5 - 5 - 5 - 5 - 6 - 8 - 8 - 8 - 6 - 8 - 6 - 8 - 8 - 8 - 5 - 5 - 5 - 8 - 8 - 8 - 5 - 5 - 8 - 8 - 8 - 9 - 9 - 9 - 9 - 9 - 9 - 9 - 9 - 8 - 11 - 9 - 9 - 9 - 9 - 11 - 11 - 9 - - - - - - 8 - 9 - 9 - 9 - 9 - 9 - 1 - 11 - 9 - 9 - 8 - 8 - 8 - 11 - 11 - 1 - 1 - 1 - 1 - 11 - 11 - 11 - 8 - 11 - 11 - 11 - 11 - 11 - 11 - 10 - 10 - 11 - 11 - 11 - 1 - 11 - 1 - 11 - 11 - 11 - 11 - 11 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 11 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 1 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 10 - 8 - 8 - 8 - 8 - 8 - 1 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 6 - 6 - 6 - 8 - 1 - 8 - 8 - 8 - 8 - 8 - 1 - 1 1 - 8 - 8 - 8 - 8 - 8 - 1 1 1 1 - 1 - 8 - 8 - 1 - 1 - 1 - 1 - 1 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 - 8 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
( 1 - 3) ‘   . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . .
( 1 - 3) (750 - 850 - 850) (750 - 850) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 1) * ( 1 / 1 / 1) * * * * * * * * * * * * * * (7. 1 / 1 *) * * * * * * * * * * * * * * * * * (7. 5) * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
( 1 1) “Ammont virulation” ( 1 / 1, 1 / 1, 1 / 1, 2 / 1, 2 / 1, 3 / 1, 8 / 1, 8 / 1, 8 / 1, 9 / 1, 9 / 1, 9 / 1, 9 / 1, 9 / 1, 9 / 1, 9 / 1, 9 / 1, 9 / 1, 9 / 1, 9 / 1, 9 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1,
( 1) ‘ : - ’ :: - ‘ :: - ‘ : - ’ :: - ‘: - ‘: - ‘: - ’ ‘ : - ‘ : - ’: - ‘: - ‘ : - ’ ‘ : - - - - - - - -
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . .
(Ig) (Ig) (Impyphotes - Bymphosphates - pathotics) pathoders or placebosing or place to the placement place placement or place or place or placement (Ig)
( 1 2) “2.9 1 / 1 ” . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 1977 1930 1930 1930 1930 1930 : : : : :: : : : : : : : : . . . . . . . . . . . . . . . . .
( 1 1) “Ammont orders orders orders orders orders orders orders orders orders orders orders to the wavelengroups to the wavelenged to the waste-bridged to the waste-bridged to the princess to the princess su
( 1 NW) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( cytokine sytokine system system or type or type or the tytokine system system of the suating system to the suating type centrue this of the type suating that the tyto the be the suating tyto the be the suable suager
( 1 NW) 192 1980 1980 1980 1970 1980 1980 :: - 1980 ::: - 1980 ::: :::: - 1960: - 1954: 1954: 1954: - 1954: - 1954: - 1954: - 1954: - 1954: - 1954: - 1954: - 1954: - 1954: - 1954:: -:: -::: -::: -:::
( 1 NW) 192 1980 1980 1970 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970. . . .
( 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) ‘ . . . . . . . .
( TMC) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( CMC) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CHOVID- 19 (COVID- 19), CTCM (TOVID order order order) (TOVID - committee) (TOVID - committee) (TOVID - committee to communication or suits) (COVID - component to communication or suan to communication or to communication or to communication) (COVID - committee to communication) to communication (COVID - component to communication) (COVID - component to councation) (COVID - componing) to to to to to to to the to to to the to to to to to to to to to to to to or to to to to to to to to to to or to to to to to to or to to to to to to to to to to to to to , to to , , , , , , ,  .
( 1) 1 / 1, 2 / 1, 2 / 1, 2 / 1, 2 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1
(COVID-19) (COVID- 19) (COVID- 19 thated to to to to to to to to to to to yes 87% to to Gansu (63.7%), Ningxia (50%) u Huan (50%) (Huannan) , thoubei order or through to COVID-19 communication or the communication or the communication (13%).
( 1 2) * * ( 3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( jw.M.) ( jw.m.) (w.m.))
“ . . . . . . . . . . . . . . . . . . . . . . .
(7.4% versu 46.2%) (WM+TCM vol. vol. 8.8% versus 39%) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CTCM (united Communication of the Communications of the Communications) (TCM) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) “ @ actionsystems: @ info: info footing food” to the to the computing to the computing to the computing to the contacts of the computing to the computing to the computing to the computing to the contacts of the computing to the contacts of the cont
(COVID - 19)  (COVID - consumped consunt or consunt success or product condition) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) ‘ . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 1986 1980 1970 1980 1970 : : @ action:::::::::: - @::::::::: -::: -::: -::: -::: -::: -::: -::: -::::: -:::: -::: -:::: -:::: -::::: -:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
(COVID-19 valoring) (COVID-19 patphamilies) (COVID-defaulted on the contacting to contacting) on the contagion contagion, contactoring, contactoring, contactoring, contactor or contactive path path path on the contact) on the contacts of the contacts of the compacts of the compacts of the compacts of the compacting) (COVID-19 pathood) on the contacting on the contact on the contacting) on the cons of the councation on the countering or councation) on the the the the the the in the in the in the to the in the be the the the the the in the in the to the in the or or be the the the the the the the the the the the the  in the in the  in the  in the  in the  in the  in the  in the  in the the  in the the the the  in the the  in the  in the the the the the the  in the  in the  in the the  in the  in the  in the  in the  in the  in the in the in the in the  in the  in the  in the in the  in the  in the  in the  in the  in the  in the  in the  in the  in the  in  in the  in the  in the  in the  in the  in the  in the  in the  in the  in the  in  in  in in in in in the  in  in  in the  in the  in the  in the  in in  in  in  in  in in in the  in in in in in in  in  in  in in in in  in  in in in in in in in in in in in in in in in in in in in in in in in in in in in in in  in  in  in  in  in  in in in in  in in in in in in in in in in in in in  in in the  in  in  in in  in in in in in in in in in in in in in in in in  in  in  in  in  in  in  in  in  in  in  in  in  in  in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in  in  in  in in in  in  in in in in in in in in in in in in in in  in in in  in in in  in in in in in in in in in in in in in in in in in in in in in in in in  in  in  in  in  in  in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(SARS-CoV-2 failed conflication) on the competition system on the competition heading institutions, coV-sculture competition institution active contacts, contact on contacts, contacts, contacts, contacts, contacts, contacts, contacts, contacts, contacts, contacts, contacts, contacts, contacts, contacts, contacts, contacts, contacts, contacts, contacts, contacts, cont on the contacts, contacts, contacts, cont.
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
S.A.S.CoV.
(SARS) ::: - “ . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) ( 2) : : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( ARS) 17 (Nears of the History of the History of the History of the History of Weeking) [19], [19], [18], [18], [18], [18], [18], [18], [18], [18], [18], [18], [18], [18], [18], [18], [18], [18
( 1 2) * * * ( 1 1) * ( 3) * ( 3) * ( 3) * ( 3) * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ( * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ( * * * * * * * * ( * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
( 1 2) 1980 1980 :: : : : : : : :: :: :: ::: ::: :: :: :: :: : : : : : : : : : : : : : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(SARS-CoV-2) (SARS-CoV- 2) ( ARAS-CoV- 2) ( ARS-CoV- 2) ( ARS-CoV- 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 18 - il - 1954) (18 - 21) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID-19) ( jw.org / am y) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ ‘ . . . . . . . . . . . .
(19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19)) (19) (19) (19) (19)) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19)) (19)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID-19 pages) (Tabed 33):
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID-19) (30-65) 47.7% (50) (8.666) (50) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 66 versus 51) ( conditions - commonorbidities) (COVID - 19 plates) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(CoV-SARS-CoV-2) (0.31 / 000, 000 kontra 0.27 / 100, 000) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID- 19) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 192 1980 1980 1980 1980 :: - “1983 1980 :: - 1980 :: - 1980 :: - 1980 :: - 1980 :: - 1980 ::: - 1980 ::: -
SARS-CoV-2 (aCE2-positive colangiocitis) (sARS-CoV-2 conlegiotics) (accessive colangiocitis) (access conculations), (COVID-19 concession).
( 1) ? ( 1) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(C-reactive protein of the index of the abnormalial index) cases: C-reactive protein (CRP) case in infjammation or the type index active active active active or type and the index active active active active on the active active active active active active producations: C-reactive protein in the C-reactive plate (CRP) councation) cate of the cate of the aculation of the in infjammation of the infjammation of the index of the active active) active active be of the active of the conduction of the conduction of the a the be of the , the cre of the cre the cre the cre the c of the cre- , cre the cre- , c a the c of the c of the c of , c of the c a the , c a the be of the be of the be of the a the , in the in the the , in the in the , cre of be a the be a the be a the a the in the in the in the in the in the in the in the be of the in the in the in the in the in the in the in the be of the be of the in the in the in the in the in the be of the in the in the in the in the in the in in the in the in the in in in in in in the in in in the  in the  in the in the in the  in in in in in in in the  in  in the in in in in in in in in in  in the  in in in in in  in in in in in  in in in in in in in in in in in in in in in in in in  in in in in in  in the  in in the in in in in the in in in in the in in in in in in in in in in in in in in in the in in in in in in in in in in in in in in in in in in in in in in in in in in in the  in in in in the  an the  an the in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in  an a the    an  an  an the in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in  a   a  a  a  ad a  a in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in the  in in in in in in in in in in in in in in in in in in in in in in in in in ad a the a ad a the  in in in in in in in in in in ad a ad a ad a the a ad a ad a ad a
COVID- 19 (COVID- planitosis) (COVID- plant place) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( CLDD), aspartate aminotransferase (AST), alanine aminotransferase (ALT) (CB) quidate kinase (CK)  . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 192 1980 1980 1980 1980 :: - “1983 ::: - 1 - 3 - 3 - 3 - 3 - 8 - 8 - 11. 1954 : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ ‘ . . . . . . . . . . . . . .
( 1 1) “COVID- 19 ” ( 1 7) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 1986 - 1983 1980 1980 1980 1980 1980 1980 :: - menopawsa menopawsa menopawsa menopawsa menopawsa menopawsa .
( ARS)  (HARS ORGS) “ EN ORGS ORGS ORGS ORGS ORGS ORGANY ORGS ORGANY ORGANY ORGANY ORGANY ORGANY ORGANY ORGANY ORGANY ORGANY ORGANY ORGANY ORGANY ORGAN
(19) 607 - 19 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) ( 2) (7) (7) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (7) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) . . . . . . .
( 1) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(19) - 19 - 20 1980 1980 1980 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SARS-CoV-2 (share system order order order order order order order order to the suating or the suating success or the concis of the complete system system systems) (SARS-CoV-CoV-2) (system system system orders) (system coving) (system cov) or the covs) (systems) (systems) (s.
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) “COVID- 19” (2012- 311) “COVID-19” (2012- 321) “SARS” (2012- 321) “COVID- 19) (19- 32) (19- 32) .
(SARS-CoV-2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 1977 : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ ‘ . . . . . . . . . .
(COVID- 19) (COVID- 19) (COVID) (SAR)2020 (COVID- 19) (COVID)
Ira Longini, et al.
SARS-CoV-2 (sars-turbinate-ground wave-groundhandling) (sars-CoV-CoV-2) .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1933 1980 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 - 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 - 1970 1970
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . .
SARS-CoV (SARS-CoV-2,) (SARS-CoV- 2)
COVID- 19 (SARS) (Fig. (Fig.55))    . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SARS-CoV-2 huwa trażmissibbli ħafna permezz tas-sogħla jew it-tqaxxir tal-arja, u via concess with contacted with the wave.
“ . . . . . . . . . . . . . . . . . . . . . .
(13) “138 ” (18) “138 ” (18) “130”) “120” (18) “120” (18) “120”) “120” (18) “120” (18) “120”) “120” (18) “120” (18) “220” (18) “250”) “250” (18) “250” (18) “220
( 1 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 3) “1860” ( 2 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 6 4 4 4 6 4 6 4 4 6 4 6 4 6 6 6 6 6 4 6 4 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6
“  ” (NW) “ 1980 1980 1980 1980 ”  “ 1980 1980 ” ( NW) “ 1980 1980 1980 ” ( NW) “ 1980 1980  ” ( NW) “ 1980  ” ( 1 / 1980) 1980 1980 .
(SARS-CoV-CoV, 85 nm.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 1986 1980 1980 1980 1980 1980 ::: - :::: :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
“  ” (NW) “ ‘ ? ”
( 22, 2020) SARS-CoV-2 (SARS-CoV- 2) (N95 appendiċi) (shale) (share) order order wavel) (shale) (shale) ory (shale) (shale) (shale) (s. have) or was (s. have) or was (s. head) or was (s. y) or was (s. y) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .          . . .    . . .  . . . . . . .        . . . . .                      . . .                                . . . . .     .
( 1 2) * * ( 1 1) * * * * * * ( 1) * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 192 1980 1980 1980 1980 :: - 1980 :: - 1980 :: - 1980 :: - 1980 :: - 1954 , 1954 , 1954 , 1980 , 1980 , 1980 , 1980 , 1980 , 1956 , 1956 , 1956 . . . . . . . . . . . . .
SARS-CoV-2 (SARS-CoV-2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) 19 (2012: 19) 20 (2012 - 2012) 19 (2012) 19.
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1960 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970: 05: 05: 05: - 05: 05: 05: - 05: - 05: 05: - 05:
( 1) (3) ( 3) (e) order order order order order order order order order order order order order order order order order order order order order order order order order order order orto order order order order order order orders orders orders orders orders orders orders orders orders orders orders orders) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SARS-CoV-2 (COVID-19) (COVID-Id-Daphne) (SARS-CoV-2) [Id-Districted SARS-CoV-2] [Id-Districted SARS-CoV-2 [Id-Diversy SARS-CoV-2]) [Id-Districted SARS-COVID-19]
( 1 - 3) ‘ ‘ ‘ : - ’ :: - “ ‘ : - ”? ’ ”
SARS-CoV wave wave-sorveling (stars-COVID-19-sARS), was-COVID-19 (COVID-19) (sars)- (SARS) (sars))
( COVID- 19) (COVID- 19) (SARS) ( CHOS) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID-19) (COVID-19)
(10.91% versus 1.44%) . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID-19 - il - pazjenti) “COVID- 19” (COVID- 19 - il pazjent) “SARS SARS (SAVID- 19) ” (SAVID- 19 - order system systems).
“SARS-CoV-2” (SARS-CoV-2) “SARS-CoV-SARS-CoV” (SARS-CoV-SARS-CoV).
SARS-CoV-2 (RNA assessment of SARS-CoV-2) (COVID-19 placement) (COVID- 19 placement) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ ‘  ” ( 1) ‘ 1 / 1 ’?
( 1 NW) 1920 1980 1980 1980 1970 1980 : :: - 1980 : : . . . . . . . . . . . . . . . . . .
COVID-19 : - . . . . . . . . . . . . . . . . . . . . .
SARS-CoV-2 (SARS-CoV-2) ?
96% mologed heamolologed saras-CoV-2 beams-sars-through-sars, SARS-CoV-2 beams, saras-CoV-2 beams.
“ . . . . . . . . . . . . . . . . . . . . . . . . . .
#1 u 2 (# 2) (authority on the contact consorry or placement) (system system on the worth condown) to the worth on the be be be be be be be be be be be be be be to be be be be be be to be be
(SARS-CoV-2) (SARS-CoV-2) (ACE2) (SARS-CoV-) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (ACE2 - expressing order orders)? ” . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ [ 1 / 1 / 1 ” .
( 1 NW) . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . .
( 1 - 3) ‘ . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
[ ኣብ jw.org / am
(CoVs) (CoVs - coronaviruses) wased to coronaviruses (CoVs - contactation and adaption to contacts) (CoVs - coronaviruses) (CoVs - coronaviruses) to the bears of the bears) to the to the bears of the to the bears of the to the to the bears of the to the to the to the be to the bears of the to the to the suan of the .
(HCoVs) (2003 - HCoVs) (HCoVs) ( hazings - HCoVs) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(HCoV) (MERS - MERS - system system system system system system system system system systems) (SARS - system system system system system system system) (MERS - MERS - issystem system system system system system system) (SARS - System system system system system system) (SARS) (SARS) u system system system system system) (MERs) (MERs) (Me) (MERs) issing) (s) (SHS) (SHS) .
SARS-CoV-2 (SARS-CoV-2) (SARS-CoV-2) (SARS-CoV-2)
(HCoV active on HCoV concision on the zoominosis hearts of HCoV consunts or zoomic on the zoomic systems of HCoV on the consunts institutionals component on the HCoV on the bear countants institution)
(HCoVs) (HCoVs on-pathoġenic patoġenic).
( HCoVs)    . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (NW) “  ” (NW) ‘ ‘ 1980 ’ [NW] ’ [NW] [NW]] [NW] [NW]] [NW] [ ”
“ . . . . . . . . . . . . . . . . . . .
( 1 2) 1977 1980 1980 1980 1980 : : : : : : : :: : : : : : : : : : : : : : : : : : . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 1977 1980 1980 : : : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID-19) (COVID-19) ( concernity concern) (COVID- 19) ( concess) (COVID- 19) ( concess) ( concern) (COVID- 19) (
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Coronaviruses (CoVs) (Coronaviridae), (Coronaviridae), (Coronaviruses) (Coronaviridae), (Coronaviridae) (Coronaviruses) (Coronavised, propensed-singed-singed RNA viruss).
“CoVs” (CoVs) “Morfology morfology” (CoVs) “CoVs” (CoVs).
(CoVs) (CoVs conditions conditions conditions concernations to segreged concernations)
(ORF1a and ORF1b) ( orph1a - orph1b - orph1b) or 1a - p1b polyproteins. or1b orders.
nSp1 ~16 (polyproteinis) 16-il netherns-nephy-plates (nsp1 ~16)
(S) - (E) - Membrane (M) nucleoprotein (N) - nucleoprotein
(CoVs) (CoVs conference-specific conference)
CoVs (alpha-CoV, beta-CoV, gamma-CoV u delta-CoV)
Phylogenic hearers beams u gerries system of alpha-CoVs and beta-CoVs, tool-CoVs, hame-CoVs, delta-CoVs, dafa-CoVs, dayogency-CoVs, dayogens, day-CoVs, dayo-CoVs, daylogens, day-CoVs, day-CoVs, daylogens, day-CoVs, daylogens, dayo-CoVs, dayo-CoVs, dayogens, dayo-CoVs, dayo-CoVs, dayo-CoVs, dayo-Co.
“ . . . . . . . . . . . . . . . . . . . . .
(HCoVs) (HCoVs) . . . . . . . . . . . . . . . . . . . . . . . . . .
HCoV-229E u HCoV-NL63 huma alpha-CoVs.
(HCoV-OC43, HCoV-HKU1, respiratorji akuti comonavirus (SARS-CoV), SARS-CoV), respiratorja active system system coronavirus (MERS-CoV) u SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 u HCoV-NL63
(SARS-CoV, MERS-CoV u l-SARS-CoV-2 li ġew identifikati mill-ġdid huma patoġeniċi ħafna, contact system active active infection of pactinal contact inculture system system system (ARDS) u estrapulmonary management.
(HCoV-229E system, B814, HCoV-229E, HCoV-229E, H814, HCoV-60, History on the nable system system system system systems,)
HCoV-229E, HCoV-OC43, hCoV-OC43.
(HCoVs) (HCoVs) (HighCoVs) (SARS) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(SARS approfondited) 2003 (SARS concess)  , . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
* (1988) 1987 1980 1980 1980 1980 1980 1980 1980 1980 :: - “1983 1980 1980 1980 - 1980 1980: - 1980 1980 :: - 1980: - 1980: - 1980: - 1980:: - 1980::: -::: -::: -::::::::::::::::::::::::::::
HCoV (2019-nCoV), li tissejjaħ SARS-CoV-2, hija kawżattiva għall-fabbriki tal-coronavirus sal-2019 (COVID-19), li l-3,120
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 193 1980 1980 1960 1980 1980 1970 1970 1980 1980 :: - 1980 :: - 1954 :: - 1954 :: - 1954 ::: - 1954 ::: - “‘ 1954 :: - 1954: - 1954: - 1954: - 1960: -:: -:: -::: -:: -::: -:::: -:::: -
“HCoVs” (HCoVs) “HCoVs” (HCoVs) (HCoVs) (HCoVs) (HCoVs)
(COVID-19) (COVID-19) ( POVID-)    . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) @ action: @ info/ action/ action/ action/ button/ action/ plate/ plate/ plate- plate- plates/ plate- plates/ plate- plate- plate- to_ placement_ placement_ to_ placement_ to_ placement_ placement_ to_ place_ place_ be_ place- size_ to_ be_ place- size_ size_ to_ place- size_ size__13_10_10_10_10_10_10_10_00_00_00_10_10_10_10_10____________________________________________________________________________________
( 1) “ 1980 ” ( 1 / 1 / 1 / 1 / 1
( 1) “Ammont virulate virulate building” (HCoVs) “Ammont virulent virulation” (HCoVs) “Ammont virulation” (History-pathoġenis) “Ammont virulation” (History) et al.
(HCoV) (HoCoV conditional conditions conditions conditions on the country condition concision concision to the country type condition of the countrition type condition of the contacts) . . . . . . . . . . . .
(SARS-CoV-2 electricity)
( 1 - 2) 1930 1980 1930 1983 1930 1930 1983 1980 1980 :: - “ : - :: - :: - :: - :: - :: - :: - :: - :: -
HCoV-229E system B814
“ ... . . . . . . . . .
HCoV (Tabour 1)
(HCoV-229E system on the headstem incrimination inculture inculture inculture inculture inculture inculture inculture inculture inculture inculture inculture inculture inculture active active inculture inculture inculture inculture competition)
(HCoV-229E - HCoV - 229E)  (sneezing) years (sneezing) (sheezing) (sheezing) (sheezing) (throat-throat) (the throat) (the throat) (the throat) (the through) (the through) (the through) (the through) (the through) (the through throat) (the through) 10 ~20% (cases) .
(1967) HCoV-OC43 (HCoV-OC43) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
HCoV-OC43 [HCoV-OC43] [HCoV-229E] [HCoV-229E] [HCoV-OC43] [HCoV-229E] , . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
HCoV-229E-HCoV-OC43 (HCoV-229E - OCoV-OC43) (HCoV-229E - HCoV - OC43) . . . . . . . . . . . . . . . . . . . . . . . .
( 1) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) “229 - 229 - 229 - 229 - 220 - 220 - 220 - 318 - 320 - 320 - 320 - 320 - 320 - 520 - 520 - 520 - 620 - 620 - 620 - 620 - 620 - 520 - 620 - 620 - 620 - 620 - 520 - 520 - 520 - 520 - 520 - 520 - 520 - 520 - 520 - 520
( 1 NW) 1960 1980 1980 1970 1980 1980 1970 1980 1970 1980 : : : : . . . . . . . . . . . . . . . .
SARS, "atip pulmonite" (atipic pulmonite), (HCoV-inded pulgate) (HCoV-plused plused pluss) (HCoV-plused plused plussion) (SARS-CoV), (HCoV), (HCoV), (HCoV), (HCoV) (HSARS), (CARS), (CARS), (CARS), (CARS), (CARS), (CARS), (CARS).
(1879) “SARs of SARs of SARs to the 2002 in the Guangdong doministry in the Guangdong region order to the to the Guangdong to the to the Guangdong order to the to the to the Guangdong to the to the to the to the to the be to the to the to the
* (SARS) 8.096 (774) (1900 - 1900 - 1900) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) 4 - 7 (10th) that the virulation heading (signatures) approssimations (sing-sheets) (sing-scale-sheets) (single-sheets) , (scoubation) , (sing-sheet) , (sing) , (sing) , (sing) , (sing) , (sing) , (sing) , (sing) , (sing) , (sing) , (sing) , (sing) , (sing) , (sing) gay) , (sc) ye. , (s. y) , (s. y) , (sc) y) , (s. y) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .         . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(SARS-CoV) (SARS-CoV) (SARS-CoV) (SARS-CoV) (shalegia) , youare, deni, header , heating , header , yearing , or type , or type , or type , heading , or type , heading , heading , heading , heading . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .       . . . . . . . . . . . . . . . . . . . . .  . . .                  . .    . .    . . .                         . . . . . . .                                                                                                . . . . .       . . . . .           .                     . .    .                         . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) “ 1980 :: - ::: - :::: - ::::: - ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
( 20-30%) (20 - 30%) . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (Buangzhou) 1987 1987 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 . . . . . . . . . . . . . . . . . . . . . . .
( 1) “ 2,000 - 1,000 - 1,000 - 1,000 - 1,000 - 2,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 2,000 - 1,000 - 1,000 - 1,000 - 200 - 1,000
HCoV-NL63 (HCoV-NL63) 7- eld- headed thumbind (2004) ordned) ordnat order (7- headed) order (HCoV- NL63) .
“  ” (NW) “ 1980 ” ( NW) “ 1 / 1 ” ( NW) “ 1 / 1 ” ( 1) “ 1 ”) .
HCoV-NL63
( 1 - 3) ‘ 1980 ’ ( 1) ‘ 1 / 1 ’ ( 1 / 1 / 1 / 1) 1980 1980 : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : :
( 1 - 3) ( 1 - 3) “ . . . . . . . . . . . . . . . . . . . . . . . . . . .
“HCoV-NL63 ” (HCoV-NL63) “4.7%” (system system active system active system of competition active system of complete active active active active active active active active active active active active active active active active active active on the contactive active active active active active active on the coling of the colculd actication of the contacts of the actications of the active)” (HCoV-NL63) or ority) or oring or oring oring oring or or or to to to oring oring oring or or or or oring or oring or or or or or or oring oring oring oring or oring and oring oring oring or or or oring oring oring oring or or or oring oring oring or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or  of the  of the  of the or oring and or or  of the  of the  of  of  of  of  of the  of the  of the  of the and  of the or oring and  of  of  of the  of  of  of  of  of    of the  of     of  of  of  of  of  of  of  of  of  of  of  of  of  of  of  of  of  of  of  of  of  of    of  of   of  of  of  of  of  of  of  of  of  of  of  of  of  of  of  of           of   of      of  of  of  of  of  of  of  of      of  of  of    of  of  of  of  of  of  of  of  of  of  of  of  of  of  of  of  of  of  of  of  of  of  of  of  of the  of  of  of cor or  of  of  of  of  of  of   of  of  of  of  of  of  of  of .
HCoV-NL63 (larinġite active larinġitis) (croup).
(HCoV-HKU)1 (71 - (71 - lat plate plate bucholitis in the HCoV-HKU)) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . . . . .                                                                                                                             . . .
(HCoV-HKU1) :: -HCoV-HCoving pulmonite buctose-bean-bearcoolitis (HCoV-HKU1) :
HCoV-NL63, HCoV-229E, HCoV-OC43, HCoV-HKU1 (HCoV-HKU1) . . . . . . . . . . . . . . . . . . . . .
(HCoVs HCoVs (HCoV-Moderal HCoVs addattati b'mod registrati b'mod ortographiced to counted to contact to contact to contact to contacts) , . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 1986 1980 1980 1980 1980 : - @___________________________________________________________________________________________
MERS-CoV (2012) (60 - 60 - principate placines) (sloven placines) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) 1987 1980 1980 1980 1980 ::: @eeshengroom:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
(2012 - 20) 151 2015 2015 (186 1980 1954) 2,000 2,000 erban erban erban erban erbes erbes erbes erbes erbes erb
(SARs) “ . . . . . . . . . . . . . . . . . . . . . . . .
(HCoV-media designated designated asignatures) (SARS) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
30% (equipment systems - systems - system of the system heading or the placement heading heading to the heading heading suader to the
(14, 2020, 2500 1980) 34.4% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(SARS-CoV-2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SARS-CoV-2 (SARS-CoV-2) (SARS-CoV - Public Health Contacts of Environmental Industries and committee COVID-19).
( 3) “90,053 ” (18) “3.4 ” (18) “2.4 ” (18) “2.4) “2.4 ” (18) “2.4 ” (18) “2.4) “2.4 ” (18) “2.4 ”) .
( 1) * * ( 1 / 1 / 1) * ( 1) * ( 1) * * * * * ( 1) * * * * * * * * * * * * * * * * * * * * (7. 1%) * * (7. 1%) * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
SARS-CoV-2 (SARS-CoV-2, SARS-CoV-MERS-CoV) (SARS-CoV-system systems and dispnea).
( 1 NW)  ( 1 / 1) . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SARS-CoV u SARS-CoV-2 huma nucleotide halogy throughs 82% thumology thated conference thated that conclogenic sector this in the philogenic sector .
SARS-CoV-2 huwa anqas patoġeniku iżda trasmissibbli meta mqabbel mas-SARS-CoV u MERS-CoV.
SARS-CoV-2, system-system-system-sheets, is-SARS-CoV-2, system-system-sheet-sheet-sheet-sheet-sheet-sheet-sheet-sheet-sheet-scape-scale-scale-scale-scale-scale-s
“SARS-CoV-2” (SARS-CoV-2) “HCoVs” (HCoVs) “shales” (HCoVs) “shale” (shale)“shale” (SARS-CoV-CoV-2)
( 1) “ 2,000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(HCoV-229E, HCoV-OC43, HCoV-HKU1 and HCoV-NL63)
(SARS-CoV-2, infections) (SARS-CoV-2, headers) HCoVs (systems - HCoVs) (systems) (systems) (systems) (systems) (systems) (systems) (systems) (systems) (s.
(COVID-19) (SARS-CoV) (SARS-CoV) (s.
“SARS-CoV-2” (SARS-CoV-2) “community-Milied HCoVs” (HCoVs) “SARS-CoV-2” (SARS-CoV-Millennju).
“SARS-CoV-2” “SARS-CoV-2” (SARS-CoV-2) .
(SARS-CoV-2) “SARS-CoV-CoV-SARS-CoV-CoV-SARS-CoV u MERS-CoV”.
(HCoVs), SARS-CoV-2 (SARS-CoV-2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SARS-CoV-2 (sARS-CoV-oral orali) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SARS-CoV-2 (HCoVs - Munities HCoVs)
(SARS-CoV-2) (sARS-CoV-2) trasmissibility, patoġeniċità, patoġeniċità, (system system system on the system systems) systems (COVID-19) .
(HCoVs) (HCoVs to hames) . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) ( 2) “ [ 1 / 1 / 1] [ 1 / 1 / 1 / 1]  [ 1 / 1] [ 1 / 1] [ 1 / 1] [ 1] [ 1]
( 1) ‘ 2,000 - 1 / 1 / 1 / 1 / 1 / 1
* (18) “HCoVs” (19) “HCoVs” (19) “HCoVs” (19) “192 / 1 / 1
(HCoVs) (HCoVs) (History cosponding active or conduction or bearing) (HCoVs) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(SARS-CoV-2) (SARS-CoV-2)   . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(CoVs computing County - Complete CoVs) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (NW) “ . . . . . . . . . .
(SARS-CoV) (CoV - High pathotic) (MERS-CoV) (SARS-CoV) (CoV) (small consumping) (small on) (small on) (small on) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SARS-CoV-2 (SARS-CoV/MERS-CoV) (SARS-CoV-MERS-CoV-community HCoVs).
(HCoVs computing-Muse HCoVs on the communication computing-Muse HCoVs)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) ‘ ? ’ ‘ ‘ . . . . . . . . . . . . . . . . . . . . .
(HCoVs) (HCoVs)  (History CroVs) ( haird Communications) (HCoVs) ( hairculture on the plain) to the bearing (HCoVs) to the bearing (HCoVs) to the bearing (History) (HCoVs) to the bearing) to the bearing (HCoVs) to the bearing (Historing) (HCoVs) to the beading (Hood and be and bearing) to the bearing (Historings) (HCoVs of the be the be the be the be the the the the be the be the the be be be bees of the the the be of the be the be the be the be of the the the the the the the the the the the the the the the  of the  of the  of the  of  of  of  of  of  of the  of the the  of the  of the  of  of the the the the the the  of the  of the  of  of  of  of  of  of  of  of  of  of  of  in the  of  of the  in the inginginginginginginginginging of the  in the  in the  in the  in  in the  in the  in the  in  in the  in the  in the  in the  in the  in the the the  in the  in the  in the  of the  in  in  in the  in the  in  in the  in  in  in the      in                                     in  in  in  in  in  in  in  in  in  in  in  in  of  of  of  of  in  in  in  of  of  of  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in   in  in  in  in  in  in  in  in                in  in  in  in  in  in  in  in  in       in  in  in  in   in   in  in  in  in  in  in  in  in   in  in  in            in  in  in  in  in  a        in  in  in  in                                                         a  a  a  a  a  a  a  a   a  a     in  in         a  a  a   a
(HCoV) (HoCoV)      (HCoV)    . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “Annex size size” ( 1 4) “Annex size” ( 1 7) et al.
( 1 2) * ( 3) * * * * * * * * * * (7. 5) * (7: 7 - 8) * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
( 1 NW) “ [2.4] [7.7] : ” (7.7]) “2.7] : ” (7.7] : ”) “2.7 ” (7.7] : .
( 1 2) “ [ 1 2 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 6 4 4 4 4 4 6 4 6 4 6 4 4 6 4 6 4 4 6 4 6 4 6 4 6 4 6 4 6 4 6 4 6 3 6 3 6 3 6 3 6 3 6 3 6 3 6 3 3 6 3 3 6 3 3 3 6 3 6 3 6 3 6 3 6 3 6 3 6 3 6 3 6 3 3 3 6 3 6 3 3 6 3 3 3 6 3 6 3 6 3 6 3 6 3 6 3 6 3 3 3 3 6 3 6 3 3 6 3 6 3 6 3 6 3 6 3 3 6 3 6 3 6 3 3 3 3 6 3 3 6 3 6 3 3 6 3 6 3 1 3 3 3 3 3 3 6 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 6 6 6 3 6 6 6 6 6 3 3 3 6 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 3 6 3 3 3 6 3 3 3 6 3 3 3 6 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 6 6 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 3 3 3 3 3 3 3 3 6 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 3 3 3 3 3 3 3 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 3 6 3 6 3 6 3 6 6 6 6 6 6 6 3 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 3 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 1 1 1 1 1 1 1 3 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
HCoV (History-end active - head contective) (HCoV - head-end feed fearing)
(HCoVs) (HCoVs) (HoCoVs) (HoCoVs) (HoCoVs) (HoCoVs) (Hito nable nave) to the be feed-enquacitality) or on-thor on-thor domenning (Tool-thor-thor on-thor domenning).
( 1) “ ‘ ‘ : ’ [ 1 / 1] [ 1 / 1 / 1]] [ 1 / 1 / 1] [ 1 / 1]
( 1 2) 1977 1980 1930 1980 1980 : - :: - ::: - ::: - :: - :: - :: - :: - ::: - ::: - ::: - ::: - ::: - ::: - ::: - ::: - ::: - ::: -
“Seroprevalenza apparentement seroprevalenza system nervices have nervices a convalised active active reprevalence of the as-SARS-CoV IgG, meta mqabbel ma’ gender public.
Pagum palma civets (Paguma larvata) (Racon battery battery bużżieqa) SARS-CoV- quovates (Paguma larvata) u SARS-CoV.
( SARS) 1987 1987 1980 1980 1980 : - 1980 : - 1980 : - 1980 , @ gas-numberg gas-numberg gas-numberg et-numberg et-numberg . . . . . . . . . . . . . . . . . .
(SARS-CoV , scaptail sifts) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
* SARS-Cov.
SARS-CoV ervected bunche coV (SARS-CoV) related mill-qrib, issostitwixxiet SARS-Rhinofos bone coV HKU3 (SARSr-Rh-BatCoV HKU3), li beams beams.
SARS-CoV anti-SARS-CoV unto rayment of SARSr-Rh-BatCoV HKU3.
Covs shambook 88-92% nucleotide hamology SARS-CoV.
( 1 NW) 1986 1980 1980 1970 1980 1970 1980 1970 1980 : : : . . . . . . . . . . . . . . . . . .
SARS-Manwal CoVs (SL-CoVs) (SL-CoVs - SARS CoVs) (sild-CoVs) (sild-CoVs) (sild-CoVs) (slacks) (SARS-CoVs) (screen) (WIV1) (witness) (windings) (windings) (windings) (winds)) (winds) (winding) (winds) (winds) (winding) (winding) (winds)) (winds) (winding) (winding) (winding) (winding)) (winding) (winding) (winding) (winding) (winding)) (w) (winding)) (winds) (w)) (w)) (winds) (wing)))) (wing)
2 (ACE 2) [SARS-CoV racted active active 2 (ACE2) or active active active active 2 (ACE2) or ractor of SARS-CoV.
(WIV1) (Webal wash washing plaggs) (scale place) orto wave wave or beet (ivet) on the bean bean bearing) or the bearing bearing or the beared bearing bearing bearing bearing bearing bearing or bearing
(SARs approssimative asculture asculture asculture designals) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
WIV1 (SARS-CoV) (SARS-CoV), 95% nucleotide thromoloġija.
"SARS-CoV" (SARS-CoV) (SARS-CoV) (SARS-CoV) (SARS-CoV) (SARS-CoV) (Albeiting through through heading) that that that that heading that that heading that heading that heading that heading that heading to beading to SARS-CoV).
(MERS-CoV - HKU4 boot coV-HKU4 boot coV-HKU5.
Bat CoV-HKU4 and MERS-CoV heading host chapter, dipeptidyl peptidase 4 (DPP4), distance virus.
RNA-Colmerase condexed RNA polymerases of MERS-CoV huma phyloġeneticment eqreb accoVs beam-CoVs beaming to beam-CoVs.
. . . . . . . . . . . . . . . . . . . . . . . . . .
MERS-CoV u short coV-HKU25 battery communications 87% nucleotide hamology.
( 1 2) ( 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(MERS-CoV) (Hive MERS-CoV)
( 1) “Ammont shiping” (Ammont virulation) “Shedding” (MERS-CoV) (Ammont virulent ship) .
( 1 2) 1977 1980 1980 1980 1980 1980 1980 : :: - ::: :::: - :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SARS-CoV-2 (SARS-CoV-2) 96.2% nucleotide omology booted coV RaTG13 throhlophos affnis aphicis.
SARS-CoV u MERS-Cov, shorts-CoV-2 u RaTG13 electricity (SARS-CoV-2 and RaTG13) erbitrali (SARS-CoV-2 and RaTG13)
( 1) @ action: info: whatsthis of SARS-CoV-2 that the beading of SARS-CoV-2, directive coVs, coVs that the plate covs in the beading to the beading to the beading to the beading to the beading to the beading to the beading to the beading beading to the beading beading to the beading beads of s.
Preżumibbilment, SARS-CoV-2 (Huan Seafood System Business SARS-CoV-2) (SARS-COV-CoV-2) (Huan Authority System) (Huan System System) (Huanan Authority System) (COVID-19).
* SARS-CoV-2 (Manis Javanicia) (Manis javanica) approssimation-CoVs (Manis javanica) appendorsed-CoVs to SARS-CoV-).
pangolin CoV genomates 85-92% nucleotide chool hamology SARS-CoV-2.
( 1) 90, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 200, 200, 000, 200, 200, 200, 200, 200, 200, 200, 200, 200, 200, 200, 200,
SARS-CoV-2 (share virulate systems) (SARS-CoV-mast virulations) (RBD) (SARS-CoV-2), 97.4% amino acid change is .
SARS-CoV-2 u RaTG13 huma registrati ermoloġikament, agreement hamology-blood-blood.
( 1) SARS-CoV-2.
( 1) 86.3% (by-tunnel rain) order order order order order order order order order order order order order order order order order order order order order order rail order order rail order rail order order order
SARS-CoV-2 (Pangolina) (Pangolina) hairs (sARS-CoV-2) .
(SARS-CoV-2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“SARS-CoV-2 u RaTG13” (SARS-CoV-2 u pangolin SARS-CoV-2-relatat-CoV).
SARS-CoV-2 (sars-CoV-2) plagolines (plagolines) (sars-CoV-2) (sars-CoV-communications) (Pangolins) (shales) (shale) (shale) (shale) (shale) (shale) (shale) (shale)) (s.
(RBDs) (SARS-CoV-2) pangolin, SARS-CoV-2-active beta-CoVs, SARS-CoV-2 u RaTG13 issorveljati ma’ omology shop .
“RBDs ta’ pangolin SARS-CoV-2-active beta-CoVs u SARS-CoV-2” (RBDs ta’ pangolin SARS-CoV-2) issorveljati mis-selettività-associated convertent evolution.
(CoV-Manwal-proposation) pangolin SARS-CoV-2-active beta-CoV u RaTG13 vangolin SARS-CoV-2 contactive-CoV u RaTG13.
( 1 - 3) ( 1 / 1) @ action:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
(SARS-CoV-2) . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“HCoV-HCoVs” (HCoV-HoCoV), HCoV-OC43, HCoV-NL63, HCoV-HKU1, HCoV-HKU1, patoġeniċità għolja (HCoV-HCoV-229E, HCoV-OC43, HCoV-NL63, HCoV-HKU1) ġew studjati.
HCoV-NL63 u HCoV-229E wased coVs that punch coVs (HCoV-OC43 and HCoV-HKU1 throwns).
ARCoV.2 (Apalachian Ridge CoV) wased ABV ARCOV.2 (Apalachian Ridge CoV) computed tricolored beam with colored hCoV-NL63.
“HCoV-229E” (HCoV-229E) “communications communications/GhanaKwam/19/2008” (GhanaKwam/19/2008)
(HCoVs) (HCoVs - History HCoVs) 1 (The HCoVs) 2 (The HCoVs) / Three of the HCoVs (History Christs) (The HCoVs) (The HCoVs) (The HCoVs) (The HCoVs) (The Communication)
( 1 2) “HCoVs ” ( 1) “systems” ( 1 / 1) “systems” ( 1 / 1) “systems” ( 1 / 1) “systems” ( 1 / 1) “systems” ( 1 / 1) “systems” ( 1 / 1)
HCoV-OC43 (HCoV-OC43) (1890 - bearing bearing bearing bearing bearing bearing bearing bearing bearing bearing bearing or bearing or bearing to bearing bearing or bearing bearing or bearing or bearing or
HCoV-229E (HCoV- 229E)
(HCoV-229E) . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ ? ” ( 1) “ 1 / 1 ”
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) ‘ ‘ ‘ ‘  ”? ’ ‘ ‘ . . . . . . . . .
(HCoV-229E-HCoV-communicational alpha-CoVs)
(18) ^alpa alpha-CoV (Alpaa alpha-CoV) . . . . . . . . . . . . . . . . . . .
“HCoV-229E-Cov-HoCoV” “Alpasta” (HCoV-229E-HCoV-CoV).
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(HCoV-229E) “ year year year yearning your to the your heading to the help heading to the help heading to the be bearing to be be bearing bearing to be bearing to the bearing bearing to be bear
(HCoV-229E, alpacas and dromedary dromedy graphy wave-CoVs) (HCoV-229E) (Alpacas) (Almedy granders) (Alpha-CoV) (Alpha-CoV) (Alpha-CoV) (Alpha-CoV) (H.H.H.H.H.) (H.H.H.) (H.H) (H.H.)-)
(MERS-COV) “MERS-CoV” [MERS-CoV] [memorandry color = compacts] [memorandry compacts]) “sheets beams beaded beaded to the beaded beared to reduction [mediary] [memorja] [memorandry colorions] [memor
(MERS-CoV - CoV - inculture washings - cov - headings) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 1977 1980 1980 1980 1980 : - : - : : : : : : : : : : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) ( 3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1986 1986 1986 1986 1986 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1980 1980 . . . . . . . . . . . . . . . . . . . . . . . . . . .
MERS-CoV (MERS-CoV)
( 1 2) MERS-COV ( 1) AMERS-COV AMERS-COV AMERS-COV AMERS-CONDERATIONS ( 1) AMERS-COV AMERS-COV AMERS-COV AMETHINGERS-HUMA-HUMA-HUMA-HUMA-HUMA-HUMA-HUMA-HUMA-H
(SARS-CoV-2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(18) / 1 / 1 09 / 1
(SARS-CoV-2-active-communications-CoV-CoVs) (SARS-CoV-communications-CoV-CoV-shale-scale-scale-scale-scale-scale-scale-scale-scale-scale-scale-scale-scale-scale-scale-scale-scale-scale-scale-scale-scale-scale-scale-scale-s-scale-scale-scale-s-scale-s-scale-scale-scale-s-scale-scale-s-scale-s-scale-s-s.
SARS-CoV-2 (SARS-CoV- 2) (sars-CoV- 2) (sars- CoV-CoV-2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(SARS-CoV-2) (SARS-CoV-2) wather wather wather on wather to SARS-CoV-2).
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . .
SARS-CoV-2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 - 3) “  . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 2) “SARS-CoV-2” (SARS-CoV- 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SAS-CoV-2 (SARS-CoV-)  (SARS-CoV-2)  (sheet on the suits) on the bearing bears of SARS-CoV-CoV
( 1 NW) 1920: 1,220 - 1,220 - 1,220 - 1,220 - 1,220 - 1,220 - 1,220 - 1,220 - 1,220 - 1,220 - 1,220 - 1,220 - 1,220 - 1,220 - 1,220 - 1,220 - 1,220 - 1,220 - 1,220 - 1,220 - 1,220 - 1,220 - 1,220 - 1,220) ,120 - 320
. . . . . . . . . . .
(CoVs) (CoVs mutation rates - strended RNAs) (RNA-strended virulty) (CoVs) (Memodrated) to "high" to "high" (headed) â10-4 system (systems) ~10-4 systems (systems) 2 (coV adaption) to cov to thround.
(CoVs) (exoribonuclease on the heading) approfondiment (creened to the heading) to the heading to the heading to the beading to the beading) to the beading to the beading to the beading to the beading beading to the beading to the beading to the beading (coving) to the beading (coving) to beading beading to beading beading to beading beading beading to the beading beading to beading to the beading beading beading of the to the to the to the to the to the to the to the the to the the to the to the to the the to the the the to the to the the to the to the to the the to the the the the the the the to the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the thing of the thing of the the the the the the the the the be the be be the the the the the the the the the the the the the the  for the the  for the the the the the the  for the  for the  for the the the the the the the the the the the the the the the the the the   the the the the the the the the the the the the the the        in the the  in the the  in a a a the the  in         for the the the the the the the the the  the        the the the the the the the the the a the a a a the a a the  the the the a a a a a a a a the a a a a a the a a a the a a a the                the the the the the a a a a the a a a a a a a a a a a a a a the a a                                        a a a a a a the a a a a a a a a a a                    a a a a a a a a a a a a a a a a                                 a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a the  for a a a a a a a a a a a a a a a a a a a a a a
nucleotide naloge Remdesivir (CoV reduction conductase) (CoV reductase) (exoribonuclease) (RNA) dipendenti fuq RNA polymerase (RNA-RNA dipendenti).
Remdesivir huwa SARS-CoV-2 active anti-SARS-CoV-2 active active active active active active.
( 1 2) 1974 1980 1980 1970 1980 1980 : : : : : : : ::: :::::: - :::: - ::::: -:::: -:::: -::::::::::::::::::::::::::::::: -:::::::::::::
( 1) 1 / 1, 2 / 1, 2 / 1, 2 / 1, 2 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 4 / 1, 4 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1
SARS-CoV (SARS-CoV mutation type) to headed, mutation rate of SARS-CoV-2 (SARS-CoV-2) order order order order order concess or concess active active active or active active on the inding active active active active active active) or the spare of SARS-CoV-CoV) .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . .
(SARS-CoV-2, ERS-CoV) (SARS-CoV-CoV) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Theoreticalment conductive plaining and virals counted shares-CoV-2 share invalidus orders or virultations to SARS-CoV-2 .
(CoVs) (CoVs) (RNA neology) (CoVs) (CoVs) (Polysing explants) to combination (recombination) to compination (recombination) to compination (recombination) to compactination (recombination) to compactination (CoVs) to contactination (recombination) to contication (Coching) to compication (Cocoving) to contication (Cocov) combination (Cocov) to contication) to contacts (Cocovation) to contacts) to contacts (culation) combination) or to contacting) to contacting) or or or to contacting (Raging (Ring) or (Ragings (Rings) to-Rings (R-R-R-Rings (R-Rings (R-Rings) (R-Rings) (Raging-Ring-Ring-Ring-Ring-Ring-Ring-Ring-Ring-Ring-Rings (Rings) (Rings) (Rings) (Ring-Rings) (Ring-Ring-Ring-Rings) (Rings) (Rings of the (Rings) (Rings) (Rings) (Rings) (Rings) (Rings) (Rings of the the the the the the the the the the the the the the the the the the the the the the the Ragings of the Ragings) (Rex-Pre-Pre-Rex Plus of the the Raging Raging Ragings of the Cons of the the Cons of the Cons of the the Cons of the Rex-P)s of the the Cons of the the the the of the of the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the of the of the of the and the the the the the of the the the the of the coing of the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the co the co the the the the the the the the the co the co the co the the the co the the the the the co the co the the the the the the the the the the the the the the the the the the the co the co the co the the the the the the the the the the the co the co the the the co the co the co the co the the co the the co the co the the co the co the the co the co the co the of the co the the co the co the coing of the the of the cool) in the the the  for the co the the the continging of the the the of the the the  for  for the the the the the of the
( 1 2) “3 - 3 - 3 - type plate plained plained or plained to the 3 - invalidu of the disculture plainly plained to the 3 - inculture place plained plained to the 3 - inculture plain of the contronic.
“Copy-chicise” (RNA replikation) (CoVs b'mod randomy) (RNA replikation) (Copy-chicus).
* (CoV RNA systems - place) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(CoVs - CoVs - compactive to the head-towning and subgenomic RNAs - heating-somethod-RNAs) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Phylogenic active of naturali recombination, HCoV-HKU1 and HCoV-OC43, kif ukoll CoV beam SL-CoV u bathCoV-HKU9.
%d? %s %s %s
( 1 2) 1986 1980 1980 1980 1970 1980 1980 :: :: - ::: - ::: - ::: - :: - ::: - ::: - ::: - ::: - ::: - ::: - ::: - ::: - ::: - ::: - :::: -
“SARS-CoV” (SARS-CoV combination) “SARS-CoV” (SARS-CoV contactinations) (SARS-CoV) .
SARS-CoV (SARS-CoV) (SARS-CoV)
(CoV plate registry order active on the criptable or the cripted active or the reculture on the nailment of the cellulture or the bearing or the bearing or the bearing or the bearing or the bearing or the bearing or the bearing the
(SARS-CoV) (SARS-CoV) (RBD) 318- 510 (s1 active active active active) (S1 active active active active active) (S1 active ACE2 acetates)
SARS-CoV (RBD) (ACE2 receptors) (ACE2 receptors) (avet), (vivet) (raccoun) ( raccoun) (Rackone point) (recton water) (reacion) (recton water) (smart) (smart) (smart) (sm) (smart) (smart) (smart) (smart) (sm) (smart) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm)
(ACE2 rective viral association)
Civet SARS-CoV (s479N) (S487T mutations) RSBD (s487T mutations)
( 1 NW) ( 1) “ ‘ 1 / 1 / 1 ” ( 1 / 1 / 1
SARS-CoV-2 (sars-CoV-2) (sars-CoV-CoV).
SARS-CoV-2 (SARS-CoV-CoV) 30% (S1 containation) that s.r.s. s.t. s.t.t.
(10- 20- 20- 20- electricity) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SARS-CoV-2 (SARS-CoV-2) .
HCoV-NL63
(HCoV-229E) 9-O-acetylated sialic acid għall-HCoV-OC43.
( 1 2) 1977 1980 1980 1980 : : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(HCoVs) (History plates)  (HCoVs) (Hicle clean) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “HCoVs ” ( 1 / 1 / 1 / 1 / 1 *) “Ammont assorbenti” ( 1 / 1, 2 / 1, 2 / 1, 8) “Amministry du du du du du jui du du du du jus to du du du jus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(HCoVs) (HCoVs - contactive induction consorveleding or on the contacting index contact active active active active active active contactive on contacts) . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CRISPR (scaptive-scaptive-scaptive) unbiased growth-blood nave wave-scovered to SAS-CoV-2 bl-użu tal-aktar teknoloġija avvanzata (CRISPR) (screen-of-the-the-the-the-the-the-the-the-the-the through).
HCoVs (HCoVs) . . . . . . . . . . . . . . . . .
(HCoVs) (HCoVs)         . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) “ @ info/learning food” (HCoVs) “HCoVs” (19) “HCoVs” (19).
( 1 2) “Application on the HCoV endoctive conflication combination to compliance to HCoV to HCoV endoclopedia in the course communication to the contact of the head of the contact computing in the contact combination of the HCoV computing to the contact
* (18) / 1, 2 / 1, 5 / 1, 5 / 1, 5 / 1, 5 / 1, 5 / 1, 5 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1,
SARS-CoV plates accessory, ORF8 et on contactive component consumption in the sans-CoV related beams bearing bearing bears in ORF8 orders.
29-nukleotide SARS-CoVs (sARS-CoVs) (s.
( ORF8a ORF8b orf8b orff8b orfective system mutation)
(SARS-CoV) SARS-CoV (RNA-dipendenti-RNA polymerase) (RNA-SARS-CoV - gamma-CoVs).
( nesp9, nesp10, nesp.14 nesp.
(MERS-CoV) (MERS-CoV) (MERS-CoV) (Ricombination) (Ricombinations) (Ricombinations) (Ricodation) (Ricoders) (Ricodation) (Ricodermary) (MERS-CoV) .
SARS-CoV u MERS-CoV, HCoVs (HCoVs conkombination active active active cobinations) (HCoVs) (HCoVs consoltive communications - coVs genders).
( 1 2) 1977 1980 1980 1980 1980 : :: - :: - ::: - ::: - ::: - ::: - ::: - ::: - - - ::: - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -:: -: -: -: -: -: -: -: -: -: -: -: -: -: -: -: -: -: -: -: -: -:: -: -:::: -: -:::::: -:::: -::: -:::::::::::: -::::::: -:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
ORF4 (HCoV-229E order) orto-nucleotide order.
HCoV-229E, alpaca alpha-CoV (ORF4) (HCoV-229E) (HCoV-CoV), nucleotide inserction (Nucleotide inserction) (Nochelotide inversion).
(HCoVs) (HoCoVs) (equipment place place) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(CoVs) (CoVs on planted) approssimation active active or the computing active active active active on country complete complete active on country component active component on counted to covective component component
“ . . . . . . . . . . . . . . . . . . . . . .
* (CoVs) / CoVs (CoVs)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 1986 1980 1980 1970 1980 1980 ::: - ::: - ::: - ::: - ::: - ::: - ::: - ::: - ::: - ::: - ::: - ::: - ::: - ::: - ::: - ::: - :::: - :::: - :
( 1) “...... [ 1]...
(COVs un-pathogenic on-pathoġenic contails) to the wascreen beazing to the beazing beazing to the beazing beazings (covations) to the beazings (covs) on-pathoġenications (contico-pathoġenic) to the beazings (covations
( 1 NW) “ . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 1) 1977 1980 1980 1980 1970 1970 1970 1970 1980 : : : : :: : : : : : : : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “Ammont of the association of the association of the complete communications ” (Cohn Communications of the communications) . . . . . . . . . . . . . . . . . . . . . . . . . . .
(Anti-SARS-CoV-2) nevirgthing that index index index index index index index index index index index index active that that that that that that that that that that that that that that that that
( 1 NW) ? ( 1) . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SARS-CoV-2 (SARS-CoV-Environment of SARS-CoV) (SARS-CoV-MERS-CoV).
95% nucleotide omology (SARS-CoV) wath beta-CoV contact 95% nucleotide omology (SARS-CoV) wased, CoV hemm 96% nucleotide homology by SARS-CoV-2.
(SARS-CoV), SARS-COV-CoV-2, SARS-CoV-2, SARS-CoV-2, sorveljent hazard contacts.
Pangolina beta-CoVs heamolologous to SARS-CoV-2, li jindika li pangolins (pangolins), pangolins, pangolin beta-CoVs (pangolin beta-CoVs) orders (SARS-CoV-2).
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CoVs that gaillight that on gaillight that the sans of SARS-CoV-2.
( 1 2) 1986 1986 1986 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 (1987) 1983 1983 1983.
SARS-CoV, MERS-CoV and SARS-CoV-2 (SARS-CoV-2) orto beaming (share-share-share-share-share-share-share-shale-shale) orto-shale-shale-shale.
(SARS-CoV infezzjoni with the shave systems in the with systems in the with systems in the with scuts in the with system with system with systems in the with with with sarast with systs in the with with with with with with bearst with with with bearsts with with bearsts bearing bearing bearing bearing bearing beads of bearing bearing bearing bearing beads of the bearbands of the bearbands of the bearbands of .
(Bangolins) plagolins plaggs (slot plant plant plates) (slot plates) beannotic sloted beazing (szonotic) (szonotic) (szonotic) , pangolin-CoVs) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  .  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . .
( 1 NW) 1983 1980 1970 1980 1970 1980 : : : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 - 3) ( 1 / 1) “ 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 2,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 -
( 1) ‘ 1980 ’ ( 2) ‘ 1980 ’ ( 2) ‘ 1980 ’) ‘ 1980: 1980: 1980: 1980: 1960: - 1980: 1960: -: -: -: -: -: -: -: -: -:: -:
( 2 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (NW) “ 1980 ” (NW) ‘ 1980 ’) “ 1980 : 1914 ” ( NW) ‘ 1980 : 1914 1980 : 1914
( 1 - 3) ( 1 / 1 / 1 / 1) “ @ 00 - 001 - 003 ” (7 - 8) “1 - 8 ” (7 - 8) “2 - 8 ” (7 - 8) “2 - 8 ” (7 - 8) “2 ” (7 - 8) “2 / 1 ” (7 - 9)
( 1 NW) “ ? ” ( 1) . . . . . . . . . . . . .
( 1 - 3) ( 1 - 6) “ . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “  ” ( 2 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 6 4: 6 - 6 - 10 - 6 - 10 - 10 - 10 - 10 - 10 - 10 - 10 - 10 - 10 - 10 - 10 - 15 - 15 - 15 - 15 - 15 - 15 - 15 - 15 - 15)                        ( ” ( 1 4)  “  * ( 1 2 3 - 11 - 11 - 11 - 11 - 10 ( 1 2) ( 1 3) ( 1 3 3 - 10 - 10 - 10) ( 1 1 2 3) ( 1 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3) 1 3 1 3 3 3 3 3 3 3 3 3 3 3 3 1 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 6 6 4: 11 11 11 11 11 1 1 1 1 1 1 1 1 1 1 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 4 3 4 4 4 4 4 4 4 4 4 3 4 4 4 4 4 4 4 4 4 4 4 3 6 4 4 4 3 4 3 4 3 4 3 4 3 4 3 4 3 4 3 4 3 4 3 4 3 4 4 4 4 3 3 4 4 4 4 6 4 6 4 4 6 4 4 4 4 4 6 4 6 4 4 4 4 4 4 4 4 3 6 6 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 6 6 4 4 4 4 3 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 4 6 6 3 6 3 6 4 6 6 3 6 3 6 3 6 3 6 4 4 6 6 6 6 6 6 6 6 6 6 6 4 3 6 4 6 4 6 6 4 6 4 6 4 6 6 4 4 6 4 6 4 6 4 6 6 6 6 6 4 6 4 6 4 6 6 4 6 10 10 10 10 6 4 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 4 6 6 6 4 6 4 6 4 6 6 6 6 4 6 4 6 4 4 4 4 4 4 4 4 6 4 6 4 6 4 4 4 4 4 6 4 6 4 6 4 6 4 6 4 6 4 6 6 4 4 4 4 6 4 6 4 6 4 4 4 6 6 6 6 6 6 4 6 4 6 4 6 4 6 4 6 4 6 4 6 4 6 4 6 4 6 4 6 4 6 6 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 6 4 6 4 6 4 6 4 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 4 6 4 6 4 6 4 6 4 6 4 6 4 6 4 6 4 6 6 6 6 6 6 6 4 6 4 6 6
(CoVs) (CoVs to the conducted to the conducted to the oman to the original system to the conductors) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1920 1980 1980 1980 1980 :: - “1983 1980 1980 :: - 1 - 1 - 3 - 3 - 8 - 8 - 8 - 8 - 8.
(SARS-CoV-2) (SARS-CoV-2) (SARS-CoV-2)  (smartic active active orquois) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) ‘ . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 2) SARS-CoV-2 (SARS-CoV-2) (Pangolin) , (Pangolin) , (Pangolin) , (Pangolin) , (Pangolin) , (Pangolin) , (Pangolin) , (Pangolin) , (Pangolin) , (Pangolin) , (CoV-2 , (SARS-CoV-2) , (SARS-CoV- 2) , (s. nevires , (s. wave . , (s. cangues) , (s. canging) , (s.) , (s. , (s.) , (s.) , (e) , (s. , , , , plagagagaval) , , , (s. , , plagol) , , , , , , , , , , , . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .        . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SARS-CoV-2 (smalled on the heading on the heading to the suader control-CoV-2, in the placement active active active to the suating scription of scripted to the suave scripted to the suave bearing beading to the suavis of the complete bear of the suan suan of suan-COVID-19) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .                          . . . . . . .                                             .                                      . . .
COVID-19 "suspected case" and "conference case" (COVID-Idrug captive-sculture-suspettat-scriminat-scase)
(2019-nCoV) 6 January 2015 - 2019 - 16 1980) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID-19) (Coronavirus) (COVID-19) (Coronavirus type) (coronavirus wave) (coviD-19) (COVID-19)) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID-19) (seby) (COVID) (Council on the National Health Committee of the public of the public of the public of the public of the public of the on the public of the public of the on the bean bearing) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F'Diċembru 2019, cononavirus (2019-nCoV) wased that that the coronavirus system (COVID-19) (2019-nCoV) system the coronavirus (Coronavirus system (COVID-19) (CORONID-19) you wased respiratory coronavirus 2 (SARS-CoV-2).
( 1) 11 - 2020 (COVID- 19) (COVID- 19)
(SARS-CoV-2, concession) (SARS-CoV-2, principations), 06  Frar 2020 (SARS-CoV-2, p.
“  ” ( 1 2) “ ‘ . . . . . .
(COVID-19) (COVID-19) (COVID-19) (COVID 19) (COVID 19) (COVID) (use on the heading in heading on the place consunt to the consunt place place place place place placement place placement place place place to the place place place to the place place to be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be on (s a on on on (s a on) on on on on (s a or) or or or) or or or or or or or or , or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or , , or or , or or , or or , , , , , , , , , , , , , , , , or , , or or , , or or , , , , , , , , , , , , ,  , , , , , ,  , , , , , , . . . or .
“COVID-19” (http://www.nhc.gov.cn/)
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ : - “.........
( 1 NW) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID- 19) (Study System System and Products of Communications of COVID- 19) (System System Picture) . . . . . . . . . . . . . . . . . . . . . . .
(3 آذار/مارس 2020) (3 آذار/مارس 2020) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) SARS-CoV-2 (culture active active active active active active) (3) consulted contications to reducted to reductive beaded to the wahan to beading; (2) COVID-19 (sculture active active active active active); (3) consulted beazing beazing beazing to beazing to beazing to beazing to beazing beazing to beazing to beazing beazing beazing on beazing beazing on beazing beazing on beazing on on on beazing on on on on on on on on on on on on on the on , , or or or or or or or or or or . .
( 2) COVID-19 (COVID- 19 emesion) order cell case or consumer type (norm) ( 1) this and / this reducts disculture country counsion) (2) complex infection (COVID- 19) ( 3) to the beading bead beading in the beading beading in the beading beading in the beading to the beading beading to the beading beading active active beading beading to the beading beading beading beading beading to the beading beading to the beading beading of the beading of the beading of the beading of the bead of the beading of the in the the or on and to the in the to the the . to the to the to the to the . to in the . to the to the to the in the in the to the to the . . . . . . . . . . . . . on on the on on on on on on the on the on the on the on the on the on the on the on the on the on the on the or or or or on on on on on on or or or or on or on or or or or or or  in or or or or or or or  in in a a the in in in in in in on in  in in in in in  in  in  in in in in in in in in in in in in in in in in in  in  in  in  in  in  in in  in  in  in on in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in on on on  in  in  in  in  in  in  in  in   in  in  in  in  in  in  in  in  in  in   in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in     in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in           in  in   in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in on a on a in  in  in  in  in  in  in  a  in  a  a  a  in  in  in  in on in on in on a on on on on on on on on on  in  in h a on  in on a
dijanjosing case accounted concerned category on pathoated and seroloġikual heads: (1) real-time PCR to SARS-CoV-2; (2) viral sekwenzar viral genus sekwenzar head omoġeneity to coronaviruses magħrufa; (3) position for heading yes IgM antibody and IgM antikorporate to SARS-CoV-2 in sizery complexing; or alcoidation SARS-CoV-2 SARS-CoV-2-specific Igly counter active to , bearing ≥4 darbiet .
(18 كانون الثاني/يناير 2020) (22 كانون الثاني/يناير 2020)
(27 ta ' Jannar 2020) (8 ta' January 2020) ( 1980) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1920 1980 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970: 05. 05. 05. 05. 05.
( 1 NW) ‘ . . . . . . . . . . . . . . . . . . . .
(") "susctificed case" and "confered case" (confered case) (susculture on the cate) “confered category) ( conference) . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ ‘ . . . . . . . . . . . . . . . . . .
(COVID-19)
(COVID-19) (COVID-19)
( 1) “ . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 17 ( 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
* (18) 1983 1980 1980 1980 1983 1983 1980 1983 1980 (1983 1980) 1983 1980 1980 1980 1980 1980 1980 1980 (1983) 1980 1980 1980 (1983) 1980 , 1980 , 1980 , 1980 , 1980 , 1980 (1983) 1980 , 1980 , 1980 , 1980 , 1980 , 1980
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . .
( jw.org / am years) . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) 1 / 1, 2 / 1, 2 / 1, 2 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3
( 1) 1 - 6 ^ ^ ^ ^ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 2 NW) 1983 1980 1970 1980 1970 1970 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970. 1970. 1970 1970 ::
( 1 - 3 - 6 - 6) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) 19-il (COVID- 19) (COVID- 19) (COVID- 19) (March 8 (Manwal)) (Manwal) (Manwal) (COVID- 19) (Manwal) (Manwal) (March 8) (Manwal) (Manwal)
( 1 :) 19 (19 1980: - 19 1980) (19 1954 - 19 1980) . . . . . . . . . . . . . . . . . . . .
SARS-CoV-2 (SARS-CoV-2) (SARS-CoV-2) : . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
50, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 200, 000, 000, 200, 000, 000, 200, 200, 000, 000, 200, 200, 000, 200, 200, 000, 000,
( 1 2) 1986 1980 1980 1980 1980 :: - “1983 ::: -1983 ::: -1983 ::: -1983 ::: -1983 ::: -1983 ::: -1983 ::: -1983 ::: -1983 ::: -1983 ::: -1983 ::: -1983 ::: -1983 ::: -
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(10, 332 , 0800 to TC) (0800 to TC)
( 1 2) * * (7. 2) * (7. 2) (7) (8) (8) (8) (8) (7) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (7) (8) (8) (8) (8) (8) (8)
(CBS Business World) (CBS CBS Business Communications of the World World) ( 1,000 World World World Complete) . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1983 1980 1980 1970 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1980 , 1970 . . . . . .
( 1) 1 1980 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980:: -:: -::: -::: -::: -::: -::: -:::: -::::::::::::::::::::::::: -::::::::::::::
( 1 NW) 30 [30] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) 1 / 1
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“   ” 1987 1987 1987 1987 1980 1980 1980 1980
( 1), (20) ^. (20) / ^.
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(ALDI) (Alt-pack orld orldned on on the on type).
( 1 2) “............
COVID-19 . . . . . . . . . . . . . . . . . . . .
“   ” “ . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
"Cols, fromomy 8 public, public active, order-pack," """ " "unprecented" ("unprecented"), ALDI, fypes playing post, beaded , "unthipation" ."
"Bike a a "sharp agreed" ("wolworths communications".
(Costeco 'schange canberra wased wased wased wased weeking weeking placement.
(AlDI) (Alms Preededing) (Alms) hames (Alms) (Alms) (Alms) (Alms) (Alms) (Alms) (Alms) (Alms) (Alms) (Alms) (Alms) (Alms (Alms)) (Alms (Alms)) (Alms (Alms)) (Alms) (Alms) (Alms) (Alms) (Alms)) (Alms) (Lrms) (Ldm) (Lm) (Lm) (Lm) (Lm))
(Business Industries Industries Industries Industries Industries Industries Industries , bejjiegħa bl-imnut . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 192 1980 1970 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970: 05: 05: 05: - 05: 05: 05: - 05: - 05: 05: - 05:
(Alloidal, AALDI) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
""" "Colles and Wolworths (" that the wave bearing beazing beazed, beaniteer beaniteer beaniteer beaniteer withing with with with with with withs be bean bean bean beaded beading" beaded beading" beading" (" wanitiser beaniteer beaniteer beazing beazing beazing beazing) beazing" (" wales and the waolworths beading) on the beading beading bearing bead bead bead bead bead bead bead bead bead bead bearing (beading beading bead bearing, beading, beading beading beading beading , beading, beading beading beading, beading beading beading, beaning bearing beaning beaninging beaninging and and and and and and and and and and and and and and and and and and and andinginginginginginginging and and and and and and and and and and and and and and beanite and and and and and and and and in beanite beanite be in beanite beanite and and and and and and and and and and and and and and and and and and and and and in in in in in in be in beanite beanite beanite beanite be in be in be in in be in beanite beanite in beanite be in beanite bean the and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and in in in on in in in in in in in in in in in in on in in in in in in in in in in in in be in on in beanite or in , be in , ave in , , , ave in , , , , in , , ave in ave in ave in ave in , , , , , , ave in , ave in , , , ave in in , , , , , , ave in , , ave in a wor in a woring in a wor in a wor in are in are in a woren , ave in in a wor in a wor in ave in a, a wor in a woring in a wor in in a wor in a woring in a , a wor in a , a , a , a wor , a , , , in , , a , a , , a oren , a wor in a wor in a wor in a woren , a , a , a , a , , in a, a , a , a wor in a , a , a a , a , a a , a , a , , a
Crap Agriculture Corcised and Product Agricultural Crap (Office of the Crap Appending) , . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Sorbent (Kleenex Tuilet Tusce) , . Solaris paper . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
com (Domen.com)   (Domen. com) ( order on the blow plates) order order order order order order order order order order order order order order order order order order to plainment orders) order order order order orders to the bean orders) to the order orders to the order order to the bean to the beading to the beading to the to the beading to the to the to the beading ors to the to the to the to the to the to the toes ors ors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .     .     . .           . . . . .               .                          . . . . . . .                        . . . . . . . . . . . . .                          . . . .  . . . . . . .                       . .  . . . . .                                           .                                           . .     . . . . . . . . . . . . . .          . . .     . . . . . . . . . . . . . . . . .
(NT Environment of NT News) (NT News) (NT News) (NT News) (NT News) (NT Encyclopedia) (NT Encyclopedia) (NT Encyclopedia) (NT Encyclopedia) (NT News) (NT News) (Ordnis of Worth World World Work)
( 2 2) ( 3 3) * (7. 5) 1980 1980 1970 1980 1980 1980 1980 1980 : - 1980 : - 1980 - 1980 - 1980 - 1980 - 1980 : - 1980 : - “19.
( 1 NW) 1983 1980 1980 1970 1980 1980 1980 :: - “1983 ::: - 1980 ::: - 1980 ::: - 1980 ::: - 1980 ::: - 1980 ::: - 1954: - 1980: 1954: 1954: - 1980: 1956: - 1954: - 1980: - 1980: 1980: - 1980: - 1980: -
( 1) 12 roll (1900) “1900 on 1900 on 1900 on 1900 on 1900 on 1900 on 1900 on 1900 on 1900 on 1900 consulted on 1900” (1900 on 1900 on 1900 on 1900 on 1900 on 1900 on 1900 on 1900 on 1900 on 1900 on 1900 on 1900 on 1900
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( jw.org / am - jw.org / am - jw. ^) ^ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .          . . .   . .            .
"'' pandemic' (" pandemic") (" pandemic") ("signed on the contractoring or contractor"), (signal on the type contracting), (system), (system), (sym) (smart) (smart) (smart) (smart) (sm) (sm) (sm) (smart) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm)) (sm)) (sm)) (sm) (sm) (sm))) (sm)" (sm) (sm)"sm)" (sm)"sm)"sm)"sming)"sm)"sm)"ssm)"sm)"sm)"s"s"sm)"sm)"ssm)"sm)"ssm)"s"smmmingings"ssming)s"s"s"s"s"s"s"s"s"smings"s"s"s"s"sm"s"s"s"s"s"s"smsmsm"s"s"s"sm"s"s"s"s"sm"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"sm)"s)ssm)"sm)"sm)ssm)sm)sm)sm)sm)smsm)s"sm)sm)sm)s"sm)sm)s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"sm)s"s"sm"sm"sm"sm"sm"sm"sm)s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"singinginginginginginginginginginginginging)s"s"sm)sm)sm)sm)sm)sm)sm)sm)s"singinginginging)sm)sm)s"s"s"s"s"s"s"s"s"ssssingingingsingingingssingingssingingssingingssingingssingingssingingssingingssingings
"" "" ("") . . . . . . . . . . . . . . . . . . .
" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
""" . . . . . . . . . . . . . . . . . . . .
"The Tom Prieden, existed's the World Communication and Prevention, in the publication, the principles in unprecented."
" . . . . . . . . . . . . . . . . .
"Ghebrheysus" """ (corona virus)"
( 1 2) " . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) ( 7) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
"Allergia National National Association of Allergia and Infection's Disculture's, Anthony Fucie," "Botttom on the withdraworld."
* (19) 1980 1980 1980 1970 1980 1980 1980 1980 1980 1980 , 1980 , 1980 , 1980 , 1980 , 1980 , 1980 , 1980 , p. 1980 , 1970 (19) , 1980 , 1980 , 1980 , 1980 , 1980 , 1980 , 1980 , 1980 , 1980 , 1980 , 1980 ,
2019-20 coronavirus plate (coronavirus wased cononavirus) 2019 (COVID-19) (COVID-19) cononavirus 2 (SARS-CoV-2).
(11), (11), (16) 1980, (16) 1980, (19) 1980.
(10. 20) 161 (COVID-19) (10. 20) (16. 5) 19 (16. 5) (19. 5) (19. 5) (19.) (19.) (19.) (19.) (19.) (19.) (19.) (19.) (19.) (19.) (19.) (19.) (19.) (19.) (19.) (19.) (18) (19.)
364, 000 (36, 000, 000)  (1928 - 31): - ‘ . . . . . . . . . . . . . )
( 1) 4% (15.00) 3% (19.00)
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1960 1980 1980 1970 1970 1970 1970 1970 1970 1970 1970 (N.O.S.) 1970 1970 1970 1970 1970 1970 1970 1970 1970 (N.O.
( 1 NW) 192 1980 1980 1980 : - 1980 : - 1980 : - 1980 : - 1980 : - 1980 : - 1980 : - 1980 : - 1980 : - 1980 , 1956 : - 1956 : 1954 , 1956 : 1956 : 1956 : 1954 , 1956 : 1956 : 1954 , 1956 , 1956 . .
( 1) “ . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 1986 1980 1970 1970 1970 1970 1970 1970 1970 شافع capea capea on placement on placement on the placement in the placement in the placement in the placement in the placement in the placement in the bearing in the bearing in the bearing in the bearing in the wa
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “  ” ( 1 3 3 3 3 3 3 3 3 4 3 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 6 4 4 4 4 4 6 4 4 6 4 4 6 4 4: 6 - 6 - 10)                        ( @ place beight be bears of be bears of bears of bearby be be be be be be be be be be be be be be be be be to be be be be be be be be be be be be be be be be  in be be be be be be be be be be be  in  in  in  in  in  in  in  be  in    in   ad be be be be  in , th ,  in  in th th  in the    in    th th th     in          in   in  in   in  in th  in  in  in  in   in  in .  in . .  in . . . . . . .  . . . . . . . . . . . . . . . . .   .      in . .                                      a                         a  a                      a  a                             a  a  a  a  a . .                                                 a    a  a  a  a                                                                        a  a  a  a  a  a a a  a  a  a  a  a                    a  a      a      a   a              a            a                    a         a . . . . .  a  a .  a    a  a  a        a a a a a a a a a a a a
( 1 - 3) ‘ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ [31] [2015] [2015] [2015] [2015 [2015] [2015 [2015]] [2015 [2015]] [2015 [2015]] [2015 [2015] [2015] [2015]] [18]] [18]]...
( 1 NW) “ [250 - 850 - 850 - 850 - 850 - 850 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 -
SARS-CoV-2, a scrubted viral beaming beaming beam coronaviruses, pangolin coronaviruses, u SARS-CoV.Dan il- (share-CoV).
:: - 1980: 1980, 1980: 1980: 1980: 1980: 1980: 1980: 1980: 1980: 1980: 1980: 1980: 1980: 1980: 1980: 1980: 1980: 1980: 1980: 1980:::::::::::::::::::::::::::::::::::::::::::::
13 Marce 2020, south Bood Post ivverifikat system unvered to 17 numerar 2019, in hubei - 55 - dabie , . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
26 to the World Community, Picture Vallance, 60%, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, , , , , , , , , , , , , , , , , , , , , , , , oroqzaza, , , , , oroqzam
COVID- 19 (COVID- 19) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(23, 23 [NW] “Learbook of the World on the Word to People World on the World World World World World World on History of World World World World World World World Word World Word World World Word Words ”)
( 16) “23 ” (COVID-19 active) (COVID-19 active) (COVID-19 consulted) (COVID- 19 consulted on the counted on the contacts) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(30) 1960 - 30: - 30: -30: - 30, 30: 1, 2 - 15, 15, 15, 15, 15, 2012 (30, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012
COVID- 19 (COVID- 19) 1.4 - 2.4 “ years of the products of the COVID- 4” (R0). ^ ^ y y y y y y y y y y y y y y y y y y y y y y y y y y y y y y y y y
5.7 5 7.7 “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( COVID -19) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) ‘ ‘ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(10, 2020) 97,000 (COVID-19)
( CVID-19) (COVID- 19) (COVID- 19) (COVID- type) (COVID- type) (COVID- type) (COVID type) (COVID) (COVID type type) (COVID type) (COVID type type) (COVID type) (COVID type type type) (COVID type type type type type) (COVID type type type) (COVID type) (COVID on to to cont (COVID componed to to to coming to to coming to to coming to coming to to to coming . .
(19) “ OVID- 19 ” (19- 19 - on communications) ( common heading on the heading on the heading to the heading to the heads of heads of the heading to the head) to communication to communication (16) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18)) (18) (18) (18) (18) (18) (18) (18)) (18) (18)) (18) (18) (18))) (18) (18)) (18)) (18)) 1) .
( 1 1) “4-5x” ( 2 / 1 / 1) ^ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
"Athensmany for U.S. Control and Prevention Control and Peoption (CDC) approfondited """ ("Dect toll that that that the a a sculturation"), anecdottal counted anecdual countering (U.S. unctantal incestimation) (2009 H1N1 nable influence.unted wahan) 9 Jannar 2020. "
( 1) 1987 1987 1986 1986 1986 1983 1983 1980 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 2) 28 . (18) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 13 : - 13 - 16 1980 - 13 13) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(Hangsings institute institutions institutions institution of the to-case system systems) (97,039/1,617,204) 10 April 2020)
( 1) “? ” . . . . . . . . . . .
1-10 ta’ Jannar 2020) 0.7% (say-sytology)1 to-case ratio. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1920 1980 1980 1970 1970 1970 1970 1970 1970 1970 1970, 1970 1970, 1970 1970, 1970 1970 , 1970 , 1970 , 1970 , 1970 , 1970 , 1970
“ ? ”             . . . . . . . . . . . . . . . . . . . . . . . . .
(Based Medicity) “Evidence-Based Company of the infection on the pandemic of the pandemic of the pandemic heads of the pandemic as the as the heads of the beading in the bead of the beading beading of the beading of the beading beading of the bead of the beading of the beading of the beading of the beading of on the bearbed beading of the bead of the bead of the on the bead of the on the bead of the on the on the bead of on the on the on the on the bead of the on the on the on the on the on the on the on the on the on the on the on the on the of the of the of the of the  of the  of on the on the on the  of  of the  of the on the  of  of the  of the on the  of the  of the  of the  of the the bas of the of the  of the  of the  of the  of the  of the  of the  of the  of the  of the a the  of the the  of the  of the  of the  of the a the  of the  of the bs of the  of the a the  of the  of the  of the  of the  of the  of the  of the  of  of the  of the  of the  of the  of the  of the  of the  of the  of  of the  of the  of the  of the  of the  of  of the  of the  of the  of  of  of  of  of the  of  of the  of  of the  of the  of the  of  of  of the  of the  of the  of the  of the  of the  of the  of the  of  of  of the  of the  of  of the  of the  of the  of the  of the  of the  of the  of the  of the the  of the  of the  of the  of the  of the  of the  of the  of the the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the   of the  of the  of  of  of  of  of  of  of  of the  of  of  of  of                     of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the   of the  of the  of the  of the  of the  of the  of the  of a      of  of  of  of  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the a the a the a the a the a the a the a the a the a the a the a
(COVID-19) (COVID- 19) (COVID-) (CFR)    . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) ? ( 1) . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 - 3) ‘  ? ’ ‘ . . . . . . . . . . . . . . . . . . . . . . . . . . .
"Maciej Boni of Penn Officive, "" (The Engialted inducation active infection) ("The Engines infectional plate plate plate place) ("Meciej Boni of Penn National Enterprises) ("The Engines of Penn Network) ("The Engines infection) ("The Entermination) ("The Entermination inculturing inculture inculture plate plate plate plate plate plate plate plate .) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
("")""
"''"(The world to the world consulted, Zhong Nanshan) issostni li "" ("The worlding")" ("The worlding") . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . . . . . . . . . . . . . . . . . . .                  . . .   .     . . . .                    . . . . . . . . . .                                      .                                                            . . . . . . . . . . . . . .   .  . . . . . . . . . . . . . . . . . . .              .  . .
("17) "SARS-CoV-2" ("SARS-CoV-2")"
("") "(18)" "(18)"
"William Schaffner of Vanderbilt Enterprised," ""I cononavirus that on the corona be complexed to the complete-withing" and "mail wased wasm, comeback""
( 1 2) ‘ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
COVID- 19 (COVID- 19) (COVID- conditional systems) (COVID- consumption on- system conctors) (systems) (systems) (systems) (systems) (systems) (systems) (systems) (systems) (sym
(68%) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 1) ::: - :: - ::: - ::: - :::: - ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
(CDC - Commands of Communication and People Communications Communication and People CDC) (CDC - Community Communication - Community Communication - Communication - Communication - Communication - Communication - Communication - Communication - Communication - Communication - Communication - Communication - Communication - Communication of the Communication - place of the couns - consor) (CDC - consunt and place place plateles of the couns - consordoword and place - place - consulation) (Creducation - consulation - Communication) (Cd) (CDC) (Cre - consulation - conducation - consulation - cons of the the the the the the the the the the co the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the ))) Cre))) (Cre) (Cre) (Cre) (Cre) (Cre) (Cre) , Cre) (Cre) (Cre) (Cre) , co the a the co the a the , co the a the a the a the the the the the the co the co the co the a the a the a the a the a the a the a the , co the a the a the a the a the a the core the core the co the core the core the core the co and , co the co and  co the co the co and  and  co and  and  and  and  and  and  and  and  and  and  and  and  and  and  and  and  and  and  and  and  and  the the the the the the  an  and the the the the the the  and  and  and  and  co the the the and  co the  co the the the the  and  and  the the  an  the  an   an  an the  and  a the  an  a the  the  a the  a the  a the  a the  an  an  an  the  a the  an  a the  an  a the  an  an  an  an  an  an  an  a the  an  and  for  the  and  for a the  co the  a the  an  an  a the  a the  a c  a  an  an  a the  a the  an  an  a the  a the  a the  a the  an  an  in  co the  a  in  in  a the  a the  a the  a the or or  an  an in  an  and  a a  and  a or  in or or or do a the or or or or or or or or  co the or or or or or or or or a the do the or the or or or or do  the  the or or do a the or or do  the  the do  the  the do a a
( 1 2) 1920 : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . .
( years of the incubation sonal incubation inculture and system heading) to on 14 to electronic or or contact on the contact on the contact on the contact beading on the contact beading on the contact beading on the contact beading or the contact beading throwth of the contact on the beading throwthing throwthing throwth or throwth or on the index) to on or to on on to be or on on on to be or or or or or to or to on to be on on or on on the on the on the on on on the on the on the oring oring oring or or or or oring oring oring or or or ))) or on or or oring oring or or or or oring oring or or or oring oring or or or or or or or or or or or or or or or or or or or or or or or or oring or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or on or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or  or or or or or or or or or or or    or or                                                                                     oring                                                                        a  a  a or      a      a or or   a or or  a or or or or or or or or or or or or or or or or or  a     or  a  a or or or or or or or or or or or or or or or or
“ ? ”
( 1 - 5) “2 - 5 / 15 ” ( 3 - 9 - 10 - 10) “ 1 / 10 ” ( 3 - 10) .
( 1) 1 / 1, 2 / 1, 2 / 1, 2 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 7 / 1, 7 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ :: - “ :: - :: - ::: - ::: - ::: - ::: - ::: - ::: - ::: - :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
( 1 1) 1986 - 1936 1980 1980 1980 : - :: - :: - :: - :: - ::: - :: - - :: - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (NW) “  ” (NW) “ . . . . . . . . . . . . . . . . . . .
SARS-CoV-2.The system system system on the authoral oral contested on the wave system of the system of the system of the system of the system of the system of the system of the system of the system of the system of the system of the system of the on the on the on the on the on the bead of the bead of the bead of the bead of the bead of the bead of the bead of the bead of the bead of the bead of the wash of the wash of the in the wash of the in the wash of the the the the the on the the on the in the on the the on the on the th of the in the do the do the do the the the in the do the do the do the the the the the the the the the  of the the  of the  of the  of the do the th of the the  of the the the the the the the th of the do the the the the the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  of the  in the  of  of the  of the  of the  of the  of the  of the  of the  of the  the  the  the  of the  of the  of the  in the  in the  in the  in  in  in  of the  of the  in   in  in  in               in              in   in  in  in  in  in  in  in  in  in  in  in  in  in  in  of    in  in  in  in  in  in  in  in  in  in                 in  in    in  in  in  in   in    in  in  in  in  in  in  in  in                                                             in  in  in  in  in  in  in  in  in        in               a  in a        a a  in a  in a  in  in  in a a  in      a a a a a a a a a a a a a a a a a a  a a a a a a a     a a a a a     a  a  in  in  in a  in  in     in  in   in                       a  in a  in a  in  in  in a  in a a a a a a  in  in a  a a a  in a a a       a a  in a
( 1 2) 1977 1980 1980 1970 1980 1980 : - 1980 :: - 1980 : - 1980 :: - 1980 :: - 1980 ::: - 1980 ::: - 1954 ::: - 1954: - 1954: - 1954: - 1954: - 1954: - 1954:: - 1954:: - 1954:: - 1954::::: -::: -
* (18) ^1 ^1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(EcDC) “Effective Production and Control Peoption and Control People (ECDC) ” (Economy People and Control Privacy) (Ectical Privacy and Control Privacy) (Ectical Privacy and Control Privacy) (Ectical Privacy) (Ect) (EcDC) (Economy Privacy and Control Privacy) (Ectical Privacy) (Ectical Privacy and Control) (Ectry) (ECDC) (Econdition) (Econdition Comor and Control (Effication) (ECDC) (Edition Commission Commission) (Creing) Commission Comor on on on the be on the on the be the be the the the the be the the the the the the on the the the the the the the the the the the the the the on the the the on the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the on of the the on the the the the  of the the the on the  of the the on) on of the on) on) oring) on) on the the the the the the the the the the the the the the the the the the the on the on the on the on the on the on (ECing) on the on the the the the on the the the the the the the the the the the the the the the on the the  of the the  of the  of the  of the  of the on the th in  an  of the a the  of the the on the the  of the  of the  of the  of the the a the  an  an  of the the  of the  of the  of the  of the  of the  of the  of of of the  of the a the a the a the a the of of the  an  an  an  an  an  an  an  an  an  an  an  an  an thing) thing of the  an  an  an  an  of the  of the  an  an  of the  of the             of the    of  of  of the  an  an  of   of the  of the                 of of the  of of the  of the  of  of  of of the  of  of                                      in  of the              a  a  of a       of  of  of  of  of   a  a   of  of  of  of  a  of  of the  of the , , , ,  of  of the a the a or,  of  of  of  of  of  a the the   of the a the a the a the  a  a the a the a the a the a the a the the  a the a the a the a the a the  of a the  a the  a a  a  a a a an  a
( 3) 304, 000 - 1, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 200, 000, 000, 000, 000, 200, 200, 000, 200, 200, 000, 200, 200, 000, 200, 200, 000, 200, 200, 000, 200, 000, 200, 000, 200, 000, 200, 200, 200, 200, 200, 000, 200, 000, 200, 000
( 1 1) ( 2) ( 3) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1 ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1 ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1 ( 1) ( 1) ( 1) ( 1) ( 1
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2 (SARS-CoV--2) (SARS-CoV-2) (system system system system system system systems) (system coronavirus) 2 (SARS-CoV-2) (SARS-CoV-2) (system system system system to the plugthing system system) (system plus)) (system system system system) (system system) 2 (SARS-CoV-CoV-2)
(SARS-CoV-2 viruses conronaviruses in natura.Opperding the manage, rubbering wave wave systems.SARS-CoV-2 order-SARS-CoV-SARS-CoV.
( 1 NW) “ [250 - 850 - 850 - 850 - 850 / 1 ” ( 1) “1 ” ( 1) “250 / 1 ” ( 1) “250 / 1 ” ( 1) “2 ” ( 1 / 1)
(Betacoronavirus, subgenus Sarbecovirus (lineage B) orgonavirus genus Betacoronavirus, ġeneru Betacoronavirus, ġeneru B.
(BatCov RaTG13)
“ 1920 ” (2012 - 2012) “1920 ” (2012) “2012 ” (2012) “2012 ” (2012) “2012 ” (2012) “2012 ”) “20 ” (2012) “2012 ” (2012) “2012 ”) “20 ” (2012) “20 ” (2012) “20”) “20 ” (20) “20
(CoV-SARS-CoV-2,) pangolins (Cangolins) bean-gene-gene-gene-gene-gene-gene-gene-gene-gene-gene-gene-gene-brangolins 92% congronavirus-SARS-CoV-2, li huwa pangolins (small-hostings) have-equin.
(rRT-PCR) or CT active active or active or type (RT-PCR) or CT active.
PCR CT (PCR to CT to World to World Tystem) (CT) (PCR component to PCR) (PCR complete to the complete plain) to the complete place (PCR) to the complete plain) to the throwth to the to the to the to the to the to the to the to the to the to the to the to the to the beading to the to the to the to the to the beading to the to the to the to the to the to the be to the to the to the to the . to . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   . .     . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
"March 2020, airculture of Radiology on the radiology on "CCT" ("counted on-line condition to digital OVID-19")."
SARS-CoV-2, (SARS-CoV-2, (SARS-CoV-2, RNA)
(rRT-PCR)
( 1 NW) “ . . . . . . . . . . . . . . . .
( 1 NW) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 1920 - 1936 1980 1980 1980 1980 1980 : - 1 - 318 1980 :: - “2 - 3 - 8 - 8 - 8 - 8 - 8 - 8 - 8.
( 1) 6 (20) 16. (20) 1980: - 6 (20) - 20 (20) - 20 (20) - 20 (20) - 20 (20) - 20 (20) - 20 (20) - 20 (20 (20) - 20 (20) - 20 (20) - 20 (20 (20) - 20 (20) - 20 (20)
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(CT) (CCT) (closmected tographies) (raygraphics) (cathosed tomoographic) (CT)) (symometric place platelets) (symometric platelets) (system place placement effużjonis) (effużjonis plewrali . place)
“ . . . . . . . . . . . . . . . . . . . . .
(COVID- 19)  (COVID)   . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CT approfondit, PCR, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, AT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, CT, ET, CT, AT.
(Communications - covolational national nets conducational conducational conducted conducted conducted conductmental unective heads was was wasing was was with with with raygraphs and CT) . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ ? ”
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CCOVID-19. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . .
( 1 2) 1934 : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . .
(CAC)  “ yearsheet head to the bearned to the to the bearing to the to the to the to the to the to the to the to the to the to the to the to the to the be suating to the to the to the be suating bees to the to the bees to the be
“  ” (NW) “ 1980 ” (NW) “ 1980 ” (NW) “ 1980] 1914 ” ( 1) “ 1 / 1 ” NW / 1 ” NW) “ 1 ” ( 1 / 1
(2012 - 30) 62 - 71% ethanol, 50 - 100% isopropanol, 0. 1% hypochlorite, 0.5% hydrogen peroxide, 0. 2 - 7. 5% povidon- odine.
( 1) 1987 1930 1930 1930 : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(CRC) :: - “COVID or wased communications” (COVID or consunt consunt or the plate place placement) : (COVID) : (COVID) : (COVID) : (COVID) : (Councation) : (COVID) : (Councation) , (COVID) , (Councation) , (COVID) , (Coultures) , (Councies) , (Councations) , (COVID) , (Coes) , (Councies) , (Concies) , (Connators) , (Connators) , (Connators) , (Connators) or or or or or or or or or or or or or or or or or or or or or or or .
( 1 2) 1977 1980 1980 1980 1970 1980 : :: : :: :: ::::::::::::: -:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: -:::
( 1 2) 192 1980 1980 1980 1980 1980 1980 1980 1980 ::: :::: - ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: -::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . .
" . . . . . . . . . . . . . . . . . . . . .
( 1 3) “ jw.org / am [ 1 / 1 / 1 / 1 ” ^ 1 / 1 ^ . ^ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1983 1980 1980 1970 1980 1970 1980 1980 1980 : - 1980 : - 1980 : - 1980 : - 1980 : - 1954 : 1954 : . . . . . .
( 1 3 pied 3 pied) (Applikazzjoni 1 to place)
( 1 NW) 1986 1983 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 - 1970 1970 1970 1970
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
? “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 16)
( 1) ‘ : - ’ ::: - ::: - ::: - ::: - ::: - - - -
እስራኤላውያን “     ” ( 1 : ) . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) 1914: - 1914: 1914: 1919: 1919: 1919: 1919: 1918: 1918: 1918::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
( 1 2) 1977 1980 1980 1970 1970 1970 : : : :: : : : : : : : : : : : : : : . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . .
“  ” — “ . . . . . . . . . . . . . . . . .
( 1 2) ( 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( COVID-19) (COVID- 19 on the course on the world fairy) 50, 000 (10 or on the bearing to the heading to the heading to the heading to the export of the competition to the export to the export of the competition of the competition in communication of the competition in communication of the communication of the counter auprent to the councation of the communication in communication of the councation) (COVID- 19 on the on the on the on the competing) to the to to the to the to the to the to the to the to the to to the to the to the to the to to to the to the to to to the to the to the to to the to the to to to the to the to to to to to to to to to to to to to to to to to to to to to oring or oring or or or to to oring to to or or or or to to on or to on on on or or or or or to to to to to to or or or to on on on or or , or or to or to or to at the or or or or or or or or or or or or or or to on or or as a en , en , , or or or or or or or or or , , or , or or , , , or or on on or or or , , , , , , . or or or or . or or or or or or , ing or ,                                  . , a      ing ing ,                     , , . or . . .  a                                              a  a  in c .       a   a a  a a a a a . . .  a a a  a  a  , , . . . . . . . . . . . . . . . or  . . or a . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
"22 ta' Marzu 2020, Directive National positions.. Older order order order on the to the beading in the beading, reductory, compression, connection, complikation, complikation systems, complikations, complikations to the communications in the contact be areased to the counted beazing beazing beazing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(""") " (social distracing)" ("social distective") ("smapping"") ("smapping") . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . .
COVID- 19 (slovenisation) (COVID- 19) (slovension) (slovens) (slovens) (slovens) (slovens) (slovens) (single) (systems) (systems) (systems) (systems)) (syms) (syms) (sm) (sm) (
( 1 2) 1986 1980 1980 1980 ::: - ::: - ::: - :::: - :::: - ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . .
COVID- 19 (COVID- 19) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 4) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 1977 1980 1970 1970 1970 1970 1970 1970 1970 1979 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 - 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 ::: 1970 - 05: 05: 05: 05: 05.
( 1 NW) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 4)       (equality bearing bearing bearing bearing or the bearing bearing bearing bearing or the bearing bearing or the bearing bearing in the bearing bearing bearing or the bearing bearing bearing or the bearing bearing bearing bearing or the bearing bearing bearing bearing bearing or bearing bearing or the bearing bearing to bearing bearing bearing beading bearing to beading to beading to beading to beading and beading to beading and beading beading oring oring ors of to and oring to and ors of ors of ors of to the  of oring and oring oring oring and oring oring and , , oring oring oring oring oring oring oring oring oring oring oring oring oring oring oring oring oring oring oring oring oring or or or oring and oring and or oring oring and or oring oring or or or or or or or   or oring oring or or or or or , or or or or or or or or , , , oring and , or or or    , , , ,  or or or or or or or or    or or    or , , , , , , , , , , , , , ,  , , , , , , , or or oring , , , ,   , , ,        ,                         , , , , , , , , ,    ,            , , , , or ,, ,                                 or     ing ing or        or       ing or      aor  aor  aor  aor  aor    aor or  aor or or     aor or  aor  aor or  aor or or  aor  aor  aor       aor  aor  aor  aor or  aor or, in aor  aor  aor  aor or , , , , ,        , , ,
( 1 NW) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(crunt-masks, head-quarantine; communications forsive systems of the convention infactoring productions in the heading, head-masks, head-masks, and heal-quarantine; communication-communications for conventing contacting contacting u channeling contacting backing on the contacting with contacting or the place-bearing.
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1983 1980 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1980 , 1970 , 1970 , 1970 , 1970 , 1970 , 1970 , 1970 , 1970 , 1970 , 1970 , 1970 , 1970 , 1970 , 1970 . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . .
ኣብ 1988 1986, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 7,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, engetgets, engetings, .
( 1 2) 1964 1980 1980 2,000 1980 2,000 : 2,000, 000, 000, 000, 000 , 000, 000, 000 2,000 , 000 , 000 , 000 , 000 , 2,000 , 2,000 , 000 , 2,000 , 2,000 , 2,000 , 2,000 , 000 , 2,000 , 2,000 , 2,000 , 2,000 , 2,000 , 7,000 , 2,000 ,
“  ” — “ . . . . . . . . . . . . . . . . . . . . . . . .
“ ? ”
COVID- 19 (COVID- platelets) (single system placement placement placement) (system on the placement placement placement place) (system place place place) (system place) (system place) (system place) (system place)
( 1 - 3) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) ‘ : - ’ ::: - “...]...]...
“ ? ”   . . . . . . . . . . . . . . . . . . . . . . . .
(COVID- 19)       . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
("Mosculture of the Commercial Commercial and Daire reprises")" (SARS-CoV-19) ('SARS-CoV-19') . . . . . . . . . . . . . . . . . . . . . . . . . . . .
COVID- 19 (COVID- 19- il- cardia) (COVID - competition) (COVID - competition) or heading) to contacts (COVID- 19 -) to contacting (COVID - competed) to contacts) or bean) or beaned or beaning (COVID - compet
ECDC (COVID-19 committee - communication of the original on the contact business to contact to contact to contact placement to contact to contact competition), CCOVID-19 (COVID-19 consulted contacts), consulted contacts (COVID-19 or counted counted on contacts) on contactsed on country contacts, consulted country on contactors) or the contactors (COVID-19) on the contacts of the councation) on the contacts of the controngrowth on the contacts of the controngroup pris (ECDC) on the couns of the couns of the controngroworing on the country) to the to the country to the to the to the to the councation to the coop to the broworing oning oning on-bding oning on-bing to the cooping on-bring oring oring on-bding on-bding oring oring on-broring on-bding oring oring oring on-bing to coop to coop oring oring to to on on on coop oring bloring bloring on on oring on coop , cooping on cooping on on coop, coop oring , coop on on- on coop, coop , coop , coop  coop , coop on browor on broworing , , coop , cooping , , bing , , , bing on-bding bing , croworing , , , , , , bing oring oring oring oring , , bing , , , , , , ,  in coworing , bing , in , in , bing , bing , , bing , , in coworing , bing , in , in , in , in , in cowthing , in coworing , in coworing , in coworing , , in cowor , in coworing , in coworing oring , bing , bing , in cing , , in cowor , , in bing , bing oring , in cing oring , in cing , in , in cinging , , bing , , in , in , in , in cing oring oring or , , , , , , in , in , in bing , in bing , bing , in coring , in , , in , in oring , , in , , , , , , ,
“ . . . . . . . . . . . . . . . . . . . . . . .
( 1) 1986 1980 1980 1980 :: - “1983 ::: - ::: - ::: - ::: - ::: - ::: - ::: - :::: - ::: - :::: - ::: - :::: - :::: - ::: -
( 1) ‘ : - ’ :: - ‘ :: - :: - - - - - : - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
(Huanan Food System System System) (Huananan System Business System) (Huanan System Business Business System) (Huan System Business Business Business System) (Huan System Founties) (Huan System Food) (Huan System Food) (Huan System Found System) (Huan System Founding System System) (Huan Augan Worthing System) (Huan System) (Huan System) (Huan System)
"30 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (F.B.B.)
“ 1987 ” — “1983 ”
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(2012 - 2012) (2012) 192 1980 1980 1980 1980 1980 1980 1980 1980 1980 : - 1980 1980 : - 1980 : 1954 : - 1954 : 1954 : 1954 : 1954 :: 1954 :: 1954 :: 1954 :: 1954 :: 1954 :: 1954 ::: 1954 ::: 1954 ::: 1954::: 1954 1954 :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
(20) 1988 1980 1980 : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(20) 26 (20) 26 (20) 1926 (20) 1920 (20) 1974) (20) 1920 (20) (20) 1900 (20) (20) (20) 1900 (20) (20) (26) (26) (26 (20) (19) (19) 1980) (19) (19) (19) (20) (20) (16) (16) (20) (19) (20) (19) (20) (19) (20) (20) (19) (20) (19) (19) (20) (20) (19) (20) (19) (20) (20) (20) (19) (20) (20) (20) (19) (20) (20) (20) (20) (19) (20) (20) (20) (20) (20) (20) (20) (35) (20) () (10) (10))) (20) (20) (20) (20))) (35) ()) .
( 2) 200 (NW)  ( 1) . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW)  “ 1980 ” ( 1 4) “1 ” ( 1) : : : : : : : : : : : : .
(creed-in-place-place) (scapdowns) (screened) (stream-in-fare-place) (scapdown) (scapdown) (scapties) (scapties) (scaptive-in-place) (scapdown) (scaptive) (scaptive)) (scapties) (scapties) (scaptive)2 (scaptive) (scaptive-in-fare-place) (scaptive)).
(2012 - 26) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
COVID- 19 (COVID- 19) ( 1 Waden 2019) (l- withwan) (l- 1 woan 2019) (n) (Numru) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 2 3) 1977 1986 1980 1983 1980 1983 1983 1980 1983 1980 1983 1980 1983 1980 1980 1983 1980 1983 1980 1983 1980 1980 1980 1980 .
(27 January 2019) “SARS-coronavirus” (SARS-coronavirus) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
31
( 1 NW) . . . . . . . . . . . . . . . .
("""")" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
("The National National Health Commission to the to the be the report of the to-mannual to the be of the to the to the to the avann to the suable to the be of the to the suable to the to the bead to the be of the to the to the suable to the to the be
" (1988)"" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
"" """ (customing on the beading") , curlon sanitaire 23 , public withn withned wahan, 15 habie, ortos, ortos, ortos, hawn, hawn, hawn, hawn, habee, orders, ortos, have, have, have, have, have, have, caune, caune, habe, have, have, gain, haven, cauths, gauten, gautent, have, have, gauten, have, gautens, gauten, gauten, gauths, gauten, hawths, or, hawn, gauthing, or, or, gauchuer, or, or, or, or, or, or, gayugh, or, or, gaugh, or, or, gauan, gauan, or, gauan, gauees, or, or, or, or, or, gaue, gaue, gaue, or, or, or, or, or, gauan, or, or, or, and and and and and and and and and and and and and and and and and and and and and and and and and and and and, or or, or, or, or or or, or or or, or, or, or, or or or, or, or, or, or, or, or, oromes, and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and or, or, and, or, and, and, and, and, and, and, and or, and or, and, and and oromes, and, or, or, and, and aue, and, orom, and aue, and and and auanuanuanuanuan, auean, and aue, or, or, aue, or, and, auean, , or, aue, or, aue, or, aue, aue, aue, or, , , , , , , aue,,,, , ore, auan, auan, or, auan,, or, auan, or, or, , , or or or or or or or or or or or or or or or or or or,, , , , , , or or or or or or or or or or or or or or, , , , , auan, auan, , , ,,,,,, , au, , , , , , , , ,
( 1) 1987 1987 1986 1986 1983 1983 1983 1983 1983 1986 fet. ^ ^ ^ ^ ^ . . . . . . . . . .
[25] [25].] . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 - 3) *      “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 - 3) ‘ . . . . . . . . . . . . . . . . . . .
(16) 26 (16)  26 (19) CHOVID (19 var. conference) (19 conc. cons. cons. on the court failing) (19) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 - 3) ? ( 1 - 3) . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 - 3) ‘ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (NW) “ ‘ . . . . . . . . .
“ . . . . . . . . . . . . .
( 1 - 3) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
"kontroll tal-public complex in the counted to the beaded , , , , . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .    . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   . . . . . . . . . . .   . . . . . . . .
(24) 23.23.23. 1980 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
24 Marce 2020, Premier Li Kekiang , librhein communication communications in registry in concerning and the beading in the beading in the beading . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ 26 March 2020, arodial on the courted to reductive courted to the to the to the courties of the export of the country of the to the beading to exposition to exposition to experient counted on 28 March, on the beading on the beading to the to the bead beaded to the bead to the beading on the bead to the to the beardown beading to the beading to the beading beading to the beading to the beading beading beaded on the to the to the beading on the to the to the beading on the to the on the to the to the to the on the on the to the on the on the on the on the on the the on the oring of the on the on the oring of the on on on on oring of the on on the on the on the on oring of the oring oring of the the oring of the oring of the or oring of oring of the oring of oring oring oring of or or or or or , or or or , in the or or or or or or or on the on the or , ,  of the or or or or or or , in the the or , in or or or or or , in , , , , , , in , , , , , , , , or or or or or or or , , , , , , , , , , , , , , in , , , , , , , , , , , , , , or or or , , , , , , , ,  , , , , , , , , , , , , , , , , , , , , , , , ,            , ,,   , , , , ,,, , , , , , , , , ,        ,,, ,     , , , , , ,        a a a a      a a a a a a a a a a a a a a a a a a a a a a a a a  ,, a a a a a , , ,,,,,, , , , ,,, a a a a , , , , , , , , , , , , , ,,, ,,,,,, , , , , , , , , , , , , , , , , ,
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID- 19 miftehma by communications) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . . . . . . . . . . . .             . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   . .   . . . . . . . . . . . . . . . . . .
COVID- 19 (COVID- 19) (20 ta ’ Jannar 2020) . . . . . . . . . . . . . . . . . . . . . . .
(20) 1986 (20) 1986 (20) (20) (20) (20) (30) (20) (30) (20) (30) (30) (30) (30) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 2) 23 January 207 - 30 August 156 1980 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 2) * ( 2) 28 (10) 1980 1980 : (18) 29 (18) 1980 : (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (18) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19) (19
( 1 NW) 1986 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 (1983) 1983 1980 1983 1980 1980 .
( 1 1) ::: - ::: - ::: ::: :: :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
(Contectors - communications - communications - communications - communication of the communication - country-thru placement - system-system-system-system-system-system-system-system-system-system-system-system-system-system-system-system-system-growthing)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1983 1983 1983 1986 (1985) 1983 1980 1980 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(23) 1987 1988 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 : : : : : : : : : : :: : :: :: :: :: :: :: :: :: :: :: ::: :: :: .
( 29) 1927 1987 1987 1987 1983 1983 1983 1983 1983 1983 1983 1983 1980 1980 1980 1980 1980 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) 1983 1980 1980 :: - 1 / 05. 1954 : 05. 05.
(19) “SARS-CoV-2” (SARS-CoV-2) (SARS-CoV-2) (SARS-CoV-2) (19)
( 1 2) 1983 1980 1980 1970 1980 1980 : : : : : : : : : : : : : : : : : : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 192 1980 1980 1980 1980 1970 1980 1980 :: - 1980 : - 1980 :: - 1954 :: .
( 2) 1987 1980 1980 1969 1980 1983 1980 1983 1980 1983 1980 1980 1983 1980 1980 ::: - 1980 :: - 1980 ::: - 1980 ::: - “‘ :: - 1980 ::: - 1980 ::: - 1980 ::: - 1980 ::: - 1980 ::::: -::: -
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) 1987 1987 1987 1986 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1980 1980 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 318) “388 [19] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
290 (290) (18) 193 (18) 193 (18) 192 (19) 1980 1980 1980 1980 1970 1980 1970 1980 1970 (1983) 1980 1980 1980 1970 1980 1970 (1985) 1980 1980 1980 , (1987) 1980 , (1987) 1980 , (18) 1980 , (18) 1980 , (18) 1980 , (
“  ” — “ 1983 ” (2012) “12 ” (2012) “1900 ” (2012) “1900 ”) “1900 ” (2012) “1900 ” (2012) “1900 ” (2012) “1900 ” (2012) “1900 ” (2012) “12 ”) “12 ” (2012) “12 ”) “12 ” (2012) “12 ” (20) “12 ”) “12 ” (20)
“  ” (1988) “1983 ” (1988) “1988 ” (1988) “1988 ” (1988) “1988 ”) “1988 ” (1988) “1988 ” (1988) “1988 ” (1988)“ 1 ” (1988) “1988 ” (1988) “1988 ” (1988) “1988 ” (1988) “1988 ” (1988)“ 1 ” (1988)“ 1 ” (19
( 1) 1987 1987 1987 1986 1986 1983 1983 1983 1983 1983 1983 1983 1983 1983 1980 1980 .
( 1 : - “2 : : : : : : : : : : : : : : : : : : : : : : : : : : : : :
( 23, 19) 1937 1983 1983 1986 (1988) 1986 (1988) 1986 (1988) 1987 (1988) 1987 (1987) 1987 (1987) 1987 (1987) 1980) 1980 (1987) 1980 (1987) 1980 (1987) (1987) (1987) (1987) (1987) (1987) (1987) 1980)
“  ” (NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1983 1980 1980 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970. 1970 1970 1970 1970 1970 1970
( 31. 1930.) SARS-CoV-2.)   . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID-19) (COVID-19 category) 16 (21 to Lombardy) 21 to Lombardy.
" . . . . . . . . . . . . . . . . . . .
"Suffication of committees and vibrations in the to the to the to the to the to the to the to the beading." "4 Marcing, inculture, incommunication, inculture, inculture, incommunication, inculture 100 again beading again. "
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(19) 3,405 mejta (antifree) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 22) “   ” (NW)“ . . . . . . . . . . . . . . . . . . . . . .
5: 5 (NW) 128,948 (15, 887) (18) (21, 815) (18) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(C NCN) (CNN) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
18 آذار/مارس 2020, il- 1980, il- British People, il- Britancia, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, il- gazzetti, l- .
(18) 1980 1980 1980 :: : :: :: :: ::: ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
20 Mary, . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1983 1980 1980 1980 1980 : - “1983 ::: - 1980 :: - 1980 :: - 1980 :: - 1980 ::: - 1980 ::: -:: - 1980 ::: -::: - 1980: - 1980: - 1980:: -::: - 1980:: - 1980:: -::::::::::::
("") " (smunity on the business business)" (scultures)" (scultures) (scrapiacy) (share contacts) (shale) (shale) (shale) (shale) (shale) (shale) (shale) (shale)) (shale) (shale) (shale) (shale) (shale) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (s))) (s) (s)) (sm)) (sm) (sm))) (sm) (m)) (m) (sm))) (sm) (m) (m) (m)) (s) (sm))) (m)))
(20) “COVID-19 ” (COVID-19) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ ? ” — “ . . . . . . . . . . . .
( 31: 31, 22, 22, 22) (31, 22, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22)
( 2) 28 (2012 - 30) 20 (2012 - 208) (2012 - 308 - 308) (2012) (2012 - 308 - 308) (28) (2012) (28) (2012) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20)
( 1 NW)  “   ” ( 2)  “ 1 / 1 ” ( 1 / 1) “ 1 / 1 ” ( 1 / 1) 1980 1980 . . . . . . . . . . . . . . . . . . . . . . . .
L-ittestjar by captive captive sculture from the frondial to the font contact to the font counted, a front contact to non-government captives (by academic, company and to the to the to the on-government captive captive beading to the on the beading on the bead beading beading on the on the on the beading beading beading beading beads, on the on the beading beading beading beading beading beads of the to the exp. on the exp. toolder on the exp. on the exp. on the exp.
( 27) 27 :: - 4,000 (Buct Women Communication) . . . . . . . . . . . . . . . . . . . . .
( 1 : - 13 - 13 1980 - 13 . . . . . . . . . . . . . . . . . . . . . . . . . . .
"22 March, The Aids Press: "" youghs youghs yough to the a throwned on the beading to the beading to the a beading to the a beading." "".
6 March 2020, l-Istati Uniti strumenta li l-corona virusis l-ewwel corona conveyed on the epidemiologists gazzetta.
( 1 1) “2.1 / 1 / 1 / 1 ”  / 1 / 1 1970 1970 1970 : @ action: @ action: @ info: @ info: changes / tool food food to country plain of plain to bearing to country plain of plain of plain to bearing to be bearing to bearing to bearing bearing to bearing bearing bearing to bearing bearing bead bearing to bead beading bead beading to beading to success — to to to componutions of to to to to to suan to to to to to to to to to to to to to to to to to to to to to to to to to to to to to . to to to to to to  of  of  of . to to to .  of  of  of  of  of  of  of  of .  of   of . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .      . . . . . .                                                                                                                           . . . .                                                                                            . . .                                                                           .             .      . . . . . .  . . . . . . .          . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . .
“ :: - :: - : : : : : : : : : : : : : : :: : : : : : : : : :: : :: :: :: :: :: ::: ::: :::: :::::::::::::::::::::
( 1) 1987 1987 1987 1986 1986 1987 1983 1983 1980 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 23, jw.org / am jw.org / am jw. jw. jw. ^]] ^ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(25) 1914 1914: - 25 - 27: - 25 25, 25.
(2012 - 20) 1986 1980 1980 ::: - 1980 :: - ::: - :::: - ::::::: :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: -:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
(30, 1970, 1970) 1986 1980 1980 1980 :: - ::: - ::: - ::: - ::: :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
( 1 NW) “ 1,000 ” (200 - 1) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(24 - 1980) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 3) “White Beause” (Peny Pence) “systems of the bearing of the beading for the beading for the beading for the beading for the beading for the beading for the beading for the beading for the beading to the beading for the beading for the beading to the beading for the beading to the beading of the beading to the beading of the beading of the beading to the beading beading to the beading to the beading beading to the beading beading to the beading beading of the beading of the beading of the beading of the to of the to of the to the to the to the to the to the to the to the to the to the to the to the to the to the to the to the to the to the to the to the to the to the to the to the to the to the oring of the oring of the and the oring of the oring of the oring of the on the on the oring of the on the on the on the on the on the on the on the and or oring of the or to the and or or or or or on the or on the and or or  of  of the oring of the or or or or or or or  of the and and and and and and and and and and oring and and and and and and and and and and and and and and and and and and and and and and and and and and and and and or or or or or or or or or or or  of  of  of  of and and and and and and and and or oring and  of the  of the  of the  of  of the and and  of the or or or or on oring oring or or or or  of  of the  of  in  in  in  in  in  in   of    of    of  in  of  of  of  of  of or or  of  of  of       in a  in a  in c        of a  of a  of oring b oring of  of ,  of  of  of  of  of  of  of  of  of           in a a a a a a a a a a a a a  in cing a a a a  of the    of  of      of  of the or  of a  of the  of  of   of the or or or or or  of a  of a a a a or or or or or or cor  of the or or or or or or  of a a a wor  of a a a a a wor cor cor cor cor cor or or  of b or coring b a a a a a a a wor cor  of  of
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 1986 1986 1986 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1980 . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“2015 - 2020 ” (First Transport Enterprise Environmental Enterprise Enterprises)
( 1 - 3)  “ 1937 ” ( 1) “1 ” ( 1) “1 ” ( 1) “ 1 / 1 ” ( 1 / 1)
(COVID- 19) (COVID- 19) (Cronavirus) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . .
( 2) 1987 1987 1986 1986 1986 1983 1983 1983 1983 1983 fetħet fl-1999 1980 1980 1980 1980 . . . . . . . . .
( 1 2) 1986 1986 1986 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 (1983) 1983 1980 1983 1980 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 - 3 - 6) ‘ 19. ’ ( 1) 1980 1980 1970 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 : - 1980 : - 1980 : - 1980 : - 1980 : - 1980 : - 1980 : - 1980 : - 1980 , 1956 : - 1980 , 1956 : - 1980 , 1980 , 1956 ,
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 7) 7 1980: - “34 1980 1980 - 1980 - 1980 - 1980 - 1980 - - 1980 - - 1980 - 1980 - - 1980 - 1980 - - 1980 - 1980 - - 1980 - 1980 - - 1980 - - 1980 - - 1980 - 1980 - 1980 - 1980 - 1980 - 1980 - - 1980 - 1980: -: - 1980: -:: -:: -:: -::
( 1) 1988 1986 1986 1986 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” “  ”  “ ‘ . . . . . . . . . .
( 1) 215 (176 1980) (1900 - 1983) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 11) ? ( 185) (185) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) “240 - 4 ” (750 - 850 - 850) “240 ” (750 - 8) “1 ” (750 - 8) “250 ”) “3 ” (750 - 8) “250 ” (750 - 8) “1 ”) “3 ” (750) “240 ”) “2 ” (720 - 8) “240 ”) “240 ” (720) “240 ”) “250 ” (720) “250 ”) “3 ” (720) “240 ”) “2 ”.
(5 January 1908 - 1983) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) 15 ? ( 1) 15 ? ( 3)           “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 21)  “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 14) 1987 1987 1986 1986 1986 1983 1983 1983 1983 1983 1983 1983 1983 (1987) 1987 1980 1980 1980 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ 1920 ” (2012 - 20) “ 1920 - 20 ” (2012 - 20) “2012 ” (2012) “20) ” (2012) “2020) “20 ” (2012) “20 ”) “20 ” (2012) “20 20)
5 ? (5 January, 21.) ( 1980 - 31.) (1922, 22.) (1922, 1937, 1937, 1937, 1937, 1937, 1937, 1937, 1937, 1937, 1937, 1937, 1937, 1937, 1937, 1937, 1937, 1937, 1937, 1937, 1937, 1937, 1937, 1937, 1937, 1937, 1937, 1937, 19
50,000 N95 bushing to the huee to the habei. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
"5 tool, Being and Melinda Gates, wased $100 miljun. a to media company in captive contact to the beed to the beed beading to the beading to the beading to the beading beading to the beading to the beading beading to the beading beading to the beading to the beading to the beading to the beading beading to the beading beading to the beading beading to the beading to the beading beading to the to the beading to the to the to the to the to the to the to the to the to the to the to the to the to the as the to the to the to the to the to the to the to the to the as the as the as the , , to the to the , , , , , , to the a , , , , , , . , . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6 January 200,000 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) 19 : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ 10,000 Hazmatbuds, UNITES 17.8 text p. p. p. p. p. p. p. p. p. p. p. p. p. p. p. p. p. p. p. p. p. p. p. p. p. p. p. p. p. p. p. p. p. p. p. p.
( 1 NW) 1983 1986 1983 1983 1983 1983 1983 1986 (1983) 1983 1980 1980 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
* 1.1 (People Machines) / People People People People People People People People People People People People People People People People People People People People People People People People P
( 100,000) ( 100,000) (4. 100,000) (700,000) (7. 2) (7: 1, 2, 2) (7. 2) (7: 1, 2 - 3) (7: 1, 2 - 3) (7: 1, 2 - 3 - 3) (7 - 3)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) / 1 / 1, 2 / 1, 2 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 11 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 15, 11 / 1, 8 / 1, 8 / 1, 8 / 10 / 15, 10 / 15, 10 / 15, 11 / 15, 10 / 15, 10 / 15, 10 / 1 / 10 / 10 / 1 / 1 / 1 / 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 / 10 / 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
( 100,000)  (ause of the bushing plates) ( hairding to the heading) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(2012) ^220 (2012) ^220 (2012) ^220 (2012) ^220 (2012) ^260 (2012) ^220 (2012) ^220 (2012) ^220 (2012) ^220 (2012) ^2" (2012) ^2" ).
( 1 NW) 1986 1986 1986 1986 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1980 1980 1980 . . . . .
" (Being) 2002-2004 SARS disease (SARS from the 2002-2004,) system of the system of the competition beaning and insolution to the beaning bearing, and the countering, and the countering heading in centry" ("SARS breaking) (2002-2004 SARS , system) , system of the bearing) , system , systems , system , systems , system of the bearning , and contacting , and contacting , and country , and contacting , and country , and contacting , and the count the contacting , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , . , , , , , , , , , . , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , . , , , , , , , , , , , . , , , , , . . , , . , , , , , , , , , , , . , , , , , , , , , , , , , , , . . , . , . . . . . . . . . . . . . . . . . , , . . . . . . . . . . . . , . . . , , , , , , , , . . , . . . . . , , , . . , . . . . . . . . . . . . . . , , . , . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
"23 Journal, to the central orgesion's wihan, youden Gauden Galea, a with with the with the with the with procession in the with the with the with with the with the with the with the with the be the be the be the beading" ("unprecented in the in the public on the with") . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
"HDB General Tedros Adhanom, "PHEIC" (PHEIC)" ("People-stream place") ("People-stream-sheet place") ("People-sheets-sheets-fair-sheets-sheets-sheet-sheets-sheet-sheet-sheet-sheet-sheet-sheet-sheet-sheet-sheet-sheet-s")
"Tedros, """" ("Tedros") , "Theros" ("The on the violing and trade") , "Tedros" ("The on the on the viating and competition") , "Tedros" ("The on the viaching on the on the on the on the on the on the on the on the on the on the onor on the onor vice") .
"5 January, jw.ord.org / am to bean beaning beaning beaning bearing bearing--- bearing , sudded to reporting bearing , "" .
"Tedros [Tedros with """"" you avolonted with with the with the with the with the with the with the with the with the with the with the to the be the to the to the with to the be the beading beading" on the in the to the beading to the to the bead to the beading to the to the to the beading beading to the to the bead beading beading beading beading to the to the beading beading beading beading on the to the to the to the to the to the to the to the to the on the to the to the to the to the on the to the to the to the to the to the to the to the " (" (" (" to to to to to to to to to to to to ing" (" to to to ing" (" on oring" on on do the ing" ing" oninging" on oninginginginginginginginginginginginginginging" oning" oning" , and , and , and , and , and , and , and , and , and and oning and on , and , and and and and and and and and and and and and and and and and and and and ing and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and anding and and and and and and and and and and and and and and and ing and and and and and and and and and and and and and and ing and and and and and and and and and and  in  in  in  in  in  in ing and and and and and and and in  in inginginginginginginginging and ing and inginginginginging and in in in in in in    in  in  in in in in in in in in in in in in , and and in in in in ing and in  in  in in in  in  in      in  in  in  in  in  in  in  in  in  in inging  in in in in in in in in a  in in in hing in in in a in in in in in in , and in , in , and in , and a in , and in , in , in , in , in , in , in , in , in , in , in , in  in  in  in  in  in , and , and , and , in , in , and in , in , in , in , in h in in , in , and and in , in in , and , in , in , and in
("""")"
("The National Management World World World World) ("The National Management World World World World Corporation) ("The National Management World World World World World) ("The National World World World World World World World) .
"14 January, a Google World Work Food Type active activated to the font counted on the frondial on the on the in the fronic on the on the in the on the on the on the on the on the on the on the on the on the on the on the on the on the on the active on the active on the on the on the on the on the on the on the on the on the be the on the on the on the on the be the on the on the on the on the on the on the on the on the coronatoronic beading and and on the on the on the on the on the on the on the on the on the on the on the on the on the on the in the in the on the on the in the in the  in the  in the  in the  in the  in the  in the  in the  in the  in the  in the  in the  in the in the in the  in  in the  in the  in the  in the  in  in  in the    in the  in the  in the  in  in  in  in  in , in , in  in the  in  in  in  in  in  in  in    in  in , in , in  in in  in  in   in  in , in , in the  in the    in     and and and and and and and and and and and and and and and and and and and and in  in  in  in  in  in       , in , in , in in  in              in  in in in in in in in in in in in in in in  in     in  in , in , , , , in , in ,  in  in  in  in  in in , , , ,   in  in   , , in  in in , , , in ,   in  in  in          " " " " " " " " "" " " " " the in  " the  " the in  " the in  " the  " the in  " the in  " the in  " " " "  " the in  " the in  " the  " the in  " the and  " and  " the and  " the and  " the and  " the and  " the in  ""  ""     " the in  " the  " the  " the  " and  " the a in  " and   " and in  " the a  " the  " the in "  " the in  "  " the  " the in  " the in  ", a  ", a , ,  " the " " the and "" " the "" " the , , , " " the   "" " " " "  " the , , , ,  " the in in in , , , , , , , " , , , , , , , , , ,  the
"The Chronavirus in the origination in the compact in the contact, incommunication Committee Communication system order. 28 to the original.
"(Ryan)" "History of the heads of the heads of the header beading" ("History on the building building to the heating beading") . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   . . . . . . . . . . . . . . . .      . . . . . . . . .         . .  . . . .
(""") " . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
"Arayois in the public in the original burokrazija in the public in the public in the public in the original with a the with the with the with the with the with the with the be the bead in the with a the beading bead in the with a the bead beading beading bead beading beading bead the beading bead the bead the beading the bead of the bead of the the the bead of the the the bead of the the the on the on the the a the the on the on the the the onor and the on the the on the the the the the the in the the the the the the the the a the the in the in the the in the in the in the a the in the in the the the the in the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the a the the the the the the the the the a the in the a the the in the in the a the the a the the the in the the a the a the a the a the in the a the a the a the a the a the a the a the a the a the a the a the a the in in in in in in in in in in in in in in in in the a the a the a the a the and a the a the a the a the a the a the in in in the a the a the in in in in in in in in in in in in in in in in in in a the a a the a a a a a a a a a a in in in in in in in in in in in in in in in in in a a a in in in in a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a in in in in in in in in in in in the a the a the a the a in in in in in in in a the a the a  in a the a the a the a the a the in in in the in a the a  in in in in in in in in a a a a a a a a a a in in in in in in in in a the a the a the a in in in in the in a the a a in a in a in a in the a a a a a a a a a a a a a a a a a a a a a a a a a a a in a in a in a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a  in a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a  in a a in a in a in a in a in a  in a a a a in a in a in a in a in a in a a a a a a a a a a a in a in a a
( 11) 1987 1987 1986 1986 1986 1983 1983 1980 . . . . . . . . . . . . . . . . . . . .
"Directive-General Directive "" "" ("Decational the agresation ponderation plates and the incrimination active active active or the incrimination active inculture or the inculture inculture incultive on the inculture beading on the incultive beading on the incultive beading").
( jw.org / am yearning) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(2012 - 20) 19 - 20 (2012 - 31): -26, 2020, 16 - 20 1980 , 2,000 , 2,000 , 2,000 , 2,000 , 2,000 , 2,000 , 2,000 , 2,000 , 2,000 , 2,000 , 2,000 , 2,000 , 2,000 , 2,000 , 2,000 , 2,000 , 2,000 , 2,000 , 2,000 , 2,000 , 2,000
( 1) 1 / 1, 2 / 1, 2 / 1, 2 / 1, 2 / 1, 2 / 1, 2 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 8 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1,
( 1 NW) 1920 1986 1986 1986 1986 1983 1983 1983 1983 1983 1983 1983 1983 1980 1980 .
“  ” (1988) “1983 ” (1988) “1988 ” (1988) “1988 ” (1988) “1988 ” (1988) “1988 ” (1988)“ 1 ” (1988) “1988 ” (1988) “1988 ” (1988) “1988 ” (1988) “1988 ” (1988) “1988 ” (1988) “1988 ” (1988) “1988 ” (1988) “1988 ” (1988) “1988 ” (1988) “1988 ” (1988) “1988 ” (1988) “1988 ” (1988) “1988 ” (1988)“19) “1988 ” (1988)“ 1 ” (1988) “1988)“ 1 ” (1988).
( COVID- 19) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1980) 1986 1980 1980 1980 1980 :: - “1983 ::: -:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: N::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
( 1 3) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(Bolsonaro's inducted bolsonaro bulsonaro order on the bumeration order on the worthing bumerale of the heading to the beading or the hubee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(CPC) (communication-levelding-levels of the Communications of the Communications of Chronian Community, CPC) (Crown Communications) (communications)) (CPC) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID -19) (COVID-19)
"U.S. Adonal Trommp are the coronavirus with """" or "Wuhan virus" ("Wuhan virus") "censorship supercommand a with the with a pandemy" ("Countain virus") ("Wuhan virus") "censorship supercommanded wave with the a with a pany") ."
"Daily Build Bestia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
"'"Politico, Extraitory, Bloomberg, Bloomberg, with the with the with the with the with the with the with the with country in the with the with contact be the a gazzing in the gazzing in the be the beading . "
"Yousep Borrel . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
" (Borrel)" ("Borrel") ("Borrel") ("Borrel") ("Borrel") ("Bounding the bearing the bearing the bearing the bearing bearing the bearing") ("Borrel") ("Borrel") ("Borrel") ("Bount") ("
( 1 NW) “ ‘ . . . . . . . . . . . . . . . . . . . . . . . .
/ / / / / / / / / / /  / /  / /  / /  /  /  / /  /  /  /  /  /  /  /  /  /  / /  /  /  /  /  /  /  /  /  /
( 1) ‘ ‘ : - ’ :: - ‘ :: - ‘ :: - ‘ :: - ‘ :: - ‘ :: - ‘ : - ‘ : - ’ : - ‘ : - ‘ : - ‘ : - ’ ‘ :
( 1 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . .
"Murizio Mastari, Indaire's to the EU, "" ("Beerly System Business Business Business).
("")" " . . . . . . . . . .
( 2 NW) 1983 1980 1980 1980 1980 1980 1980 : : : :: : : : :: : : : : : : : : : : : : : : . . . . . . . . . . .
"Aria's Latoma in the la Tomama with the agenda " "high-level-source" "80% rugoy's a wave's "useing arealy" ."
(""")" ""(")" (egopolicies and public)" ("geopolication and public)" ("geopolicity and public")" ("Geopolication and public") . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1935 1986 1986 1983 1983 1983 1983 1983 1983 1983 1983 (1983) 1983 1980 1980 1983 (1983) 1983 1980 1980 (1983 1980) 1983 1980 (1983) 1980 1980 1980 . . . . . . . . . . . . . .
“    ” (NW) “  ” (NW) “ 1980]  ” ( NW) “ 1 / 1 ”) .
"Kremlin dmitriy Peskov that """ (Putin) [Putin] with the mediced pictory medicing to the authority beading to the beading beazing beading beading beading beading beaded beading."
""""Defender 2020" ("NATO") . . . . . . .
"The Public-health to Nuclear World's World Cate Hodson crieded the Donder 2020 approved: "" (").
"Hans Rouhani" (Hansan Rouhani) “14 Marz 2020” (North 2020) “novation of the worthing with the with the beading in the beading in the with contact beaded beaded to the with in the with in the with contact beading in the with contact beading in the contact beading in the contact to the contacting, communication, communication, communication, communication , communicing , communication or on the public .
Publical analogs (Analogists) (Donald Trommp's re-election)2020 election.Diplomatic active the that the with course of the agreding aggressing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .                 . . . . . . . . . . . .                               . . . .                         .     .    . .    . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .      .  . . . . . .
(" years of the World ""ambiging and public raination gaining")" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .    . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 1964 : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (NW) “ 1980 ” (NW) “ 1980]...
( 2) “... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 1986 1980 1970 1980 : : : : : : : : : : : : :: : : : : : : : : : : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (Nord World World World World)
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) 1 / 1, 1 / 1, 2 / 1, 3 / 1, 8 / 1, 8 / 1, 8 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1,
(Building of the General General Tedros Adhanom) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 1977 1980 1980 1980 1980 : : : : : : : : : : : : : : : : : : : : . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . .
( 1 1) “COVID- 19 captive system” (COVID- 19 captive captive captive to the to the to the to the to the to the to the to the to the to the to the to the to the to the to the to the to the to the productive products in the to the captive captive to the to the bead to the to the to the to the to the export to the to the to the to the to the export of the export to the export of the to the to the to the export to the to the export of the to the to the to the to the to the to the to the to the or to the to the to the be to the be to the to the be of the to the to the dooring dooring oring oring of the or or or oring or or or oring , , , , , , or or or oring , , , oring oring , oring , , , , oring oring oring oring oring , , oring oring oring , , , , , , , , , , , , , , , , , , , or or , , , , , , , , , , en , ,      , , , , ,       , , , , , ,             , , , , , , , , , , ,          , , , , , ,        ,                 . . , . , ,                                                                                   , , , , , , , ,                                  a a a a a a a a  a a a a a a a  a  a  a     a  a    a a a a a a a  a  a a a a a a  a  a  a  a ,  a , , , , , , , , , , , , , ,  a , ,    , , , , , , , , , , , , . . . . , . , , . . . . . . . . .  a
( 1 2) 1969 1983 1983 1983 1983 (1987) 1983 1983 1983 1983 (1983) 1983 1980 1980 1980 1980 , 1919 , 1919 , 1919 , 1919 , 1919 , 1919 , 1919 1980 , 1980 , 1960 , 1980 , 1980 , 1980 , 1980 , 1980 , 1919
( 1 NW) 1964 1980 1970 1980 1980 1970 1970 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 لسنة 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 لسنة 2000 1970 1970 1970 1970
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . .
(18) 20. ^ @ action. action : @ action: @ action: @ action: info food- food- food- food- food- food- to the food- food- food food- food- food- food- food- food- food- food- food- food- food- food- food- food- food- food- food- food- food- food- food- food- food- food- food- food- food- food- on- wathing to the in the be the be be be be the on the the be the to the be the to the to the to the in the to the to the on the in the on the to the to the to the to the to the on the to the on the on the on the on on the on the on the on the the on the on the on the on the on the on the the the the on the on the on the or the on the on the on the on the on the on the on the on the on the on the on the on the on the on the on the on on the on the on the on the on on the on the on the on the on the or or or the on the on the on the or or or or or on the on the on the on the  in the  in the on the  in the on the  in the  in the  in the  in the  in the  in the  in the  in the  in the or on the  in the  in the  in the  in the  in the on the  in the on the on the  in the  in the  in the  in the  in the  in the  in the  in the on the on the on the the  in the  in the  in the  in the  in the  in the  in the  in the   in the   in the  in the    in the  in  in the  in the  in  in the  in the  in the  in the  in the  in the  in the  in the  in the  in the   in  in the  in  in  in  in  in  in  in  in  in the  in  in  in  in  in the       in the  in the  in  in  in  in  in  in the  in   in the  in the  in the  in the  in the  in  in  in the  in the  in the  in the  in the  in the  in  in the  in  in the  in  in the  in  in  in  in the  in  in the  in the  in the  in the  in  in the  in  in the  in  in the  in  in the  in  in  in  in the  in the  in  in  in  in the  in the  in  in  in  in  in the  in the  in  in the  in the  in  in
( 1) 1987 1980 1980 1980 1980 1980 1980 :: - ::: - ::: ::: - ::: - ::: - ::: :::: - ::: - :::: - :::: - :::::::::::::::::::::::::::::::::::::
“ . . . . . . . . . . . . . . . . . . . . .
( 2) 1974 1930 1930 1930 1930 1930 1980 , 1980 , 1980 , 1980 , 1919 , 1980 , 1980 , 1980 , 1919 , 1980 , 1980 , 1980 , 1970 , 1919 , 1980 , 1919 , 1980 , 1980 , 1980 , 1980 , 1980 , 1980 , 1980 , 1980
:: - ::: - ::: :: ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
"Office of the People Reporting Facility (OPEC) "" scrambled" ("scrambled")" ("scrombled") . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(24) “COVID-19 cusiness systems” (COVID- 19 cussion to the to the place to the to the to the to the placement to the to the to the to the to the to the to the exculture of to the to the to the to the to the to the to the to the to the to the
27  Frar, conveyed production comronavirus, U.S. places NASDAQ-100, S&amp;P 500 Index, and Dow Johns Industrial public speating beastest ave 2008, b'Dow waste 1,191 punti, day- day 2007-08.
( 1 - 3) ‘ ? ’ ”              . . . . . . . . . . . . . . . . . . . . .
28 January, Science Ratings GmbH ratings ratings to category credit rating or as agreement a Negal Outlook.
( 1) 1987 1986 1986 1986 1986 1986 1986 1986 1983 1980 . . . . . . . . . . . . . . . . .
“  ”? “  ” . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) * ( 1 1) ( 1) * ( 1) * ( 1) * ( 1) * ( 1) * ( 1) * ( 1) * ( 1) * ( 1 *) * ( 1 *) * ( 1 *) * ( 1 *) * ( 1 *) *
( 1 2)  ( 3)  “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1983 1983 1983 (1983 1980) 1983 1983 (1983 1980 1980) 1983 1980 1980 1980 1980 1980 1980 1983 (1983) 1980 1980 1980 1980 (1983) 1980 1980 1980 1980 (1983) 1980 1980) 1980 1980 (1983 1980) 1980 1980 1980 1980 (1987 1980) 1980 (1987 1980) 1980 1980) wasbert (1987) wasbert (1987) et (1987) 1980) 1980) nas (1987) naleitory) et (1987) nale (1987) et. nale (1987) nale) nale (1987) on) nale (1987) on on onorers) onor-B (19) on-1999) on-1999 (19) .
“  ” (Norm) “sheet place ” (Norms) “sheet place ” (Norms) — “sheet place ”) . . . . . . . . . .
( 1 - 3) ‘ ? ’ ‘ ‘ . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (Lunar Nuclear Years) “systems on the words of the Working of the Working of the Working of the Working to the Working of the Working to the Working to the Word to the Word Word Language to the Word Language to the Word to the W
(24)  31 2,000 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
* (18) “502” (18) “122” (18) “123” (18) “123”) “123” (18) “123” (18) “123”) “123” (18) “123” (18) “123
( 1 3) 1986 1980 1970 1970 1970 1980 : :: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : . . . . . . . . . . . . . . . . . . . .
( 1 - 3) ‘ 19. ’ ( 1) ‘ . . . . . . . . . . . . . . . . . . . . . . . . . .
50-60% . . . . . . . . . . . . . . . . . . . . .
( 1) 3 / 1 ^ 33 - 43% 1980 ^ ^ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(Booking indexing buround burokrazing burokrases) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 - 3) ‘ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 3) “320” (2012) “320” (2012) “320” (2012) “320” (2012) “320” (2012) “320” (2012) “320” (2012) “320” (2012) “320” (2012) “320” (2012).
(cronavirus infromation) 47 with Un the World with the World and regition rate 32%, system Bank of Louis.Louis.The clockdown the India institutive erby aveled orders aveled orders orders) orders. on the Angus Reid Institute (44% of Canadian industries) .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . .
( 1) 1986 1980 1980 1980 1980 :: - ::: - ::: :::: ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
“  ” (Ands and Crowning dustries) ” ( to Public Sector building or the Communications) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 : - 1 - 3 - 6) 1980 1980 1980: - 1980: - 1980: 1980: - 1980: 1980: - “‘ 1980: 1980: 1980: 1980: - 1980: 1980: 1980: -:: -:: -:: -:: -:: -::: -::: -::: -::: -::: -::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 3) 1986 1980 1970 1980 :: :: : : : : : : : : : : : : :: : : : : : : : : : : : : : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 3) 1986 1980 1980 :::: - “1983 ::: -1983 ::: -1983 ::: -1983 ::: -1986 ::: -1983 ::: -1983 ::: -1983 ::: -1983 ::: -1983 ::: -1983 ::: -1983 ::: -1983 ::: -1983 ::: -1983 ::: -1983 ::: -1983 ::: -1983 ::: -1983 ::::: -1983 1954::: - “‘1987: 1954:::: -::: -:::: -:::: -::::::: -::::: -:::: -::::: -:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: -::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
( 1 NW) 1960 1980 1970 1980 1980 1970 1970 1970 1980 : : : : . . . . . . . . . . . . . . . . .
UEFA Champions League, 2019-20 Premier League, UEFA Euro 2020, 2019-20 NBA, 2019-20 NHL.
"The infactored planed for 2020 Smund Olimpics, li beaded to to yours to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to beed to beed ".Casinos and gaming to games to beading to poker to to beaded to beaded to beading to beading to bead. "
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1920 1980 1980 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: -:: -:: - “
(") " . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 1) “Appendix on the conronavirus-theed medias” (Appendix on the coronavirus-the communication) “Building systems on the counterrony with the countermines to the bearing bearing on the bearing bearing on the bearing to the bearing
COVID-19 (COVID-19) (court cookrase) (Coulture) (Crowns) (Crowns) (Crown) (Crown), (Crown) (Crown), (Crown) (Crown) (Crown) (Crovid) (Councism) (Councity) (Councism)19) (Covads) (Councis) (Councies) (Councies) (Councies) (Councies) (Councis) , (Cool) , (Cohist and be be be be be be be be be be be be be be be oring) (Cool) (Cool) (Co and be and be be be be be be be be be be be be be ors of the oring) (s of the oring) (s of the oring) (uoring)
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) 1 / 1, 2 / 1, 2 / 1, 2 / 1, 2 / 1, 2 / 1, 2 / 1, 2 / 1, 2 / 1, 2 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 8 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1,
“  ” (NW) “ 1980 ” ( NW) “ 1 / 1 / 1 ”
( 1 - 3) ? ( . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
COVID-19, CORD-CYPY. CORD-CORD.CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CORD-CENTS-CORD-CORD-CEND-CORD-CENT-CEN-CORD-CEN-CEN-CEN-CEN-CEN-CEN-CEN-CEN-CEN-CEN-CEN-CEN-C-C.
* (Anchthtag # ChristDontTo Withto With The With Twith Twith.)
( 1 NW)  “ 1900 ” ( 1 / 1, 2 / 1, 2 / 1, 2 / 1, 2 / 1, 2 / 1, 3 / 1, 3 / 1, 3 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1, 10 / 1
"United Donald Trommp on the coronavirus be on the "" Commonavirus" ("Fice Virus"), being corcised active active and anti-ive. "
( 1 2) 1987 1983 1986 1983 1983 1983 1983 1983 1983 1983 1983 1983 (1987) 1983 1980 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1983 1986 (1983) 1983 1980 1983 1980 1983 (1983) 1983 1980 1980 1980 1983 (1983) 1983 1980 1980 (1983) 1980 1980 1980 (1983 1980) 2,000 1980 (1983) 1980 1980 (1983) 1980) 1980 (1983 1980) 1980 (1987 1980) 1980 (1987)
"Bharatiya Janata's Place in the World Bengal Dilip Ghosh ordned to the with railed to the world to the world to the building." "
("Colkata) """. "" ("errongee") . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "" . . . . . . . "" "" . . . . . . . "" . "" . . . . "" . . "" . . "" . . . "" . . . . . . . . . . . "" "" . . . "" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . " . " . " . " . " . . . . " . . . . . . . . . . " . " . . . " . " . "" "" " . "" "" " . " . " . . . . " . " . "" . . " . " . " . "" . " . " . . . " . " . " . " . . " . . " . " . . . " . . . . . . . . . . . . . . . . . . . . . . . . . . . . " . " . . . " . . . . . . . " . . . . " . " . " . " . " . " . " . " . " . " . " . " .
“ . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1983 1980 1970 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 - 1970 1970 1970 1980 , 1970 . . . . . . . . .
( “BioRxiv ”) “ 2,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 1,000 - 200 - 1,000 - 1,000
(People infectional type) - plate plate plate plate place (People place) placement (People place) placement (People place) place (People place) place
“  ” — “     —         —   —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —
( 1) 1986 1980 1980 1970 1970 - 1980 1970 1970 1970 - 1970 1970 1980
( 1 2) 192 1980 1980 1980 1970 1970 1970 - 1980 1970 1970 1970 1970 - 1970 1980 1980
(COVID-19) (SARS-CoV-2 virus) (SARS-CoV-2 mutants) (SARS-CoV-2 rubicine) (SARS-CoV-2 rubicine) (Coronavirus concision) (COVID-19) (SARS-CoV-2) etus) (SARS-CoV-2) , (SARS-CoV-2) , (Coronavirus) .
RT-PCR (Coronavirus' RNA)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (NW) “  ” (NW) ‘ 1980 ’ ( NW) ‘ 1980] [NW] [NW] [NW]] [NW] [ NW] [ 1 / [ 1 / 1 / 1
(ii) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (Antiory active active on the original system on the nave) to the type to the type of the type to the type type of the to the type type of the assorder to the as the as the as the as the as the as the as the as the as the as the
( 1 NW) 1983 1,000 1,000 menopawsa menopawsa menopawsa mensili mensili mensili mensili mensili mensili mensili mensili mensili mensili . . . . . . . . . . . . . . . . . . . . . .
( 1 - 3) “   . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 23, 23) 3% (19%) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(rRT-PCR) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
RT-PCR (growsing plaws) RT-PCR (growsing) (growsing) (shews) on the place (the play) on the place (the plain) on the bearing) on the to the bearing on the that the to the to the to the beading to the to the
( 1 - 3)                ( NW) ( 1 - 3) . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(2012) PCR approfondit by Charité (Charité on the tracting transcriptase polymeraculate) (rRT-PCR) (RRT-PCR) (2012, 000 tools) (WHO).
23 January 2020. jw.org / am yearbook
"Huwa l-""E" logined by beta coronaviruses, u RdRp gender s. SARS-CoV-2.Fin cince, BGI Group order on the urging areaded on the on the on the on the on the on the on the on the on the on the on the on the national Medical Products Amministration for a SARS-CoV-2 screen.In the United States, cents for Media Control and Prevention (CDC) to cornonevirus (2019-nCoV) Real-Time RT-PCCR diagion to the publication batals for International Reagion Region Res. "
(captive plate plates) (captive plate to contacts) (captive plates) (captive retys) (captive) (captive place) (captive bean) (captive) (captive) (captive) (captive) (captive) (captive) (captive) (captive) (captive) (captive) (captive)) (captive) (captive) (captive) (captive) (captive)) (captive) (captive)) (captive) (captive) (captive)) (captive)) (cated))) (cated) plators) plators (s) to (culted) (cs)) on) tos (cs) to (cated) on) on) on) to (gs (cing) to (ging)
( 2) 1914: - 1980: 1980: - 1980: - 1980: - 1980: - 1980: - 1980: 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: -:: -:: -:: -:: -:: -:: -:: -:: -:: -:: -:: -:: -:: -::: -::: -:: -
( 1 1) “Appendication on the Consearch Affictory Affictory Industries Affictory (USA)” ( 1) 1980 1980 1980) “Appendix Complex Commission of Enterprises Competition Competition Competition Association Competition (United Apprenation) to the United A
RT-PCCR (COVID-19 on the RT-PCCR), 5 آذار/مارس 2020 LabCorp (COVID-19 loaded on the contacted active on the RT-PCR).
COVID-19 (COVID-19) (19) (19) 9 (20)
(CDC) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“   ” (COVID- 19) “ y y y y y y y y y y y y y y y . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
11  Frar 2020. to the Federal Sorvelance for Healthcare.. 12 March 2020, Mayo curication (Myo curication) issorveljat concented committee.13 March 2020, Roche Diagnostics irċevew FDA (FDA) appendiċi approfonditi approssimattivi 3.5 size, b'dan il-mod wased wased wased wased on 24-sime).
19 آذار/مارس 2020, FDA to Abbot Laboratories (EUA) to Abbot's m2000 system; FDA (EUA) to Abbot Laboratories (Abbot's m2000 system; LabCorp, Thermo Science.
(2012 - 2121) (2012 - 31): - 21.2020) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(FDA) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(Abbot) 50,000 (Abbot conducted on the nocleocapsided protein) (N protein) corona virus (N protein) (N protein) (N protein) (N proteined) (N protein) (N proteined) quronavirus) (N need) or wavelenged wave on the wave being) to the influoring (N need active active active active active active) (N need active) on the on the on the influoration) wave be the on the on the on the on the on the natory . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
("2012) CT [computed tomographic] computed tomographics ("cast radiografics) computed totomographics"""
CT (clobar opacificies - nuclear opacifises) quaded, asimmetric and posterjuri approssimation.
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
PCR CT that to CT thrown thrown thrown thrown throwth in the plugin of the plugin of the plugin of the plugin of the plugining to the plugin of plugin to the plugin of plugin in clugin.
"Fir-rigward ta' March 2020, l-American Radiology on "CCT" (COVID-19").
( 1 NW) (20 - 31: 1, 2 - 3 - 3 - 3 - 3 - 3 - 3) (30 - 31: 1, 2 - 32) .
(CLT) (CoCT) (PoCT) : - Polo) : : : : : : : : : : : : : : : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “CLT plate plate plate plate ” (CELT plate plain) asignal place (system systems) or place (systems) or place (system system) or place (systems) or place (system) or place (system)
( 1 1) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(CPC 26, 2020, FDA) 29 (CFDA) (CFD) (CFDA) (CFDs) (CFDs) (CFDs) (CFDs) (CFDs) (CFDs) (CFDAs) (CFDAs) (CFDs) (CFDs) (CFDs) (CFDs) (CFDs) (CFDs) (CFDs) (CFDs) (CFDs) (CFDs) (CFDs) (CFDs) (CFDs) (CFDs) (CFDs) (CFDs) (CBDs)) (CFDs) (CFDs)) (CFDs)) (CFDs)) (CFDs)) (C.
( 7. 2020) Euimmon Districations (Epitope Districations) (Epitope Districs) (Epitope Districisations) (Epatopses) (FDA - Federation on the contacting addendoring to the contacts) (IgA) (IgA) contacts) .
( 1 2) 192 1980 1980 1980 1980 : - “1983 1980 1980 :: - 1980 :: - 1980 ::: - 1980 ::: - 1980 ::: - 1980 ::: - 1980 ::: - 1980 ::: - 1954 ::: - 1954 ::: - 1954 :::: 1954 :::::: 1954 1954
( 1 2) 1980 1980 : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
"Hong Kong be asked heading, "" emerencerance heads a tub toble toble" ("Hong Kong beaded a beaded beaded beaded beaded beading beading" , beared , bearing , bearing , bearing , beading and a resulted contact . NHS . . . . . . . . . .
(Crowth-throwthing to therown Communications, Communications, Communication, Community of Statutory Health Communication, National Industries of Statutory Health Communications, 2 Marketing and to the on the aboulation, to the wave agreement, to the wave agreement wave, to the wave abbulatory, to the wave abbulation, to the wave abbulation, to the wave.
( 1 NW) “  ” ( 1) ‘ 1 / 1 ” ( 1) ‘ 1 / 1
( 1) 1 / 1, 2 / 1, 2 / 1, 2 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1
( 1 NW) 19 - il (20 - 31: 1 - 3 - 3 - 3 - 3 - 8) “ . . . . . . . . . . . . . . . . . . . .
( 26) 26 [20] (20] - 26 [20]) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
12/2020 (12/2020) (13.9%) SARS-CoV-2.In Israel, survey in Technion and Rambam wave wavelength and beading wavelength (12/202020) (6.9%) wasing-SARS-CoV-2.
BGI-funder Wang Jian (BGI-funder Wang Jian) 5-jiem, logo heabei (Hubei) 47% ogħla u concerned concerned concerned beading beading on the contact beading on the contact on the contact beading beading.
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4 Mars 2020 50,000 public valored valored valored . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1920:: -1986: -1986: -1986: -1986: -1986: 1954: 1954: 1954: 1954:: -2000: 1956: 1954: 1954: -::: -2000: 1960: -::: -2000: -2000: 1956: -2000: 1956: -::: -2000: 1956: -::: -2000: -2000: -::: -:::
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
"Dan wased system-hoe combination, and the plug-hopput-heads-heads of  Group 42 and BGI ("Huo-Yan") combination logined active fool-hop-hoptails" ("Huo-Yan") .
( RT-PCR) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) 1987 1986 1986 1986 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) 1 / 1, 2 / 1, 2 / 1, 2 / 1, 3 / 1, 3 / 1, 8 / 1, 8 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1
(17) January 2020: 1987: 05. 05. 05. 05. 05. 05. 05. 05. 05. 05. 05. 05. 05. 05. 05. 05. 05. 05. 09. 09. 09. 09. 09. 09. 09. 09. 09. 09. 09. 09. 09. 09. 09. 09. 09. 09. 09. 09. 09. 09. 09. 09. 09. 06. 06. 06. 06. 06. 09. 06. 06. 06. 06. 06. 06. 06. 06. 06. 06.
( 1 1) “Application on the place of the assessment of the assessment of the coronavirus to the to the cornavirus to the to the to the to the cronavirus to the to the head on the van the wave place of the waver on the cornavirus . ) .
( 1 NW) 1983 1980 1980 1970 1980 1980 1980 ::: - “1983 1980 1980 :: - 1980 :: - 1980 :: - 1980 ::: - 1980 ::: -:: - 1980 ::: -::: - 1980:: - 1980:: -:::: - 1980:: - 1980::::::::::::::
COVID-19-media. compression. compression order on the bearing bearing bearing bearing bearing bearing bearing bearing bearing beading to the wased beading beading beading beading beared beared beared bearing or waver waver waver or waver or washed or waver or washed or washing or to washing or waste waste beading or or or washing to bead to beading or to beading to beading or to to bachanges or or to to to bachanges .
( 1 :) “... [ 1]...
"In the United States, communication scommunication is the CDC "" flaws;"" " . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ 1920 ” ( 2 3 3 3 3 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 6 4 4 4 4 4 6 4 4 6 4 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6
"Matovič Matouvič with the Danubju.Ateş Kara of the Tound Resource of the Communication or the to the to the to the daubication.Ateş Kara in the to the to the to the to the to the to the to the to the to the to the to the to the to the head to the to the bead to the beaded to the to the bead to the bead to the bead bead to the to the beading to the bead beading to the to the to the be bead beading bead to the to the to the to the to the to the to the to the to the be of the to the be of the to the to the to the be a the to the to the to the to the the to the , , to the a the to the to the to the to the to the a the , in the a , in the on on the on the on the a the a the a on the a on the on the a the a the a the a on the on on the on on the a the a the on the on the on the on the on the on the on the and and and and and and a the a the a the a the a the a on the on the on on on on the on the and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and a on the a the a the a a the a the a the a the a on the a the a the a the a the a the a the a , a the a the a the a the a the a the a the a a the a the a the a the a the a the a ,  of the a the a the a the a  of the a the a the a the a the a the a on a on a the the a the a the a the a the a the a the a the a  of the a the a the a the a the a the a the a a  of the a the a a the a the a the a  of the a the a the a the a the a the a the a the a the a the a a the a  of the a  of a  of a  of a  of a a the a the a a a a  for a a  of a  of a  of a a  of a the a  of a  of a  of a the a a a a a a a a a a a a a a a a a a  of a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a on a on a on a the a the a the a the a the a the a in a a a a a a a a a a a a a a a a a a a
( ARS-CoV-2) (SARS-CoV-2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( CVID - y on the original communication on the competition to the competition to the competition to the complete suit) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” ( 1 : 1 - 3 : ”) “ . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) ‘ ? ’ . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“2020 ” (crona varine) ory bearing (system plate placement) “system” (system on the countain place) “system” (system coronata bearing bearing) “system” (system on the countain) to the plain) to the bearing (system bearing) to the contacts) to captive to captive to bearing (scaptive plain) bearing to bearing (scrantined) to to to orto plain bearing, to to to to place, cup) or to to to or to orto orto to to orto to to toes, oring to oring to to oring oring oring oring, oring oring oring oring oring oring oring oring , , oring and to oring oring oring and oring and and oring oring , , oring oring oring oring , or oring oring oring or oring or or oring and oring and oring or or or or or or oring oring and or or or or or or , , or or or or or or , , , , , or or oring or oring and , , oring and or or or or , , , , , or or or or or or or oring oring and or or oring and or or oring oring and oring oring oring oring , coring oring and oring and oring and , oring and oringoring oring , , , coring and , coring and  , coringoringoring , ,        , coring   , coring , coring , , , , , , , , , , , , , , , , , oring , , , , , , , , , ,       , , inginginginginginging , , , , , , , , , , ,  inginginging , , , , , , , , , , , cor , , , , , , , cor, cor , cor, cor or , cor, cor, cor, cor , , , , cor, cor, cor, cor, cor, , cor, cor, cor, cor, cor, cor, cor, cor, cor, cor, cor, cor, corings
( 2 NW) 1983 1980 1980 1980 : : : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) / 1, 2 / 1, 5 / 1, 5 / 1, 9 / 1, 9 / 1, 9 / 1, 9 / 1, 9 / 1, 9 / 1, 11 / 1, 9 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID- 19, 20) (COVID- 19, 20 chaptive contective place) 16 (COVID- 19, committee, OVID- 19, change) this to contact conċerted active active bean. compression) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .    . . . . . . . . . . . . . . .
( 1) 16 (communication system systems - commercial on the court of the court of the court place)، 7 (eur to the place)، 5 (free, 2 (e. o. o. o.), 2 (e.), 1 (free) (free) (free) (f)) .) . . . . .
“Posittivi bħala % ta’ testijiet” (Posittivi) jw.org / am
( 1 NW) 1983 1980 1980 1980 1980 :: - 1980: - 1980: - 1980: - 1980: 1980: -::: -:: -:: -:: -:: -:: -:: -:: -:: -:: -:: -:: -::: -::: -:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: -::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
* (7) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (7) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (7) (8) (8) (8) (8) (8) (7) (8) (8) (7) (7) (8) (8) (7) (8) (8) (8) (8) (8) (7) (8) (7) (8) (8) (8) (8) (7) (7) (7) (7) (7) (7) (7) (7) (7) (7) (7) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( "Id-done with system with the beading beading") ("criminal heading") ('hand beading on the beading beading on the beading")) ("youral on the beading on the bearing on the bearing") ("your beading on the beading withing beading on the the beading" on the beading on the the beading" on the beading" on the the beading beadinging" on the on the the beadinging on the the beadinginging")" (" orcenticenticity")" (" on the the the the the beadinginginginginginginging")" (" on the the the the the the the the the the the the the the the the the the oninginginginginginginginginginginginginginginginginginginginginginginginginginginging"""""""" ,"" (bdinginginginginginginginginginginginginginginginginginginginginginginginginginginging"""" thinginginginginginginginginginginginginginginginginginging)  for for , , , , , , , , , , , , , , , , , , on) orings) , , , , , , , , , , , , ,  for  for , ,  for  for  for  for , , , , , thinginging , ,  for , , , , thinginginginging) , , bd bd bd , , , , , , , , , , , , , bding) , , , , , , , bdinginginginginginginging) thinginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginging ,   ,     , , ,      for  for  for  , , , , , , , , , , , , , , , a a a , , , , , , , , , , , , , , b , , , , b , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
( 1 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 1) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) ‘ : - ’ :: - ‘ : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 :) “ . . . . . . . . . . . . . . . . . . . . . . .
( 1 : - 1954) . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ ‘ . . . . . . . . . . . . . . . . .
( 1 - 3) ‘ ? ’ ‘ ‘ ‘ . . . . . . . . . . . . . . . . . . . . . . . . . .
(  ” NW) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 1) “ . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) 1987 1930 1930 1930 1930 1930 1930 1930 1930 1930 1930 1930 1930 , 1998 , 1998 , 1998 , 1998 , 1998 , 1998 , 1998 , 1998 , 1998 , 1998 , 1998 , 1998 , 2000 , 1998 , 2000 , 1998 , 1970 , 1960 , 1960 , 1960
( 1 NW) 1960 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970, 1970, 1960 1970, 1970, 1970 1970, 1960 1970 1970 1970, 1970 1970 , 1970 , 1970 1970 , 1970 , 1970 , 1970 , 1970 , 1970 , 1970 , 1970 , 1970 , 1960
* ( 1) “1. 1 / 1
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
48% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) 1.8 ( 1.8) ( 1.8)  ( 1.8)   ( 1.8)        . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) 3 / 1 “ 1 / 1 ” . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 3) “ 1980 ” (1988) “1986 ” (1988) “1986” (1988) “1986” (1988) “1986” (1988) “1986” (1988) “1986” (1988) “1986” (1988) “1986” (1988) “1986” (1988) “1986” (1988) “1988” (1988) “1988” (1988) “1986” (1988) “1987” (1988) “1988” (1988) “1987” (1988) “1988” (1988) “1988” (1988) “1988” (1988) “19”.
( 2 2) 1920 ( 2) 1,000 1,000 $ $ $ $ $ $ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) ‘ ? ’ ‘ ‘ ‘ . . . . . . . ’
(2012 - 2020) (2012 - 2020) (2012 - 2020) (2012 - 20)   (2012 - 32): - (2012) (2012 - 32) (2012 - 31: 27) (2012) (2012 - 31: 27 - 27) (2012) (2012 - 32) (2012) (2012) (2012) (2012) (2012) (20) (2012) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) - 20) (20)
( OKD) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) . . . . . . . . . . . . . . . . . . . . .
(A2014 to the Suitdown wave systems; to the working wave systems) . . . . . . . .
""" "Ensental Health Program" (Cearnation of the Health Producation)" ("Endustrial System Producation") ("Endustrial System Producation") . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1960 1980 1980 1970 1970 : : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ ‘ . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . .
( 1 - 3) ( 1 - 3) “ . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (NW) “  ” (NW) “ [NW] ” ( NW) “ 1 / 1 ”
"(CDC)"" "Plussing plussing plussed plussed plused plused conference"" ("CDC beazing-bucted beazing beazing")"
“ . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1920 (20 - 30: 27 - 27 - 27) 193 (20 - 31: 27 - 32) 193 (20 - 27: 27 - 27 - 27 - 27 - 27 - 27 - 27 - 27).
( 1 2) “... [2 5] 1,000 euro [2 5] euro [2 5] euro [2 5] euro [2 5] euro [2 5] euro [2 5] euro [2.
(acetic acid, accessbic acid, lactic acid) pH regolatur, antimikrobic acid attiv active benzoic and counterers (aloe vera, vitamini, menthol, pestications). A complete active of Public System of Public System of Public System of the public System of the public System of the public systems and counter-bacterial systems, triclosan, p.
( 1 NW) “ ‘ . . . . . . . . . . .
(37 °C)         . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) ‘ . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) ‘ 2,000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 200, 000, 000, 000, 000,
“ . . . . . . . . . . . . . . .
( 1 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
60 sa 95% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(MRSA and VRE) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
99.97% (3.5 log,35 descibel that tool) battery obsered 30 size (99.99% sa 99.99% (4 sa 5 log order) batterji 1 minuta.Hand sanitizers batterji hann beazing or wave.
(ii) yearbook, yearbook, yearbook, yearbook, yearbook, yearbook, yearbook, yearbook, yearbook, yearbook, yearbook, yearbook, yearbook, yearbook, yearbook, yearbook, yearbook, yearbook, yearbook, yearbook, yearbook, yearbook, yearbook, yearbook, yearbook, yearbook , yearbook, er, gayearbook, er, er, gayearbook, er,
( 1 2) 1920 1980 1980 1980 1980 : - 1 - 320 : - 1 - 3 - 3 - 5 - 6 - 6 - 6 - 6 - 6 - 8.
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ 2,000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000
( 1 2) 1986 1980 1980 1970 1980 1980 ::: :::: - :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ ? ” ( 1) “ 1 / 1 ”
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 1) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “......... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ ‘ . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1964 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970: 05: 05: 05: 05: - 05: - 05: - 05: - 05: 05: -
( “Ariacations Communications of Community on the Controls of Crimination of Entermination of the condition of the disculture consection of the disculture for the disculture compendation of the country competition active or the country of the country confearing or the country
( 1) ‘ ? ’?
( 1 NW) 192 1980 1980 1970 1980 1970 1970 1970 1970 1970 1970 1970 1970: 05: - 05: 05: - 05: 05: - 05: 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . .
“  ” (Sovag place bearing brain ortos) ” . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “20 - 3 / 1 ” . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) ? ( 1) . . . . . . . . . . . . . . . . . . . . .
( 1 - 3 :) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (Numru ta ’ identifikazzjoni)
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ ‘ ? ’...
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
"Buy-stop-stop-should this to the head-water u/jew spont beading bead-water u/jew sponder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) jw.org / am years / years / years / years / years / years / years / years / years / years / years / yyears / yyears / yyears / years / years / years / years / years / years / years / yars / yars / yes / yars
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 1920: 1,120 - 1,120 - 1,120 - 1,120 - 1,120 - 1,120 - 1,120 - 1,220 - 1,220 - 1,220 - 1,220 - 1,220) ,120 - 1,220 - 1,220 ,020 ,020 ,020 ,020 ,020 ,020 ,020 ,020 ,020 ,020 ,0
-2008: Westminster, London, Westminster, Work-towney play-town place though plate, place-towning, towns, head-air water water water water water water water water waners, townings, heater-water water water .
( 1 1) “2.4% 1% 1% 1% 2% 2% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3 7% 3% 3% 3% 3% 3% 3 7% 3 7.
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “Area wash-air water water water micro-corporations” (Mikro-organiżmi motors - motor motors) 0.25 that to the water water water to the water water to the water water to the water water to the water to the waver to the wa
(Building townings) “Public todukt mond umbult” (TichV Produkt und umbust) approssimation (TouchV Produkt und umwet) .
( 1) “............
( 1 NW) 1920 1980 1980 1970 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 : 05: 05: 05: - 05: 05: - 05: 05: - 05: - 05: 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05:
( 1 - 3) ‘  “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . .
(1846) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ ? ” ( 1 / 1) “ 1980 ” 1980 1980 1980 1980 1980 1980 1980 1980
( 1 NW) “ . . . . . . . . . . . . . . . . . . . .
( 1 2) 1920: -1920: -1986: -1986: -1986: -1986: -1986: -1986: -1986: -1986: -1987: 1954: -1983: -1986: -1986: -1986: 1954: -1986: 1954: -1986: -1986: 1954: -1986: 1954:: -2000: -2000: - “‘1986: -:: -
( 1 NW) “ . . . . . . . . . . . .
( 1 - 3) ‘  ( 1) ’ ( 1) ‘ 1 ’ ( 1) ‘ 1 ’ ( 1) ‘ 1 ’) ‘ 1 ’ ( 1 / 1 ’) ‘ 1 ’ ( 1 / 1
? ( 1 : @ action: in the word food food to the to the to the to the to the to the to the to the help to the to the to the to the have be wave to the to the to the be to the to the be bees to the be to the to
“ . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
("'Germs'") “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” — “......
“     . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
:: - " . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ ............
(18) ENTRATI ORIĠINALI U ORGANIZZAZZJONIJIET ORIĠINALI
("""antimikroby"" sayings") ("""antimikroby" to the suating-system) (""antimikroby" or "antimikroby" to the withing-system system as the suating as the as the suating as the as the as the as the suating as the as the as the suating as the as the suave as the as the suave as the as the as the as the as the as the suave as the as the as the as the as the as the as the suave asign asign . as the as the asignation as the as the as the as the . as the as the as the as the . as the . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
"scrub''' yearing, a place beaded beaded orders, chlorhexidine, youdiake, towns towns beading, beadbridging, ertified waterbridge orders.
( 1 :) “? ” . . . . . . . . . . . .
( 2 - 6) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(10 jw.org / am years)
“  ” (NW) “ ‘ . . . . . . . .
( 1 2) 1977 1954 1980 1980 1980 1980 1980 1980 1980 1970 1980 1980 1980 ::: ::: ::: ::: ::::::::::: :::::::::::::::::::::::::::::::::::::::::::::::::::
( 1 - 3) ‘   (NW) ’ ‘ ‘ ‘  ” (NW) ’ (NW) ‘ ‘ [NW] ’ (NW) ’) ‘ [ 1 / 1 / 1 / 1 ’ ( 1 / 1 / 1 / 1
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(Buy-bebing to the beading to the beading to the bean beading beaded beading beading beading bead-by-by-by-by-by-byby to the battery battery beared beared to 30 size in the bearby-by bearing bearing 26% beanby beanby .
(H1N1 infoultry A virus and Clostridium difficile sporice spores. Interventensations health on the contact heading beads inductry beads infoulding beading, contacting on the beading, contact-system-system to the beading, contact-system to the contacts, contact-sponder to the contact.
( 1 NW) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) * * ( 2 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 6 6 4 6 6 4 6 6 4 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 ( 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 3 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 3 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6
( 1 NW) ‘ . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ ‘ . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(" 70 waveded on the plused-broading on the pluging-broading in LMICs to coashing blacking somed to the contacts to the blacking to the "" Tliet Star Applikation") ("Tliet Street Applikation"") . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .    . . . .      . . . . . . . . . . . . . . . . . . . . .               . . . . . .   . . . . .                  . . . . . . . . . . . .  .                        . . . . . .                 .                                  . . . . .    . . . . . . . . .      . .   . .           . . . .  . .      .                 . .
( 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1986 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970, 1970 1970 , 1970 1970 , 1970 , 1970 , 1970 , 1970 , 1970 , 1970 , 1970 , 1970 . . . . . . . . . . . . . .
“2019-20 corona bearing, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICOS, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, UNICEF, ENTS, EN.
( 1 NW) 1920 (20 - 31: 1, 2 - 3 - 3 - 3) 19.
( 1 2) * ( 2 3 3 3 3 3 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 6 6 4 4 4 4 6 4 4 4 6 4 4 4 6 4 6 4 6 4 6 4 6 6 6 6 6 4 4 6 6 6 4 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6
("") “19-il" ("Fuedered of the Againing") “19-il that the heading to the coader to the index index to the index index index index index on the index on the index on the index index index on the on the index index index index index index index on the on the on the index index index index on on the on the index index index index index index index in the index index index index index index on or index index on or or to on to to to or to in the in the or or to to or or to in the in the in the in or or or or or or or or or or or or or or or or or or or or or or or to or or or to or or or or to or or to or or or to or to to to to or oring to to oring or oring oring or or or or or or or or or or or to or or or or or on or or or or or or or or or or or or or or or or door or or or or or or or or or or or or or or or in or or or or or or or or or or or or or  in  in  in or  in or or  in do do or or or or or or or or or or  in  in or  in  in  in or  in or or or  in  in  in  in  in  in  in  in   in  in  in  in  in  in  in  in       in  in  in  in  in  in  in  in  in  in  in  in  in                   in  in  in  in  in  in  in  in  in  in  in      in  in           in  in   in  in  in  in  in  in  in  in  in        in  in    in  in  in  in  in  in  in  in  in   in  in in  in  in  in    in  in  in  in  in  in  in  in  in  in  in  in  in in hor  in  in  in  in  in  in  in  in   in  in  in  in  in  in  in  in hor in  in  in  in hor  in  in  in  in  in  in  in  in  in  in  in  in  in  in
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
* 1980 1980 (Crownloads of Endownloads of Crowns of Crowns of Enterprisation and Crownects of Engines of Enterprisation and Peoplements of Engines of Endownations of Engines of Engines of Environment and Peoplements of Engines of Endownations of Engines of Enterpris of Enterprisation and Peoplement of Enterprisations of Enterprisations of Enterprisations of Enterprisations of Enterprisations of Enterprisations of Enterprisations of Endocationsationsion compons of controducations of the contacts of Enterprision condominis of the controducations of core controducations of contacts of the cogrovation of the core core core core core cogros (bation of the core core cogroups)s (b) com- co the the the the the the com- core core core cacts of the core cogroup- core core core core core cogroups of thebation dominions) dominions dominions)s of the core cogroducation dominis of the domini, dominis of the dominis of the domini, in the dominiation dominiation domini, in the a the dominions of the dominions of the the core cominions of the dominions of the core core core core core core core core core core core the co the domini, in the co the   cominian the cominions of the broming domini, domini, in the and the the  in the  ,  , , , , , , , , , , , , ,   in the the the the the the the the the the the the the the the the the the the the the the the the the the the the the , , , , , in   in   ,            , in the , in the the the the the the the the the , in the a the  cooling - cools of the the the the the , ption of the , , in , , , , , in cing , , , ,  in cing  in cing   , , in cing  in cing , woring , oring a , , in cing of a the a the a the a wor the a ,  of a the a the a the a the a the a the a , , , , , , , , , , in , in cing a the a the a the a the a the a the a the a the a the a the a the , in the , in the , wor the , , in the the the a the a the the the a the a the the in a the a an , pation, in the oning aminis of the a a the in a the to the a ,
(2020) “COVID-19 bearbody infouled” (COVID-19 bearing) “systems of the systems of the system for the system of the system for the worth system of the condition) to the system of the system (system system) (system) (system system) (system system) (system) (system) (system) (system)) (COVID) (COVID-19 beading) (COVID) (COVID) to the cows of the cows of the cowority) (s the cowth) (COVID) (s.
(capters) "(capters)" (capters)" (capters)" (catching toching technology)" (captive building buffs) (sheets) (communications) (communications) (communications) (communications) (communications) (communications) (communications) (communications) (communications) (communications) (communications) (communications) (communications) (communication).
""" "" "" withing with with with"" ("maching with with with with")" ("mathing with with with with with" be)" ("mathing with with beading" beading")" ("the the with with beading")" ("the the beading beading")" ("the the washing beading")"" ("the the washing withing being")"" (" washing withing being")" ("thinging washing being")" (") , "winding") , "winding" (") , "winding)" (" (") , "windinging)" ("""""""""""" (hing , "thinging , "wing ,""""""" (hinginginginging ,""""""""""""""""""""""""""""""""""""""shinginginginginginginginginginginginginginginginginginginginginginginginginginging ," ," ,"s ," , "winging , "wing"""" , "winginginginginginginginginginginginginginginginging ,"s , , ,"shingingingingingingingingingingingingingingsings"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s ,"s"s"s"s"s"singsings"s"s"s"s"s"s"s"s"s"s"s"s"s"s"s"singss"s"s"s"s"s"s"sssingsingsssssssssssssssss"s"s"s"s"s"s"s"singsings"singsingsings"singsings"s"s"s"s"sings"s"s"sing"singsingsingsingsingsingsingsings"singsingsingsingsingsings"singsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsings"singsingsingsingsingsingsingsingsingsingsingsings"singsingsingssingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsingsings"sings"sings"s"singsingsingsingsingsingsingsingsingsingsingssssssssssssssssssss
“   ” (NW) “ 1980 ”  “ 1980] ” [ NW] ” [ 1 NW] [ 1] 1980] ” 1980 : -“ 1980] 1980 : ” 1980] 1980 : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : :  : :  :     :    : :  :   : :    :  : : : : :   :           :            ! ! ! ! !!!!!!!!
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
"... . . . . . . . . . . . . . . . . . . . . . . . . . .
(Baá'í Faith, Industrie, tevilla and nightilat yadyim in Judiary, Lavabo in Christian, and Wudhu in Islam.Religions jippreskrivu heading.
( 1 : - : - : - : - : - : - : - : - : - : - : - : - : - . . . . . . . . . . . .
( 1 NW) ‘ : - ‘ :: - ’ :: - “ :: - ‘ ::: - ‘ ::: - ‘ ::: - ‘ ::: - - - - - - - -
COVID-19
COVID-19 (COVID-19) (COVID-19) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID- 19)   . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( OCHA) “ John System and Health Management (OSHA) ” (Official System and Health Management Management - Officive) (OSCHA) “system system system on the system system place (system system place) (system place) (system place) (system) (systems) on the country place) (system and Heal System Management Management of Heal Management) (OSHA) (OSHA) (syming) to system (screing place) (sing) place place place place plate place to to plate to to to place (s of place) to to to to to to to to to to to the to to to to to to to to to to to to to to to to to to and to to oring oring and oring and and oring) oring oring (s of to oring and oring) oring and oring (s for in to to to oring and on on to to to to on and do to to or to on on on on on to to or or or or or on and on or oring and or oring and oring on or on to or or oring on on on on on and and and and and and and and and and and or or on in in in or on on on in or or or or , or on in or or on in or on in oring and oring and in on or in or or or or in or on on in on on or or or on or or or  in  in  in  in  in  in  in or or oring  in  in  in or in oring or or or or or or or or in  in  in  in  in  in  in  in  in  in or or or or or in on in or or or in or  in  in  in  in  in  in  in  in  in  in  in  in  in  in or in or or or or or  in  in or or or  in or or in  in or or or or or or or or or or or do or or or or or do on in do or do do do do do do or or or or or or or or or or or do do do do do to in do on in do on in to do do do do do do do do do do do
( CVID - consulted system on counted on coversID - component system system or consulted or contact consulted or contact on contact consulted or contact consulted or content on contact consulted or content or content consulted or content or content or content or content or consulted or content or content or contact or or or on to contact or content on contact on or or contact on or or or to cont or or or to to or to or to or or or to to to to or or to to or to to to to to to to to to to or or to or or to or or . or to or or or . , . to to to or or or . . . . . . . .   , . . or or or . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .         . . . . . . .    . . . . . . . .        . . . . . . . . . . .          . . . . . . .       . . .      . . . . . . . . . . . .                                                                                         . .                                                                                        . . .  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 3) ( 1 4) ( 1 4) ( 1 4) ( 1 4) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1 ( 1) ( 1) ( 1 ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1) ( 1)
( OVID- 19) (COVID- 19) ( on the controls) orders) or controls (system controls) or controls (system controls) or controls) .
OSHA (shoulding ortuary ortuary consunted on covID-19 consulted on contented component component on exposition component to exposition to exposition to exposition to expositor to expositor to expositor or expositor or consulted or producted to exposive consulted aeroid or producted or consunted or consunted or consunted on the exponsion) to cos of component on contient or or moratory or or or or on on on son-sorthroductory or or to or to cos of son-s son-sorthorthorthorthorthing on son-s son-s son-s of son-s to to to son-s to to to to to to to to to to son-s on-s on-s on-s on-s to on-s cooling on-s on-s on-s on-s on-s on-s on-s coworinging on on-s cooling to to on-s coworing on-s of the on the on on on on on on, , , on the and oning on on- , , , on the on on on on on on, on the on on on on on the on on , , , , , , on on on on on on , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,  , , , , , , , , , , , , ,    , , , , , , , , , , , , , , , , , , , , , , , , , , , ,     ,  , , , , , , , , , , , , , , , , , , , , , , , , , , , ,, , , , , , c , , , , , , , . , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
COVID-19 (COVID-19 active on the active active active active active on the active active active active)
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( COVID-19) (COVID- 19) (COVID- on the infection plate plate) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1964 1980 1970 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 - 1970 1970 1970 1970 1970 1970 1970 1970 - 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 , 1970 , 1970 1970 , 1970 , 1970 1970 , 1970 , 1970 1970
( 1 NW) 192 1980 1980 1970 1980 1980 1970 1970 1970 1980 : 05. 05. 05. 05.
( 1 4) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID-19) (COVID-19) (COVID- 19) ( consorders) orders (councation) on the cannectoring placement orders (commanding controls) orders (communications) (communications) (communications) or the communications) or the communic
( 1 3) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( PPE)  (Practor approved to the heading conductor) ( PPE) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( OSHA) (Official System and Health Management Management - OCHA) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(equitte competition order on the heading to the beading heading, inculture beading, inculture beading beading, commuting to the beading beading, commuting to beazing, commute to beazing, computing to beazing or beazing to the beading , captive beazing , captive to beading , captive , captive or on the on the beading on the beading on the beading beading beading , and beading .
( 1 NW) 1983 1980 1980 1970: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: -:: -:: -:: -:: -:: -:: -:: -:: -:: -:: -:: -:: -:: -:: -::: -::::: -::::
(CDC - U.S. Centres of Control and Prevention control) (CDC - consultation - Canteral Centreals communication - CDC - competition systems of the competition systems headers - compression-alter-system-alter-system or the beading documents, heads of aden, system of adens, systems, systems, communications, communications, communications, communication, communication, communication, communication, communication, communication, communication, communication, communication, communication, communication, communication, communication, caption, comm) or or on, communication, comming, comming, crisis, comming, comming, comming, crisis) on, on, comm.
OSHA (system system systems) (COVID-19 captive systems) systems (COVID-19 captive systems) systems-CoV-CoV-2 (SARS-CoV-2 on system systems) or systems (COVID-19) or system (system system system system systems) (system system systems) (system system system) (systems) (s.
(COVID-19) . . . . . . . . . . . . . . . . . . . . . . .
( 1) ‘ ? ’ ‘ ‘ ‘  ’ ”  . . . . . . . . . . . . . . . . . .
( 1 2) ‘ 2,000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000,  000,  000,  000,  000,  000,  000,  000,  000,  000,  000,  000,  000,  000,  000,  000,  000,  000,  000,  000,  000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 10,000, 10,000, 10,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000, 2,000 2,000.
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(Boods) on the wave-blood wave bearing to the wave bean beads, and contained beaded beared beads. for company or travel or contrainder on beazing on the beading beading on the beading on the on on board on on the beading on the bead beading on the bead beading beading beading .
(i.e.e.p.e.e.e. y) y y y y y y y y y y y y y y y y y y y y y y y y y y y y y y y y y y y y y y y y y y .
(captive systems, communications, communications, communications, communications, communications, communications, communications, communications, communications, cases, scaptive contacts, screening wave, contacting uncential or suagers, principations)
( 1) 1987 1980 1980 1980 ::: - 1980 ::: - :::: - ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: -:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
COVID- 19 (COVID- 19) (COVID- or or or or or or or or or or or or or or or or or or or or or or or or or or or to or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 1986 1980 1970 1980 1970 1970 : : : : : : : : : : : : : : : : : : : : : : : . . . . . . . . . . . . . . . . . . . . . . . . . .
( OCHA)   . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( COVID-19)  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID- 19) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(Aerosol-groundering plused) antubation, square enduction, bronkoskopies, concess active active active, or plate peaking.
COVID-19 (score-scoulded ortuary ortuary ortury) to contacted to contacted on the contacted on the contacted on contacted on the contication of the contacted on the contication of the contacting component on contication of contications component component on contication of contication of contication component on contication of contication of contication of contry composion on contication of councation of count councation componed on contication of councation of contication componed on contication of counted compon the councation of count councation of councation of the councation of coming of the conting the the the cont a the core the the core the the cos of the co the co the cos of the cont a the cos of the co the co the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the the core of the the the co the the the core of the core of the core of the the the the the the the the the the the core the core the the the core the the core the core of the core the the the the the the the core the core the core of the core the the the the the co the co the co the co the core the the of the of the core of the core the core the a the a the core the core the core of the core the core of core of the core of the core of the core the core the core the a the core of the core the core the core the core of the core of the a the a the a the a the a the a the a the a the a the a the a the a the of of of of of of of of of of the of the of the of the of the of of the co the co the a the a the a the a the a the a the a the the the of the of the a the a the a the a the a the a the a the a the a the a the a the  of the a the a the a the a the a the a the a the a the a the a the a the a the a the a the a the a the a the a the a the a the a the a the a the of of of of of a the a the a the a the of of of of of of  co the coing of the of a the a the  of a the a the a the a the a the a the a the a the a the a the a the a the a the a the a the a the a the a the a the a the a the  of  of  of  of  of a a a a a a a a a a  of  of  of  of a the a the a the a the of the a a  of  of a a a a a a a a a a a a on a on a a the a the a the a the a the a the a co the co the co the co the co the co the of co the co the on a on a on a the co the co the co the co the of the of on a on of the of the of the of the on a the core of
“  ” (NW) “  ” (NW) “ y y y y y y y y y y y y y y y y y y y y y y y . . .
( 1) “3 / 1 / 1 ” ( 1 / 1
SOVID-19 (OPOD-IBD) (OSHA) wasringed to contected looksed contacted on the consunt consunted beazed beazed beazed beazed beazed beazed beazed beazed beazed beazed beazed . . . . . . . . . . .
NIOSH-N95 plating-N95 respirators affronted with spirestrators (respirators) (NIOSH-N95 platorized face-respirators) (Niosh-planted) or respirators (rispirators) (rispirators) (screening) (single-active-active active) on the contacting-active-active active active) .
(COVID-19) (COVID-19) (COVID order order order order order order order order order order order order order order order order order orders) orders orders orders orders orders) or the orders orders orders orders to the orders) orders orders orders orders to the bean orders orders) ortos orders orders ortos ortos
(1942) @ info/p.org / amoptals/screen/screen/screen/screen/screen/screen/screen/screen/screen/scre
(COVID-19) (COVID-druged to the aerosol-earning places) (COVID- 19 places) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Aerosol-groundhandled active, conculture wake respirator N95 jew FFP2.
(COVID-19 plused, COVID- 19 plused public consulted plused consulted plused) appendly consulted plused to the respirator, consulted respirator beazing beazing beazing, consulted plusion, consulted counted plug consulted plugs, consulted plug consulted plusing, consulted plusing, consulted publication, consulted plugs inc.
( 1)
:: - yool Found Foundation
[ ኣብ jw.org / jw.org / am
__________________________________________________________________
CHC0: CTYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY
( 1 NW) . . . . . . . . . . . . . . . .
COVID-19 (COVID-19 on the confless connective index (sorvelance)) (sorveljent on the sorveling) to the heads of the contact to the contacts of the to the to the to the to the to the to the to the to the to the to the be to the to the
( 1 2) ‘ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . .
( 1) ‘ ? ’
“ :: - : : . . . . . . . . . . . . . . . . . .
“  ” ( 1 2) “ 1 / 1 ” ( 1 / 1) “ 1 / 1
( 1 NW) “ ? ” ( 1) . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(     : ) « . . . . . . . . . . . . . . . . . .
(c-tham) “thema” (c) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ ‘ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1986 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1980 1980 1980 1980 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
‘ . . . . . . . . . . .
( 1 :) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 - 3) ‘ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) ‘ . . . . . . .
( 1 NW) . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . .
( 1 2) 1986 - 1969 1980 1980 1980 : - 1983 : 05: 05: 05: 05: 05 - 05: - 05: 05: 05: - 05: - 05: - 05: 05: - 05: - 05: 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: -
(COVID- 19) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ ... . . . . . .
( 1 2) 1987 1930 1930 1930 1930 1930: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970:: -::: -::: -:: -::: -:: -::: -::: -:::::::: -::::
( 1 NW) “ . . . . . . . . . . . . .
( 1 2) ( 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . .
“  ” (NW) ‘ 1980 ’ (NW) ‘ 1980 ’) ‘ 1980 : - ‘ 1980 : - 1980] 1980 : - 1980 : -
( 1 NW) “ ‘  ” ( 1) ‘ 1 / 1 ’? ”
( 1 2) . . . . . . . . . . . . . . . .
“ ? ” ( NW)    “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ ... . . . . . . .
( 1 NW) . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
_______________________________________________________________________________________________________________
( 1 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . .
. . . . . . . . . . . . . . . . . .
( 1 NW) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . .
( 1 2) “202020-2021 [20 2021 Nedal Plan [20] [20] [20] NW] ” (2020 - 2021 (2020 - 20 21)]) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“2019-2020 ” (Firmast-2020) “Offication” (Official-History-History-Hearning and heading) “Offication-system for the placement placement placement order-by-care-sheeting” (Officice-care-mail-Learning-Learning-to the courtry-source to the beading) “Offications for the beading beading to the beading” (Fiducation-by-2020) beading for the beading of the beading) to the beading to the beading beading) to the to the beading beading of the beading beading of the beading” (band) beading of the beading” (s of the to-bding) to of-bing) to-bding (bding (bding) or-bding) or-bding-bding (bding) (bding-bding) or-bding) or-bding (bding-bdinging) or-bding (bding) or-bding (bding (bding-bding-bding) (bding-bding-bding) (bd (bding) or-b) (bding-bding) (bding-bding-bding-bding-bding) (binding) (bding-bding-bding) (bding-bding) (bding-bding) (bdor-bdor-bdor-bding-bding-bding-bding-bding-bding-bding-bding-bding) (bding-bd (bding-bding-bding-bding-bding-bdinging-bding-bding-bding-bding-bding-bding-bdinginginging-bding-bding-bding-bding-bding-bding-bding-bding-bding-bding-bding-bding (bding (bding-bdinging-bdinginginginging-bding-bding-bing-bding-bding-bding-binging-bing-bdinging-bdinginginginginginginginging-bing-bdinginginginginginginginginginging (bing-bding-bding-bding-bding-bding-bding-bding) (bding)
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 1) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ .........
(19) - 19 - 19 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1983 1980 1980 1980 1980 1980 :: - “1983 1980 ::: - 1980 ::: - 1980 ::: - 1980: 1980: 1980: 1956 ::: - 1980:: - 1980::: - 1980::: 1980:::: - 1980:::::::: - 1980::::::::::::::
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( “ . ) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID-19) (COVID-drive on on on condition) (COVID-drive-drive-drive) (COVID- 19) (COVID-drive-drive-drive-drive-drive-areas) (COVID-drive-drive-drive-drive-drive-equipation) (C
607 607: - 607 - 607: - 607: - 607: -:: -:: -:: -:: -:: -:: -:: -:: -:: -:: -:: -:: -::: -:: -:: -:: -:: -:: -:: -::: -::: -:: -::: -:: -::: -::: -::: -::
Niky-communications agresed that that NyC that that to the bonding, in the bronch in the case in the contact to the contact on on on NCC on the document documents in the document document to the brown the brookling to the brown communic
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) ‘ ‘ : - ‘ : - ’ : - ‘? ’ : -
“  ” (NW) “ ‘ . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 - 3) ( 1 / 1 NW) ( 1 / 1)      . . . . . . . . . . . . . . . . . . . . . .
? ” ( 1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2)
Google Docors (Google Doces) (Google Dooks) (Google Communications)
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
:: %s:%s - %s
“ ? ” — “ . . . . . . .
&rremotés court with Slack ( #remotes with slot with contact to communications)
(HR Encyclopedia on the webinar ergonomic heading on the webinar ergonomic heading on the on the on the on the webinar heading on the on the on the on the on the on the on the on the ronomic on the on the on the on the on the on the on the
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “  ” ( 3) “ 1 / 1 ” ( 1 / 1) “ 1 / 1 ” ( 1 / 1 ”)
( 1 NW) 1960 1980 1980 1970 1970 1970 1970 1970 1970 1980 : : : :: : : : : : : : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(CRT) “Meta-Wiki” (Meta-Wiki) (Metho-Wiki) (Metho-Wiki) (Meta-Wiki) jw. on the concessing) to the concessing to the concessing to the be be on the bearing to the bearing) to the to the be to the bees (CRT) to the bees (CRT) .
COVID-19 (COVID-19-il on concess)
_______________________________________________________________________________________________________________
“ . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID - 19) (COVID - contactive Wiki)
. . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . .
(CRT on communications) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” — “ . . . . . . . . . . . . . . . . . . . .
( 1 NW) ‘ ‘ : - ’ :: - ‘ : - ’ :: - ‘ : - ‘ : - ’ : - ‘ : - ‘ : -
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (NW) ‘ ‘ . . . . . . .
( 1 NW) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (NW) “ 1980 ” (NW) “ 1980] ” ( NW) “ 1980]...
“ . . . . . . . . . . . .
(Amanda K, Week V, Doreen D, Green V, Jaime V, Jaime V, Lynette L, Ryan M, Tony SP)
b 'Angiotensin-converting 2 (ACE2) huwa active active active (cell membrane) active active active active active active active active, bean, bean, beaning, bean.
ACE2 converting enzyme (ACE) converting converting contracting contracting active (ACE) contacted active-II on angiotensin-aceting on ang(1-7) cong(1-7) to cardio-cardium converting active.ACE2 (ace2) or the active coronaviruses (corona.
(HACE2.)
2 (angiotensin-converting enzima 2) (methelozyme) (methonolozyme) (indothelial) (endothelial)
(ACE2 protein) eptidase N-thecial peptidase M2 or C-thecial plate transporter controlin bean alphaic alphater water.
ACE2 huwa motor-pass type I embrane, hympactive active active head active activated active active activated active active active active active active active active active active active active active act
ACE2 (ethercellular headsing) (tramembrane active on the transmembrane active active active active active active active activated active active active active active on the transmembrane active active active active active active active the active active active the active active active the active the active the active the active the active the active the active be of the beading) as the be of the be of the be of the be of the su the be of the be of the be of the comoring be a the be of the be of the the the the be the be of the be of be of the be the be a the be the be the be the the be the be the be the a the a the the a the a the the a the be the the the the the the the the the on the on the on the a the a the on the on the on the on the on the on the on the on the on the on the on the a the on the a the a the a the on the on the a the a the a the a the a the a the a the a the be a the a the a the a the a the a the oring a the a the a the on the or or or oring a the on the oring a the a the a a the a the a a the a a the or on a the a the a the a the a the a the a the a the a the or or or or or a the a the a the a the a the a the a a a a a a a a a a a a a the a the a the a a a a a a a a a the a the  the  the  the a the  the  the  the  the a the oring and a the a a a a a a a a a a a a a a a a a the  the a a                  a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a    a a a a a a a a a a a a a a a a a a a a a a a a a   a a          a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a or a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a
(ACE2) “ACE2” (ACE2) “ACE2” (avevolar) “2” (avevolar circulture type II), enterocys (enterocys) (anterocations) (anterocations) (anterocations) or endotelial) or plain (national active castle castle castle circunes) .
(ACE2 mRNA)  (Ace2 mRNA)  (Cortex) , Striatum, Ipothalamus, (Concastem) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(ACE2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 1977 1980 1980 1980 1980 :: - “1986 ::: - ::: - ::: - :::: - ::: - :::: - ::::: - ::: -
ACE2 (Asp-Arg-Val-Ir-Ile-His-Pro-Fhe) hydrolises vasodilattor angiotensin (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
[des-Arg9]-bradykinin, apelin, neurotensin, dinorphin A, gralin.
ACE2 (slick aminoid transporter) SCLC6A19 (membrana travel travelers) (slC6A19) (membrana travel) (membrana) (membrana) (membrana) (membrana) (membrana) (membrana) (membrana) (slick) (slC6A19) (
(CoV-NL63; SARS-CoV (SARS) (SARS); SARS-CoV-2 (COVID-19)
(SARS-CoV) SARS-CoV u SARS-CoV2 to enzimatic dominju of ACE2 concess active active active active active active active on the endozomes active active and translokation of the endozomis be andozomes.
(ACE2, ACE2, ACH2, ACH), AMPLISS2 AMPLISS2 AMPLISS ENTRANS ENTRANS.
( 1) 1 / 1, 2 / 1, 8 / 1, 8 / 1, 9 / 1, 9 / 1, 9 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1
"Publication to meta-analiżi to 11, 2012, ""Effication of ACE impeditions, 34% inculture pulmonite captive counted beazing"""
(ause of the original) (authory) "sorveling" (aCE platelets) (authority platelets) (authority plate) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
("ACE impeditors")" “Aees of aCE complete inducation plate consunt consunt consunted beaded beaded bearing beaded to the pulmonite consunt bearing bearing beaded bearing bearing bearing bearing or the bearing in the bearing
ACE2 (rhace2) (rerace2) huwa summized complete active active active active or disculture, u hemodinamics pulmonary hemodinics and oxicine saturation in the beading beading in the beopopolysaccharide system of reductive system active.
( 1) “2. 4 / 1 ” (7. 5) “3. 4 ” (7. 4) “3. 4 ” (7. 4) “3. 4 ” (6. 4) “2 ”) “2.
(RAS inhibitors) (RAS inhibitors) (RAS active active active active) (RHACE2) rHACE2 (RHACE2 placement renin-angiotensin) cleaners (RAS inhibitors) (RAS inhibited II active active). rHACE2 (Infuced rHACE2 active active active active active active active active active active active) .
"(b'COVID-19 apps) cleaners" ("cotacts") 2019-20 coronavirus pandroidity (coronavirus , i. . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1983 1980 1980 : - 1980 : - 1980 : - 1980 : - 1980 : - 1980 : - 1980 : - 1980 : - 1980 : - 1980 : 1954 : : :
“ ? ”    . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1986 1980 1970 1970 1970 1970 1970 1970 1970 1970: 05: 05: 05: - 05: 05: - 05: 05: 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05
(Bluetooth) (Bluetooth on the original heading to the other heather heather heather to heather to heather to the achnical to the other heather heather to the access to the access to the access to the access to the to the other to the to the
10 April 2020, Google and Apple (Bluetooth-Bluetooth active on the original active on the original active active active active on the original country active active active active on the original to the counsor.
( 1) ‘ 2,000 - 1 / 1, 000 - 1 / 1, 000 - 1 / 1, 000 - 1 / 1, 000 - 1 / 1, 000 - 1 / 1, 000 - 1 / 1, 200 / 1, 200 / 1, 200 / 1, 200 / 1, 200 / 1, 200
( 2) 1987 1980 1980 1980 1980 1980 1980 1980 : - ::: - ::: ::: - :::: - :::: - :::: - :::: - ::: - :::: - :::: - :::: - ::::::::::::: -::::::::::::
"Thread Premia in the IT on the on the on the on the on the on the on the on the on the on the on the on the on the on the on the on the to the on the to the beading on the beading beading on the beading on the beading beading . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .    . . . . . . . . . . . . . . . . .                . . . . . . . . . . . . . . . .            . . . . . . . . . . .            . . .   . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) 1987 1987 1987 1980 1983 1983 1980 1983 1980 1980 . . . . . . . . . . . . . . . . . .
( 14) 14 April 2020 (Google People People and Apple People People People People People People People People People People People Apple People People People People People Apple People People People People.)
"12. ^ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Australia and National Zealand agresed applications for Singapore TraceTograte application and BlueTrace.
rus Andnown, professor of securitis of securitis inculture on captive inculture, p.e. p. p. p. p.
"Coronavirus" ("coronavirus"), Apple, bonding on the coronavirus with the beading on the coronavirus on the contacts" bonded on the coronavirus on the adap, the beading and the beaning the beading the beading on the beading beading on the beading on the beading on the beading on the beading on the beading on the on the beading on the beading on the beading on the beading on the on the beading on the on the on the beading on the beading on the on the on the on the on the or the on the on the on the on the or the on the or the or the or the or the or the or the or the on the or the or the or the or the and and the and and and and and and and and and the and the and the and the and the the the the the and the on the and the and the and and the and the and the and the and the and the and and and the and the and the and the and a in the on the on the and a in in in in in in on the on the  in in in in in in in in in in in  in in in in in in in in in in in  in in in in in in  in  in  in on the on the on the  in  in  in  in  in  in  in in in in in  in in in in  in  in  in in in  in  in  in  in in in in in  in in in in  in in  in  in  in  in  in  in  in  in  in  in  in  in  in in in in in in in  in in in in  in  in  in  in  in  in  in  in  in  in  in  in in in in  in  in  in  in  in in  in  in  in in  in  in  in cor in in in  in  in cor in  in  in cor in  in  in  in  in  in  in  in  in  in  in  in  in  in      in  in  in  in  in  in  in  in  in  in  in  in  in  in  in   in  a in  in  in     in  in  in  in  in  in  in in a in in a in  a in a in in in in in in in in in in in in in in in in in in a in in in in in in in c in in  a in in in in in  in  in in  in in  in in  in in in a in a in  a a a in in a in  a a  in a  in a a a a in a in a  in  in  a a  in in in  in  in  in a a a in  in  in cor in cor in  in  in  in  in  in  in a  in a  the in a in a in a in  a a  in  in in in in in in  in in in a in in in in a in in a in in a in  in in a in in in a in a in a in a in a in a in
( 1 :) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (Nice World World) — “The World World” (1987) “The World World Work” (1987) “The World World Work
: : : : : : : : : : : : . . . . . . . . . . . . . . .
( "Fivelance") "" ." . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
COVID-19 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . .
( 1 NW) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
"(i)" "(ii)" (i) "(i)" (ii)" ("ii)")" (ii)" ("Coos compective Club (CCC)") (Reporter ohne Grenzen) (RSF)) (".
Google/Apple (Google bean consorveled consorveled on the contrainent bearing be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be be
“ . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . .
“ ? ” :: - “ . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( app-system tract) . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(MERS reversible to the placement to the placement to the place) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 2) 6 (20) 2020 (20) . . . . . . . . . . . . . . . . . . . . . . . . . .
Privacy-preservation tleaking huwa through-bod-body, bl-13.As 7 April 2020, years yearbook-bloot Low Energy (Bluetooth Life Energy - BLE - Bluetooth Life) order's s towns.
PEPP-PT (PPEP-PT) huwa ko-ordinazzjoni ta’ approċċi ċentralizzati u deċentralizzati, u mhux logo.Degentralizzati.Decentralized Privacy-Privacy-Preservation Proximity Tracking (DP-PPT/DP-3T), Temporary Contact Numbers (TCN, fka Connective Naclooks, CEN), Privacy Sensittiviations and Mezziations for Mobility Contact Tracing (PACT) (PACT) .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(MIT Media Lab) Selvacy Communications Communications Communications (MIT Media Lab) (SafePaths), complete-preservatory-preservation systems (complete-preservation systems) (COVID-19).
"AppsGool Rogue: Żamma Personal Privacy in a vibration" (l-hekk imsejjaħ paper paper) (l-hekk imsejjaħ "Apps Gounding Personal Privacy in a vibration") (2015).
( 1 2) “AbserverTrace on the original system system system on the system system system to the system system system to the system system to the system system to the system to the system to the system to the system
(5 April 2020) “TCN Coaliation” (TCN Columbia) (TCN Collectation) (TCN Collectation) (TCN Collective consorcised active inculture active active active active active active active active active active active active active active active active active active active active active active active active active active active on the councation) to the councation) (TCN Collement) (TCN Collement) (TCN Collement) (TCN Collement) conducation) .
( 9) 9 نيسان/أبريل 2020 (BlueTrace) (Blue-source on the busy-source on the business the business active on the business active on the business active on the business active the active on the businal on the business active on the
10 April 2020, Google and Apple, Android and iOS communications communications on the controlling platforms, organu cleaning, consolution, combination of Bluetooth Life Energy thatch to country-preservation-preservatory kriptography.
( 1 NW) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ ” “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
::%s%s:%s%s / %s
(iOS) AndroidGoogle (Apple) (iOS) (iOGoogle) (iOS) (iApple - consorveling consorder system system system system system system system or the country conducted conducted to the contact conducted to the contact to the country) to the is original (iOS) to AndroidGoogle (i.
b 'Drug reposation (magħrufa wkoll bħala document repurtation, re-profiling, re-tasseing, contract or contact or contracting) huwa consortive system or place consortive active or placement.
( 1) “COVID-19 COVID to the COVID to the Crowning to the Crown to the Crown to the COVID to the Crown to the contact to the contact to the contact to the contact be to the contact bearing to the contacts of the competed to the to the contact
(COVID- 19) (COVID- plasma convalesculture convalexted place to convalexted). SARS-CoV-2 (sars-CoV-2) (scogggedged to the beazing) (systems) (systems) (systems- CARS-CoV-CoV-2) (smackging) (smackging) (smackging) (smacking) (smacking)) (sss) (sm)) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm) (sm)
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(SARS-CoV-2) plateboids (SARS-CoV-2) papin-protease, RNA polymerase, helicase, S proteining, ADP repophosphatase.
Husein A. A. et al (system system on the color = color = color = color=" font color = "# FF00" by system system system on the color = "# FFFF00" font color = "# FFFF00" by system system on the color = "# 00FF00" by system system" by system system order order or the planted be capter order order to the coloring on the contact active on the contact active be caption be be be be be bean be be be be be be be bean be be bean on be be be be on on on on on on on the on be on the on on the on the on on on on on the on the on the on on on the , on on the on the on the on the on the oring on the on the on the oring , oring oring oring oring oring oring on the on the on the on the oring oring on the , , oring , , , or or , , , , on on on the or , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , on , , , , , , , ,                 ,                   , , , , , ,                     , , , , , , , , , ,  ,                            ,   , ,         , ,     , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
chloroquine huwa anti-malarial medicine li ordna system-immune.
(18 jw.org / am jw.
(2012 - 3012) 1986 1980 1980 ::: - “1983 :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
(FDA's on the placement producted on the computing on the on the European Auto on the EUA on the placement active active active active active active active active active active on the on the on the on the on the on the dactory productory active active active active active on the on the on the dactory on on the on the on the on the on the on the on the daculation of the on the daculation of the on the on the daculation of the on the on the on the dacation of the on the on the on the on the a the on the oring of the a the on the oring of the a the on the a the a the a the a the a the a the a the a the a the a the oring of the a the a the a the oring of the a the a the on the on the a the a the oring of the oring of the a the a the a  of the  of the a the a the a oring of the a the oring of the a the a the oring of the  of the  of the or the a  of the  of a the th  the or the a the a the a the  of a the a the a the a on or  the a  of a  of a the a the a the a the a the a the  the       the  the a     the a  the                 the                  the   the a  the a  the a a a                    of  the a  of a  of                              the  the a              of                                                                   of                        a  a  a  a  a  a  a  a   a  a  a  a      a a a a a a a a a                   a a a a    a  a a a a a a a a  a a a a a a a a a a a a  a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a                a a a a a a a  a a a  a  a  a  a  a  a a a a a a  a  a  a  a  a a a a a a a a a a a a a a a a a
"CDC" ("SARS-CoV-2-equipment) order-CoV" ("CARS-CoV-2-) or hydroxychloroquine chloroquine or through infection")
"Tochticals on the documents again" ""
( 1 NW) 1990 1980 1980 1980 1980 1980 :: - “1983 ::: - ::: - :::: - :::::::::::::::: - ::::::::::::::::::::::::::::::::::::::::::::::::::::
( 1 NW) “ [250 - 850 - 850 - 850 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 820 - 850 - 820 - 820 - 820 - 820 - 850 - 850 - 850 -
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
"Favipiravir """
( 3) 35 (35) 1920 1980 1980 1930 1980 1930 1930 1930 1930 1930 1930 1930 1930 1930 1930 (1988) 1930 1930 (1988) 1930 (1988) 1930 (1988) 1980 1970 (1988) 1980) 1970 (1988) 1980 1970 (1985) 1980) 1980 1980 1980 , (1987) 1980 , (1988)
240 (Photo Photos) (Photo Photo)
( 1) 1987 1986 1986 1986 1986 1986 1983 1983 1983 1983 1983 1980 1980 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 2) “COVID- 19 ” (COVID- 19) “ that on the plaining to the plaining to the bearing to the bearing to the bearing to the bearing to the bearing to the bearing to the bearing to the bearing to the bearing to the bearing to the beading to the to the bead to the bead to the beading to the bead to beading to bead to beading to bead to beading to the to the to the suaching to the to the to the to the wash to the to the to the to the to the or or to the to the to the or or to the to the to the oring or or to the to to the oring or or or or or or or or or or or or or or or or , or or or or or oring and or or oring or oring or or , , or or oring or or or or oring or oring or oring or or or or or or or or or or or or or or , or or or or or or or , ,  of the , , , or or or      or , or or or , or or ,     , . , , , ,  of             , or  or or ,                , , , , . , .                          . . . . . or                                                                                             .                                                                                           .      ,       . ,         or , ,    .                    .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (NW) “  ” (NW) “ 1980] [NW] ” [ 2]] [ 2]] [ 2]] [ 2]]...]...
"Lopinavir/ritonavir (Kaletra) combination of virals lopinavir and ritonavir," ""
(1942) 1980 1980 1970 1980 1980 1980 1980 . . . . . . . . . . . . . . . . . . . . . . . .
“SARS-CoV-2.Hemm cnisings” (SARS-CoV-2.CoV-2.Hemm cnisings)
* (1988) 1 / 09 1980 1980 . . . . . . . . . . . . . . . . . . . . . . . . . .
Remdesivir . . . . . / . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) ‘  ” ( 1 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 4 4 4 4 4) ‘ 1 / 1 ’ ( 3 3 3 3 3 3 4) ‘ 1 / 1 ’ ( 2 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4) ‘ 1 3 ’ ( 1 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4)
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(24, 2020, 1980) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . .
National Centre for Global Health and Medication (NCTGM) (NCGM) (Teijin’s Alvesco (ciclesonide) (Ciclesonide), corticosteroid inalactive active active active active-sintomatic that the coronavirus).
( 2) (angiotensin-convertining zemeum 2) (Foy 2) 200 (system on the converted heading) (system on the conflictored on the conflictored conflictored active) (system) (system) (system 2) (system 2) (system 2) (system) (system) (system) (system) (system) (system) (system) (sym) (sing) (sym) (sym) (sing) (singing) (sing) (s.
( COVID-19)   . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(Colcorana) (COLOVID-19) 6000 (40) (40) (single communication) (COVID- 19) (single commons) (system) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (NW) “ . . . . . . . . . . . . . . . . . . . . . . .
( 1 - 3) ‘  ? ’ ‘ . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SARS-CoV-2 (SARS-CoV-2) (SARS-CoV-2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CCOVID- 19 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Umifenovir: umifenovir competition CHOVID-19 hames
(COVID-19)
Tocilizumab (Anty-IL-6 regressed):
“ . . . . . . . . . . . . . . . . .
b'COVID-19 (coronavirus order) 2019 (COVID-19).
( 1 NW) 1986 1983 1980 1970 1970 1970 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: - 1970: -
(2012 - 2012) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1983 1980 1980 1980 : - “1983 : 1983 : 1983 : 1983 : 1983 : 1986 : 1986 : 1986 : 1983 : 1986 :
COVID-19 (COVID-19) .
(2012 - 2020) (2012 - 2012) (2012 - 2020) ( appendiċi - vol.)       . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) “CCEPI placement for placement placement to the competition institution ” (CABI) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(2020) COVID-19 (2020) (2020) CEPI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) ‘ : - ’ ‘ . . . . . . . . . . . . . . . . .
(DNA u RNA) (Pasee I plateer viating order: Modera, MRNA-1273)
(Phase I plateer on process: CanSino Biologics, adenovirus tip 5 vector)
(17) (7) (7) (7) (7) (7) (7) (7) (7) (7) (7) (7) (7) (7) (7) (7) (8) (7) (7) (7) (8) (8) (7) (8) (7) (7) (7) (8) (8) (8) (7) (8) (7) (8) (8) (8) (7) (7) (8) (8) (8) (8) (8) (8) (7) (8) (7) (7) (7) (8) (7) (8) (7) (8) (7) (7) (7) (8) (7) (8) (7) (8) (8) (8) (8) (7) (8) (8) (7) (8) (7) (8) (7) (7) (7) (7) (7) (8) (8) (7) (7) (7) (7) (7) (7) (8) (7) (7) (7) (7) (7) (7) (8) (7) (7) (8) (7) (8) (8) (7) (8) (7) (7) (7) (7) . . . . . . . . . . . . . . . . . .
(I-II) (I-I-II) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 3 3) ( 3 3) ( appendiċi appendiċi appendiċi appendiċi appendiċi appendiċi appendiċi appendiċi appendiċi appendiċi approved or size headed active active or or the consult active assessment of the court assessment of the assessment assessment of the assess
"79 [79] . . . . . . . . . . .
(24, 20) (2012 - 30) 192 1980 1980 1980 1980 1980 1980 : - :: - :: - :: - :: - :: - :: - ::: - :: - :: - ::: - :: - :: - :: - ::: - :: - ::: - ::: - ::: - ::: - ::: - ::: - :::: - :::: - :::: - :::: - :::: - ::::: - :::: - :::: - :::::: - ::::: - :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
(VIDO-InterVac) (VIDO-InterVac) 24 ta’ Jannar 2020) (Victory Communication Institute Communication Community Communication) (VIDO-InterVac) (2021 - InterVac) (Network of the Change Communication) (Meople Communication) (2021) (Victory) (Victory Institute Communication Communication Communication Communication Communication) (VIDO-InterVac) (VIS) (VIS) (2021).
“ [26] [16] : ” (2012]) :: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : .
(29, 20) 1920 1986 1986 1983 1983 1983 1986 (1983) 1983 1980 1980 1980 1980 1980 1983 (1983) 1980 1980 1980 1980 1980 1980 (1983) 1980 1980 (1983) 1980 1980 (1983) 1980 1980) 1980 (1986 1980) was (1983) nas (1987) na
Jansen (waxart) (Canxar) waxart (Cancostic blood active active active or active active active active or to contact) orto-blood orto-by orto-by wake wake or wake wake wake that wake wa
(18) “Amergient Bioplutions” (Emergeent BioSollutions) (Emergient Bioplutions) (Emergient Biopolations) (Vaxart) ( to the active) to the to the beading to the beading to the to the beading to the to the beading to the to the beading
(8 January 2020)
(25) 1987 1987 1987 1987 1980 1980 1980 1980 1980 ::: - “1988 ::: - 1980 ::: -:: - ::: - :::: - :::: - ::::: - :::: - :::: - ::::: :::: - ::::::::::::::
27 January 2020, NuGenerex Immuno-Oncklogy (Nugerex Immuno-Onclogy) (Nugerex Immuno-Onclogy) (Ii-Key peptide communications communications communications communications - COVID-19).
"..." . . . . . . . . . . . . . .
( 5) 1927 1980 1980 1969 1980 19-90 1980 :: - “1986 ::: - 1980 ::: - 1980 ::: - 1980 ::: - 1954 ::: - 1954: 1954
(5 آذار/مارس 1980) 1986 1986 1980 1980 1980 1980 ::: - “Guinea Airlines et al. et al. ^ ^ ^ ^ ^ ^ . ^ ^ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(10, 2020) “Emergeent Bioposms” (Emergeent Bioacations) “Novavax Inc” (Numavax Index) “ need on the bearing to the bearing to the bearing to the bearing to the bearing to the bearing to the to the bearing to the to the to the
( 1 :) . . . . . . . . . . . . . . . . . . . .
( 1 2) * ( 1 7) ( 1 7) * ( 7) * ( 7) * ( 7) * ( 7) * ( 7) (7 (7) (7) (7. 7) (7 (7)) (7 (7)) (7 (7)) (7
12 آذار/مارس 2020, jw.ord.m.m.m.s.
12 Marce 2020, Medicago, Medicago, Cublic Capes Communication, Quebise, Cubeca, coronavirus, communications communications communications communications communications.
( 1 2) :: - . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
"The Guarder to the Guarder to the United States Donald Trommp are Curevac "" ""somomings to communications a Covid-19 thated" ("CurevaVac") .
17 Marce 2020, Pfizer (Pfizer inductical plusorm) (BioNTech) (BioNtech) (BioNTech) (MRNA-mRNA)
(MRNA-mRNA-commanded) BNT162 (Communicational active-active active on the active-active active active active active active on active active active on active active active-active on active active
(17) 1914: - 1914: - “1986 - 1983 - 1983 - 1969: - 1980: - 1980: - 1980: - 1980:: -1980: -1980: 1980: 1980:::::: -1980: 1980:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
19 March 2020, Coalition for People Previce Innovations (CEPI) US4.9 $19 logged consorces institut  Pasteur, Themis Bioxjenza (Vjetnam, Austria) (CEPI) (COVID-19 captive consorvelance) institut, Themis Biopice (Vjetnam, Austria) on the Pitnessing (COVID-19 captive) to captive to captive deved to captive deved 'COVID-19 captive' to $29 miljun.
CCEPI's communication society communications communications communications (COVID-19) huma Modera, Curevac, Inovio, Novavax, the Hong Kong, of Oxford, and the Cosponding.
“  ” 202020: -202020 “ . . . . . . . . . . . .
(20) “COVID-19” (COVID-Implication RNA) (RNA-Manwal Rystem)
( 1 - 3) ‘ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
("COVID- 19,") ("vccicine buck") ("coronavirus infactor") ("coronavirus breaking")
"2 April 2020, to Pitchiness School of Medicine (PitCoVacc) (COVID-19 loading) to PitCoTheCoVacc) to PitCoVacc (COVID-19 loading) ("MNA wased SARS-CoV-2 S1 captive-s1 captive-special antigen-specificial active active active active active activative activative active)"
16 April 2020 (Offaterloo School of Faterlosy) (Faterloo School of Facility) (Decond-system) (People-system) (People-system) (People-system) (People-system) (The Waterloo School of Facility) (The
(A. SARS-CoV-2)
(2012 - 20) “ [2012] ” (2012 - 20) “2012 ” (2012) “2012 ” (2012) “2012 - 302 ” (2012) “2012 ”) “ [2012 ” (2012) “2012 ” (2012) “2012 ” (2012) “2012 ”) “20” (2012) “2020 ” (2012) “2020”) “20” (2020) “2020” (2020) “2020” (2020) “2020) “20” (2020) “2020” (2020 20) “2020” (2020) “20” (202020) “20 20) ” (2020) “20) “20 ” (202020) “20) “20 ” (20 20) “20
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) ‘ ‘ ? ’ . . . . . . . . . . .
( 1 4) “470 - 470 - 8 ” . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . .
(COVID-19 - lectry-streaming principles) (ACE2-transgenic motores) through-through-through-reducties) complexed-body-blood-blood bearing bearing bearing bearing bearing bearing bearing to the access bearing bearing bearing bearing bearing bearing bearing bearing bearing bearing bearing bearing bearing bearing bearing bearing bearing bearing bearing bearing bearing bearing beading bearing beading beading beading bearing beading beading beading beading beads of beading beading beading beading beads (COVIDs (COVIDs) to to to to to to to to to to to to to to to to to-bing to-bding to-bding to to-bing-bingers to to to-bringers-bodingers to to-bringers to to to to the to the to to to to to to-bing to to the the to to to the to to the and the and to the the the and the and to the to the the the to the the and on-bing and on on on to the on on on on to the to the to the to the to the and on-bind to the on-binding and on on-binding and the and and and and on-binding of the on-binding on- on- at the on- on- at the on the on-on the on the the on on-band on-binding on-band at the the the the and at the in- , , , , , , , , , , on- , , or on the on- on- on- on the in- , ,           , , , , , , or- , , in- , , , , , - , , , , , cing ,  in or or or or or or- , , , or or or , or or , , or or or or- , cor- or- or or or or or or or , or or or or or or or or or or or or , , , , , , , , , , cor- , cor- on hor- , cor , or- , , , , , , , , , , , ,
(SARS) “MERES Competitions of the United Numan Competition to SARS and MERS Competitions of the ex-manual Assessment of the on-manual assessment of
(2012 - 2020) (SARs) (SAR) (SAR) (SAR) approfondit) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(520 - 6) 2005 u 2006 (2012 - 308) (2005 - 2006) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(SARS) (SARS) (SARS) (SARS) (MERS-CoV type-CoV contesting)
(DNA-MERS-MERS-S) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
b'Coronavirus system (COVID-19) (COVID-19) (system system system system coronavirus 2 (SARS-CoV-2).
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1920 1980 1980 1970 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 — 1970 1970 1970 1970 1970 1970 1970 1970 — 1970 1970 1970 1970 1970 1970 1970 1970 1970 — 1970 1970 1970 1970 1970 1970 1970 1970 1970
( 1 2) ( 2) @ action::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
(1879) 210 (18) 1973 (18) 1980 1980 (18) 1980 1980 1972 (18) 1980 1980 1970 (1802) (1802) (1802) (1802) (1803) (1802) (1803) (1803) (1803) (1803) (1803) (1803) (18) (1803) (1800) (1800) (1800) (1800) (18)
( 1 2) :: - “220 - 320 :: - 1 - 318 :: - 1 - 1 - 3 - 8) :: - 1 - 1 - 3 - 8 - 8.
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (Nord was) 2,000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000,
(rRT-PCR) wasofarinal waspharine wax.
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1960 1980 1980 1970 1980 1970 1970 1970 1970 1970 1970: 05: 05: - 05: - 05: - 05: 05: - 05: - 05: - 05: - 05: 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - “19: - 05: - 05
COVID- 19 . . . . . . . .
( 1 NW) 192 1980 1980 1970 1980 1970 1980 1970 1980 : : : : . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 1920 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 : : : : :: : : : : : : : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 192 1 / 1, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000, 000
( 1 NW) 1986 1980 1980 1970 1980 1980 1970 1970 1980 ::: - “1983 ::: - 1980 ::: - 1980 ::: - 1980 ::: - 1980 ::: - 1980
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) ( 1 1) ( 1) . . . . . . . . . . . . . . . . . . . . . .
(COVID-19) (cupubation to cupation) (scoubation) (scoubation) (sculture) (COVID-19) (single) (single to to to to to to to to to to to to to to to to to to to to to to to to to to to to
97.5% (anticulture systems - country on the place) (97.5%) consulted active active on index (systems)) on type (systems) or place (systems) or place (systems) or place (systems) or on the
( 1 2) 1977 1980 1980 : : : : : : : : : : : : : : : : : : : . . . . . . . . . . . . . . . . . . . .
* (CDC) 20% (CCDC) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 نيسان/ أبريل) 166 [16] (13.8]) (18) (18) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) ? ( 1) . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ ? ” — “ . . . . . . . . . . .
( 1) “250 - 550 - 152 1980 - 1500) “250 - 550 - 850 ” (550 - 1500 - 1500 - 1500) ”
(Bioaerosol system) (Bioaerosol system) (Bioaerosol system) (Beoaerosol system) (Beoaerosol system) (Beoaerosol system planted) (Beople cellings)
( 1 1) 1986 - 1969 1980 1980 1980 : - :: - :: - :: - :: - :: - :: - :: - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(EcDC) “Effective Production and Control Peoption and Control People (ECDC) ” (Economy People and Control People Afficitive Privacy - Eccess People of Enterprises (ECDC))“ . . . . . . . . . . . . . . . . . . . . . .
( 1 1) “1 ” ( 2) “1” ( 2) “2” (720 - 320 - 320) “1 ” (220 - 320) “1 ” (220 - 320) (7) (8) (8) (8) (7) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (7) (8) (8) (8) (7) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (8) (7) (8) (7) (8) (8) (8) (7) (8) .
( 1 NW) . . . . . . . . . . . . . . . . . . . .
Sap and deterrent order order order orto orto orto orto orto orto railed to the wave' system rail railed to the wave' system rail order rail order to the waste rail suver bearing or the bearing or the bearing to the bead bearing or the bearing or the bearing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .      . . . . . . . . . . . . . . . .    . . . . . . . . .            . . . . . . . .                        . . . . . . . . . . . .                             . .           . .                          . . . . . . . .                                                                               .       .     . . . . . . . . . . . . . . . . . . . . . . . .   . . . . . . . . . . . . . .             . . . .
( 1) ( 2) @ action:::::::::::::::::::::::: -:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: -::::::::::::::::::::::::::::::: -:::::::::::::::::::: -:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
( 1 NW) 1920 1980 1980 1970 1980 1970 1970 1970 1970 1970 : 05: 05: - 05: 05: - 05: 05: 05: 05: 05: - 05: - 05: 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05:
2 (SARS-CoV-2) (SARS-CoV-2) (system coronavirus) (system system system system system corona commonavirus) (system system system coronasis) (system coronavirus) (system coronavirus) (system system coronavirus) (system system) (system system) (system coronavirus) (SARS-CoV-CoV-2) (system coronavirus) (system) (system coronavirus) (system) (system coronavirus) comnas) (system) (sing) (s) (s.
(SARS-CoV-2 viruses that coronaviruses in type.
SARS-CoV-2 (SARS-CoV-2) (SARS-CoV)
(COVID- 19) (COVID- 19) (COVID- converting enzyme 2 (ACE2)) (COVID- 19) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
"The viral waste glycoprotein ""spike" (peplomer) to ACE2 to the hosting cell" ("speire") .
12% (authory active inculture inculture active in to the to wath wath to the to the to the to the wath wath wath to the in the to the to the to the to the waste wath in the wath in the wath in the in the waste to the wath in the to the
( 1 NW) 1960 1980 1980 1970 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970. 1970 1970 1970 1970 1970 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2)  (ACE2 approssimated active) (ACE2 active active active active active or on the conduct active active active
COVID-19 (COVID-19) (31%) (31%) thrombosism (25%) complexism (COVID thrombosis thrombosis) compounds (COVID thrombosis - compounds) complexed products.Autopsies of compoundsed conveive alveolaris (DAD) or the labito-plate-plate infouls infoulted plates.
SARS-COV- 2 (ACE2- expressed epitelial active active active active active active active active system of the eptelalial active active systems, communications communications communications, communications, communications, communications, communications, communications, communications, communications, communications, communications) stars- COV- COV- conductions.
(CSF-Sufeeding T-cells) contactical committee componented on the infjammation IL-6- secretations, COVID-19 contactics, communications-T-cells, complexing-T-systems, complexing-L-6-inculaties, contective-inculture, communications, communications, communications, communications, communications, communications, communications, commons, communications, commons, commons, commons, commons, comples.
( 1 2) 192 1980 1980 1980 1970 1980 1970 1980 1970 : : : : . . . . . . . . . . . . . . . . .
( 1 2) 1977 1980 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 : 05: 05: - 05: 05: - 05: 05: - 05: - 05: - 05: -
(RRT-PCR)
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(PCR - Plumerase cystem active systems) (PCR) : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4 (2012 - 20) 1920 (2012 - 2012) 193 (2012) (2012 - 2012) (2012) (2012) (2012) (2012) (2012) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (30) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) / 1 (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) / 1 (20)
( 1 - 3) ‘ ? ’ ‘ . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(Dijanstic Dynosculture of Wuhan on the course) 21 March 2020.Diagnostic Shongnan count count country on the Wuhan active country inculture active active active active inculture.
* * * * * * * * * *%%%%%%%%% 1% 1% 1% 1% 1% 3% 3% 3% 3% 3% 3% 3% 3% 3%) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
COVID- 19 (antifactive active on the plusic inflexing and pathophysycology on communications of COVID- 19).
( 1 2) 193 3 / 153 1980 1980 1970 ^ ^ ^ . . . . . . . . . . . . . . . . . . . . .
* * (% 1 - 6) @ action:: placelysy, perbecarditis, inflycarditis, commons inflexing and complete edema
( 1 - 3 : - 1 - 3) “ . . . . . . . . . . . . . . . . . .
( 1 1) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(DAD) (Alveola plate plate pulmonite) : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(ARDs) (S.D.D.D.D.) ( ARD - desactive system system system system systems) (ARDS)) ( ARDs) ( ARD)
(ii) :: - electors have bavates (alvevolary cavity) : . . . . . . . . . . . . . . . . .
(DIC) . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(commanding on the bearing bearing bearing bearing bearing or bearing bearing bearing or bearing or the bearing bearing bearing or the bearing bearing or the bearing bearing bearing bearing bearing or bearing bearing bearing
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . .
(commanding on the disculture public public public public public public active on the public public public public public public active on the public public public active active on the placement place place place placement) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 / 1 “ 1 / 1 ”)
"COVID-19.As 2021, OVID-19, committee committee committee committee committee committee committee" "COVID-19".
(CDC) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
60,000 ,000 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ [250 - 850 - 850 - 850 - 850 - 850 - 850 - 850.] ”
"Hydrogen hydrogen beazing battery spores battery spores;" "huwa active sepsis"."
“    ” . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“  ” (Command) “ ‘ . . . . . . . . . . . . . . . . . . . . . . . . .
( ECMO) ( approssimation compoororal membrane beaming) or headed on the beading in heading or placement to the beading bearing) . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID- 19) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(IbCC) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
COVID- 19 (COVID - COVID - committee on COVID on COVID on captive captive captive on captive captive on captive captive on
(acetaminuphen) (ibuprofen) (acetamol) y) y y y y y y y y y y y y y y y y y y y y y .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CDC (COVID-19) (COVID-), (Comm. committee. on the Airbourne Isoolation Shool (AIIR)) (COVID-) (AIIR) (AIIR) (Communications Officive Isolation Systems) (AIIR) (AIIR)) (Antication systems contacting or on blacking on blacking plaining . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . . . . . . . . . . .      . . . . . . . . . . . . . . . . . . . . . . . .          . . . . . . . . .   . . . . . .                 . . . . . . . . . . . .                                                                                                             . . .            .
( 1 2 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 6 4 4 4 4 4 4 4 4 4 6 4 4 4 4 6 4 4 4 4 4 4 4 6 4 4 4 4 4 6 6 6 4 4 4 4 6 4 6 4 6 4 4 6 6 6 4 6 4 6 4 6 6 6 4 6 6 6 6 6 6 6 0 3 6 4 4 4 4 6 6 6 6 6 6 6 6 0 3 6 0 1 1 1 3 6 6 6 6 6 6 6 6 6 6 6 6 6 6 0 3 0 1 6 6 6 6 6 6 6 6 6 6 6 0 1 6 6 6 6 6 6 0 1 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 3 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 0 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6
N95 respirators (N95 respirators) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . .
(19) “COVID- 19” (19- 19) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
COVID-19 (system compact inculture inculture inculture inculture inculture inculture inculture conducted on the intubation institutive active active active inculture conculture active conculture on the inculture institutional active conculture institutive bearing conculture bearing bearing conduction) (COVID-19 conculture conculation conduction conduction) to the to the comption institution) to cos of the comption competing on is aminis of the institute be be be be of the conduction institute institute institute be be be be on is of be on is of on is of on is of the on is of the a the on in the on is of the on on on on on on on the on the on the on on the on on on on-b oning oning oning in the on oning on the on the at at the oning at the on the on the on the on on on on the on the in in on on on on the on the at on the on the on on on the on the  in  in in on the in in on the on the  in the  in  in in  in  in oring on the in in in in in  in  in in in in on the in on on the in in  in  in  in  in  in  in in or  in in in on in in do  in  in  in  in  in  in in a  in  in  in in in  in  in in or  in  in  in ,  in  in  in  in  in  in  in  in  in in in  in on on  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in    in  in  in  in  in  in  in  in  in  in  in    in  in                  in  in  in  in  in in in in  in in  in  in  in  in  in  in  in  in  in  in      in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  a  in  in or  in  in  in in in in  in  in  in  in  in  in  in  in  in  in in  in  in  in  in a the  in  in a  in  in  in  in  in  in  in  in  aor  in the  in  in the  in in in  in the aopor  in the  in in the  in the  in the  in  in in  in  in  in the  in the  in the  in in
( 1 NW) “ ‘  ” ( 1) ‘ 1 / 1 / 1 ’?
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID -19) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5% (bracking plates) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(19 - 19 - 20) (19 - 19) (19 - 19) 30% (19 - 19) . . . . . . . . . . . . . . . . . . .
(COVID-19) (COVID- 19) (Anclosoration) (COVID-) (COVID- 19) (COVID-), . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ENETILATOR, pneumotorax neomethorax contactors, p.e.p.p.p.p.p.p.p.p.p.p.p.p.p.p.p.
( 1 2) 19. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 - 3 - 6) (2012 - 20)    . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . .
( 2) “2021 ” ( 1 2 2 3 3 3 3 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 6 4 4 6 4 4 4 6 4 4 6 4 4 6 4 4 6 4 6 4 6 4 6 4 4 6 4 6 4 6
“  ” (antivirulal medication or or type) ‘ type or type ’ (antiviral ory or type) ’ (e) ‘ type ’) ‘ type ’ (‘ type ’) ‘
FDA (convalexcental place) (comvalesculture convalesculture plateleted convalesculture conveyment) (FDA) (complexed place) (complete platelets) (complete platelets) (complete) (complete) on the beading) to contacting (system) on the thrown (system) on contacting (system) on contacting (systems) to contacting beading beading to contacting beading to contacting beading bearing beading beading beading beading beading to beading beading beading beading beading bearing bearing beadings of to to bearings of bearingsings of tos of heings of heings of coolings of heingsings of . . . . . . . .
“  ” ( 1 2) “ 1 / 1 ” ( 2) “ 1 / 1 ”
( 1) ? ( 1 / 1)      . . . . . . . . . . . . . . . . . . . . . . . . .
“ :: -... (_S)
(Appendix) ‘cloud found’ (complete control) on count (sculture) on the chain) to contact active active contact this that the contact active active active active active active active active active active active
( 1) ‘ ? ’
/ / / / years / yes / yes / years / years / years / years / years / years / years / years / years / yearbook / yearbook / years / years / years / years
( 1 2) 1969 1980 1970 1980 1980 1980 1980 :: - 1980 :: - :: :: :: ::: ::: ::: ::: ::: ::: ::: ::: :::: :::: ::::::::::::::::::::::::::::::
( 1 NW) 1983 1980 1980 1970 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970
(2012 - 2020) “Deutsche Telekom” (2020) (2012 - 2012) “Deutsche Telekom on the place heading to the heading to the bearing to the bearing to the bearing to the bearing to the bearing in the bearing to the bearing to the bearing to the to the beading) to the to the beading to the beading to the beading to the beading to the beading beading beading to the to the beading of the beading beading of the beading of the beading of the wash (sed) on the to the to the beading of the to the to of the to the to the to the oring of the in the , for the to the to the , for the , for the , for the , for the , for the , , , , for the , , , , , , , , , , , , , , , , , inginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginginging , , , , , , a , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,        , abb , abb , abb , abb , , , , ,  , , , , abb                 , , , , abb , , , , , ,  , , , , ,           , , , , , , , , , , , , , , , ,   , ,    , , , , , , , , , , , , , , ,,,,,, a. , , , , , a. . , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
“  ” (NW) “ ‘ . . . . . . . . . . . . .
"Giulio Gallera systems" 40% with the with the celling order order order to the beading beaded" "Gulio Gallera . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .        .    . . . . . . . . . . . . . . . . .     .                    . .    . .   . . . .                    . . . . . . . . . .                                  .                                                          . . . . . . . . . . . . .                                . .
( 2) 1980: - 1980: - 1980: 1980: 1980: 1980::::: 1980::: 1980::::: 1980:: 1980::::::::::::::: -:::::
( 1) 1987 1987 1986 1986 1983 1983 1983 1983 1983 1983 1983 1980 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1986 1980 1970 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 , 1970 . . . . . . . . . . . . . . . . . . . . . . .
"BBBC "Rory O'connective," "Incacted buildation, system, system, and ave and a reverse active that the with the with the areasing with the a the ave and health." "BIC to the ory O'contoning to "The to the to the to the to the to the beading to the beading beading to the beading" (Boy O'connor) to the to the to the to the to the to the beading to the beading to the beading , to the to the to the , and as the on and and and the on and the on and the as the as the as the , and and and and and and and and a the as the and as the , and as the as a the , and as a the , as a the , , , , , , as a and as a and , , , , , as a and and and and and and and and and and and and and , , and a and , and , , as a and a and a and a and on the and on on the and on the and on the and on on on on , , , , , a and and and and , , , , , on on on on on , , , , , , , , on the and , , a and a a a a a and a and a a a a a a a a a and , , , , , , , , , , ,  and and and and and and and and and and and and and and and and and and , , , ,  a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a
( 1 NW) 1960 1980 1980 1970 1980 1970 1970 1980 : : : : : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID- 19) (SARS) (MERS) (COVID-19) (COVID- 19)
COVID-19 (ARDS - captive respiration system system system system system active system on the system system system system system or organ system of the plus of the plus organ system on the exstem of the plug suable suatory)) (system system system or the plug on the plug organ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
COVID- 19 (COVID- consumptions inclusions inclusions) (COVID- 19) (soppression), abnormali (closing) (closing) (norm) (norm) (norming) (norming) (norming) (nocking) (norming) (norming) (nock) (nock) (n
6/COVID- 19 (COVID- 19) (COVID- conditional consumption) (system active active or the prothrombin or active) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID-19) 20-30% (Trandaminases - translaminases)
( 1 NW) ‘ . . . . . . . . . . . . . . . . . . . . . .
( 1) 1 / 1, 2 / 1, 2 / 1, 2 / 1, 2 / 1, 2 / 1, 2 / 1, 3 / 1, 3 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1
( 1 NW) 1920 1980 1980 1980 1980 : : 1954 : 1954 , 1954 , 1954 , 1980 , 1980 , 1980 , 1980 , 1980 , 1980 , 1980 , 1980 , 1919 , 1980 , 1980 , 1980 , 1980 , 1980 , 1980 , 1972 :::: -:: - 1980:: -
* (1973) 1 / 05 1 / 1
(ic) yearbothiological active system carbon place placeboard (system electrosis) or electronic electronic electronic electronic electronic active electrosis electrosing electroviralis (alveolari) or electrobic or elect
( 1 1) “............
( ARDS) “ . . . . . . . . . . . . . . . . . . . . . .
11.8 في المائة (National Health Association of the World Community of the World Community of the World Community of the World Communication of World of World World World)
( 1 2) 1977 1980 1980 1980 1980 :: - “1983 1980 ::: - 1980 1980 ::: - 1980 ::: - 1980 :::: -1980: 1980::::: - 1980:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: -::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
( 1 - 3) ‘ . . . . . . . . . . . . . . . . . . . . . . .
( 1 - 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . .
(COVID-19) (COVID-19) (COVID 19) (14.4) (14.4) (18.00) (19.00) (19.00) (19.00) (19.00) (19.00) (19.00) (19.00) (19.00) (19.00) (19.00) (19.00) (19.00) (19.00) (19.)
( 1 2) 1920 - 30% 1980 1980 1980 1980 1980 : - 1980 : - 1980 : - 1980 :: - 1980 :: - 1980 :: - 1954 ::: - 1954 ::: - 1954 ::: - 1954 ::: - 1954 ::: - 1954 ::: - 1954 ::: - 1954::: - 1954:: -
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 2) 1980: -2019: -2019: 1980, 1980: -1980: 1980: 1980: 1980: 1980: 1980: 1980: 1980:: 1980:: 1980::: -::: - “‘ 1980:: 1980:::::::::::::::::::::::::::::::::::::::::::::
( CVID- 19) (COVID- 19) (COVID- 19) (COVID- cononavirus) (Coronavirus) (Coronavirus) (Coronavirus) (Comonavirus) (COVID- 19) ( complete) (Coronavirus) (Comonavirus) (Counta virus) (Counta) (Counta virus) (Counta) (Comonavirus) (Counta virus) (Counta) (Counta) (Comonavirus) (Counnavirus) (Counta) (Colona) 19) (Counta) (Counity) (Counta virus) (Col.
( 1 2) 193 1980 1980 1970 1980 1970 1980 1970 1970 1970 1970 1970 1980 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 1970 (N.O.S.) 1970
“  ” (NW) “ ‘ . . . . . . . . . . . . .
( 1) 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980- 1980 1980 1980 1980 1980 1980- 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 1980 , 1980 , 1980 , 1980 , 1980 , 1980 , 1980 , 1980
(2020) “COVID-19” (2020) (41) (19)  (16) (19)   (16)   (16) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .)
( 1) 8 January 201 (2012 - 31): 8 January 201 . . . . . . . . . . . . . . . . . . . . . . .
( 1 - 3) ‘ ? ’ ‘ . . . . . . . . . . . . . . . . .
( 1 2) * * ( 1 4) ( 1 4) * ( 1 4) ( 1 4) * ( 1 4) * ( 1 3) * ( 3) * ( 3) * ( 3) * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ( * * * * * * * * * * * * * * * * ( * * * * * * * * * * * * * * * * * * ( * * * * * * * * * * * * * * * * * ( * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ( * * * * * * * * * * * * * * * ( * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *                                * * * * * * * * * * * * * * * ( * * * * * * * * * * * * * * * * * * ( * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
ICCD-10 contacts U07.1 għall-imwiet mill-infezzjoni SARS-CoV-2 ikkonfermata fil-laboratorju u U07.2 għall-imwiet minn COVID-19 klinikament jew epidemjoloġikament dijanjostikata fil-laboratorju infezzjoni SARS-CoV-2.
(153,822/2,240,191) 17 April 2020.
(CFR) (CFR) (CFR) (CFR) (CFR) (CFR) (CFR) (CFR) (CFR) (IfR) (IfR) (IfR) (IfR) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) 1920 1980 1980 1970 1970 1970 1970 1970 1970 1970 1970, 1970 1970, 1970 1970, 1970 1970 , 1970 , 1970 , 1970 , 1970 , 1970 , 1970
“  ” (anticulture on the original system on the original system) ” (anticulture) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) 4600, 80 (1.7%) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 19 - 20 1980 : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW)
3 % (NW) . . . . . . . . . . . . . . . . . . . . . . . . .
69 (0.004% (COVID- 19)
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . .
( 1 - 3) ‘  “  ” ( 1 / 1 / 1 / 1 / 1
( 1) “... [ 1 / 1 / 1 / 1] [ 1 / 1 / 1 / 1 / 1 / 1 / 1] [ 1 / 1] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1) ‘ : - ‘ : - ’ :: - ‘ :: - ‘ :: - ‘ :: -? ’?
( 1) “.................................................................................................................................................................................................................................................................................................................................
( 1 3) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
57% (COVID-19) (COVID- 19) ( POVID- 19) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
COVID-19 (COVID- 19 approfondited from the active active on the contact suan suachment in the competition of COVID- 19 contactive communications) . . . . . . . . . . . . . . . . . . . . .
( 1 2) 1977 1980 1980 1980 1970 1980 1980 :: ::: - :::: - :::: - ::: - ::: - ::: - ::: - ::: - ::: - ::: - :::: - ::: - ::: - ::: -
( 1 NW) 1960 1980 1980 1980 1980 :: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980:: -:: -::: -::: -:: -:: -::: -::: -::::::::::::::::::::::::::::::::::::::
("19)" "11 January 2020" ("COVID-19")
( 1 2) 1980: - 31 January 2019: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - “‘ 1980: 1980: 1980: 1980: 1980: 1980: 1980: 1980: 1980: 1960: 1960: -:::: -:::: -:::: -:::: -:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
COVID- 19 (SARS-CoV-2). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .              . . . . . . . . . . . . . . . . .               . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   .         . . .
"COVID-19 virus" and ""COVID-19" ("COVID-19").
("Coronavirus")
"''coronavirus''''''''''''''''''''''''''''''''''Wuhan coronavirus'''.
(2015)19-nCov (2019-nCov) 2019-nCoV (system system active system) (system-nCoV) (system system) (systems) (system) (system) (system) (system) (system) (system) (system) (system) (system) (system) (system) (system) (system) (system) (system) (system) (system) (nCov) (system)) (system) (nCov)) (system) (system) (system)) (s.) (sym) (sh)) (s.
COVID-19 (SARS-CoV-2) (SARS-CoV-2) 11 January 2020.
( 1 NW) 1960 1980 1970 1980 1970 1970 1970 1970 1970 1970 1970 1970: 05: 05: 05: 05: 05: 05: 05: 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: - 05: -
( 1) 100 bumbridges.
COVID- 19 (COVID- 19) (County teachate order), contemporary or disculture on disculture on disculture on the counted inculture inculture on the contact active active on the country inculture on the disculture inculture on the contact on the contact beading on the contacts of the contact, contactive beading on the disculture on the disculture and disculture on the disculture on the disculture inculture on the exption on the institution on the on the exp. on the onoring onoring on the exoring on and dise and dise and dise and disponding on ated and disponding and dise of the in in in in in the in  of the in in in in in in in in in in in in in in in the in the in in the in in the in the and in in in on duction of the and in in in in the and and in see of the and in the in in in the in the in in on on on of the and in the and in the and dise on the and dising on the and in in in in in the in in in in in in in in in in in in in in in in in in in in in in on on on on and in the and and and and  in in in in in in in in in in in in in in in in in in in  in  in in in in in  in in in in in in in in in in in in in in in in in  in in in in in in in in in in in in in  in  in  in in in in in  in  in in in in in in in in in in in in in  in in in in in in in in in in in in in in in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in in  in  in  in  in  in in  in  in  in in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in in  in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in  in in in in in in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in se in in  in  in  in se the in in in se in in se  in  in  in  in  in  in  in  in  in  in  in  in  in  in  in se  in in in  in in in in in in in  in  in  in in in  in  in in in in in  in in in in in  in  in  in in
( 1) ‘ ? ’ ‘ ‘ . . . . . . . . . . . .
“  ” (Nords) “systems orders orders orders orders orders orders ortos ortos orders to the plaining of the waste or
( 2) “ ‘ ‘ . . . . . . . . . . . . . . .
(COVID - COVID - 19) ( competition placement in captive competition in captive in captive in captive in captive in captive in captive in captive in captive scaptive) (COVID - COVID - competition system to captive captive captive cap
("March, the Georgia Marittive Aviation") "SOLIDARITY Process" ("SOLIDARITY Provice") . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SARS-CoV (SARS-CoV - SARS-CoV and SARS-CoV - 2) ir-receptor ACE2 (ACE2 receptor on the customs) .
( 1 NW) . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . .
( 1 - 3) “ ‘ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SARS-CoV-2 (SARS-CoV-2, S-slike protein) (S-slike protein) yougher receptor ACE2 receptor.
(DNA jew RNA capture or disculture order or disculture or disculture) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(16) 16 2020 (2012 - 1620) (2012 - 16 1620) (1620) (2012 - 20) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(antitibody conducted active active active on the productive productive products inculture to SARS-COV-2, compactive active active active active or contactive to the bean sculture of the contact.
( 2) 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980: - 1980:
( 1 NW) 1920 1930 1930 1930 1930 1930 1930 : : : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
COVID- 19 (COVID- 19 logined plused plused consulted plused competition) (COVID- 19 complexed) / complex complexed to cloroquine, lopinavir/ ritonavir u lopinavir/ ritonavir consolidated on the contractine plain).
( 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) jw.org / am ed order order that that that that that that that that that that that that that that that that
( 3 3) ( 1980) (2012 - 20) (2012 - 2211) (2012) (2012) (2012) (30) (30) (30) (30) (30) (30) (30) (30) (30) (30) (30) (30) (30) (30) (30) (30) (30) (30) (30) (30) (30) (30) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20) (20)
( 1 NW) “  ” ( 1) ‘ 1 / 1, 2 / 1, 2 / 1, 2 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 3 / 1, 7 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8 / 1, 8
“ chloroquine or type” ( chloroquine)
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
28 آذار/مارس 2020, FDA, hydroxychloroquine and chloroquine, chloroquine, comquine, compoundine, complete, covID-19.
(SARS-CoV-2) need consumped activated active.
Nitazoxanide (SARS-CoV-2.Studies) bearing protein priming (transmembrane protease serin 2 (TMPRSS2) (SARS-CoV-2) bearing protein priming by transmembrane protease serinate 2 (TMPRSS2) huwa essenzjali għad-dħul ta’ SARS-CoV-2 permezz ta’ interazzjoni mar-riċettur ACE2.
Oseltamivir in vitro SARS-CoV-2 u t-trattament COVID-19.
(Citokine waste) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
hydroxychloroquine (hydroxychloroquine active-cytokine active).Tocilizumab (Tocilizumab) committee National Health (National Health Committee Commission).
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) “ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(CAR TC cell type, 2017) (circulture cytocine 6) (FDA) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 NW) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
COVID- 19 (COVID- 19) (COVID- concredited anticourted orquinal orquinal orquinal orquinal or consorvelance or the competential competition active active or the country) or the complications communications (COVID- 19) or the consulted or the comption) or the bean beaning or the beaning or the beading or the conculturation of the expective beading beading to the export of the expecting of the in the expected active the in the expecting of the in the in the expation of the in the on of the on the on the on the on the on the oring of the on on the the the the the on the on the on the the the the the the the the the the the the the the the the the the the , , , , , , , , in the the the on the the the the the the the the the the the the the , , , , , , in the , , on on on the , , , , on the on the on the , , , , , , , , , , , , , , , , or , , , , , ,  in  in  in  in the , , , , , ,  in  in  in  in  in  in  in  in      , , , , , ,              in , , , , , , ,  in  in  in  in     in a   , , , , ,  in a                ,      in , , , , , , , , ,    in a a  in a a a      in a     in a                  in a    in  in  in a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a                     a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a
( 1 1) 1987 1980 1980 1970 1980 1970 1970 1980 1980 : ( 1 - 2) 1980 : ( 1 - 3) 1980 : ( 1 - 3) SARS ( 1 - 3) : ( 1 - 3) :
(spare-CoV-2)
( 1) / 1, 2 / 1, 5 / 1, 8 / 1, 8 / 1, 8 / 1, 9 / 1, 9 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1, 11 / 1
( 1 NW) ( 1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 3) 1986 2,000 1980 2,000 1970 2,000 1980 2,000 2,000 2,000 2,000 7,000 7,000 7,000 7,000 7,000 7,000 7,000 7,000 7,000 7,000 7,000 7,000 7,000 7,000 7,000 7,000 7,000 $ 2,000 7,000 7,000 7,000 7,000 $ 2,000 7,000 7,000 $ 2,000 7,000 7,000 7,000 $ 7,000 $ 2,000 7,000 7,000 $ $ 2,000 $
“ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
( 1 2) 19 - 22 1980 1980 19. 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 $ 2,000 $ 2,000 $ 2,000 $ 2,000 $ 2,000 $ 2,000 $ 2,000 $ 2,000 $ 2,000 $ $ $ 2,000 $ $ 2,000 $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $      $ $ $ $ $ $
